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ABSTRACT 
 
I.  Synthesis, Reactivity Structure and Application of Spiroepoxy-β-lactones:  Studies 
Toward (-)-Maculalactone A  II.  Metal Mediated Couplings of Dichloroolefins 
Applicable to the Haterumalides.  (December 2007) 
Richard Jeffrey Duffy, B. S.; B. S., University of Oklahoma 
Chair of Advisory Committee: Dr. Daniel Romo 
 
Marine natural products have continued to be a source of compounds with 
interesting structures and biological activities.  Two such compounds are maculalactone 
A and haterumalide NA.  In the process of exploring a route to the synthesis of 
haterumalide NA, the novel ring system, spiroepoxy-β-lactones were discovered.  
Spiroepoxy-β-lactones were synthesized by the oxidation of ketene-homo dimers with 
dimethyldioxirane (DMDO). After a synthetic route to this ring system was obtained we 
next explored the varied reactivity of spiroepoxy-β-lactones, and it was apparent that 
they might be applied to the synthesis of maculalactone A. 
Also with the aim of the total synthesis of the haterumalides, a palladium 
catalyzed cross coupling was developed.  This reaction couples a 1,1-dichloroolefin with 
an alkyl zinc reagent.  It was found that this reaction necessitates a heteroatom on the 
zinc reagent in order to proceed. 
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CHAPTER I 
INTRODUCTION:  THE SYNTHESIS OF UNUSUAL STRAINED SPIRO RING 
SYSTEMS AND THEIR EXPLOITS IN SYNTHESIS 
  
 Small ring compounds have continually fascinated chemists due to their unusual 
structures, and the reactions that are made possible due to the inherent ring strain of these 
compounds.  Isolated small strained carbocyclic and heterocyclic rings have been known 
for quite some time, as of late there have been a number of new spiro-heterocycles 
described.  Specifically, the utility of oxa- and dioxa-spiropentanes and spirohexanes has 
been demonstrated for the synthesis of natural and unnatural products.  These ring 
systems investigated have shown varied and interesting reactivity due to the unique 
physical properties of these small rings.  The aim of this review is to provide an overview 
of the synthesis and reactivity of small strained spiro-heterocycles and to illustrate their 
applications in synthesis.  This review will be restricted to spiro-ring systems since other 
strained systems have been reviewed previously.1, 2 
Oxaspiro[2.2]pentanes 
 The first and simplest of these spirocycles, oxaspiro[2.2]pentanes, is also the 
oldest in the group with confirmed syntheses dating back to 1968.3  These spiro systems 
were initially synthesized by the action of peracetic acid on unsaturated cyclopropane 
derivative 1.1 to give oxaspiro[2.2]pentane 1.2 (Scheme 1.1).  This method proved to be 
quite general, as the substrate can be made by olefination of the corresponding carbonyl 
compounds with cyclopropyl phosphonium ylides.  However, this method suffers from  
____________ 
This dissertation follows the style of Journal of the American Chemical Society. 
 2 
only modest selectivity requiring an appropriate directing group (i.e. ether).4  After this 
first synthesis, several other methods were devised for the synthesis of 
oxaspiro[2.2]pentanes.  These methods include addition of lithiated 
bromocyclopropanes,5 and diazocompounds to ketones,6 reaction of singlet oxygen with 
bicyclopropylidene,7, 8 selenone additions to ketones,9 and the addition of cyclopropyl 
sulfur ylides to carbonyl compounds.10, 11  
 
Scheme 1.1. First Synthesis of an Oxaspiro[2.2]pentane. 
CH3COOOH, Na2CO3
CH2Cl2(96%)
O
1.1 1.2
 
 
  By far the most widely used and arguably the most selective synthesis of 
oxaspiro[2.2]pentanes remains to be the addition of cyclopropyl sulfoxonium ylides to 
carbonyl compounds.  This particular method has several advantages over the previously 
developed methods in that the reaction conditions are relatively mild and the addition is 
quite diastereoselective.12  Through a series of elegant studies it was determined that the 
ylide addition proceeds via equatorial attack at the carbonyl carbon, in cyclic compounds.  
While this process is highly diastereoselective, there has yet to be an enantioselective 
process developed.   Johnson reported chiral sulfoximine ylide additions to α,β-
unsaturated carbonyl compounds, however the racemic counterpart performed poorly 
with simple carbonyl compounds such as the reaction of cyclohexanone 1.3 with 
sulfoximine ylide 1.4 to yield oxaspiro[2.2]pentane 1.5 and thus the chiral series was not 
attempted (Scheme 1.2).13 
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Scheme 1.2.  Reaction of Sulfoximines with Cyclohexanone. 
Ph S
O
NMe2
O O
(40%)
1.3 1.4 1.5
 
 
Oxaspiro[2.2]pentanes display two primary modes of reactivity.  One mode, 
leading to a cyclobutanone, appears to be driven by the release of the strain energy of the 
ring system (Scheme 1.3).12  However, this is not entirely satisfactory, as cyclobutanes 
possess essentially the same amount of strain energy as cyclopropanes, 26 kcal/mol and 
28 kcal/mol respectively, due to the eclipsing interactions of the substituents of a 
cyclobutane.14  Alternatively, the ring explansion of a cyclopropane to a cyclobutane 
proceeds when appropriate functionalization is present, such as with 
oxaspiro[2.2]pentanes 1.6.  Ionization of the epoxide, either by addition of a Lewis acid 
or thermally induced, would yield a highly stabilized intermediate cyclopropylcarbinyl 
cation 1.7.  This type of cation is uniquely stabilized due to the pi-character of the σ-
bonds in cyclopropanes, and consequently they undergo a pinacol like rearrangement to 
cyclobutanone 1.8.  This process is favorable due to the release of ring strain of the 
starting epoxide and cyclopropane in addition to the formation of a C=O bond. 
 
Scheme 1.3.  Rearrangement of Oxaspiro[2.2]pentane to Cyclobutanone. 
O O O
1.6 1.7
1.8
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 The second major mode of reactivity of oxaspiro[2.2]pentanes is their base 
induced elimination to form vinyl cyclopropanes.  This particular transformation is driven 
by the relief of ring strain upon opening of the epoxide.  Trost developed conditions 
allowing access to both regioisomeric products 1.10 and 1.11 from spiroepoxide 1.9 
(Scheme 1.4).15, 16  Use of the more hindered base, lithium diisopropylamide, led to 
deprotonation of oxaspiro[2.2]pentane 1.9 at the more accessible Ha (Path A) to yield 
olefine 1.10.  Use of the less sterically demanding lithium amide of pyrrolidine leads to 
deprotonation of less sterically accessible Hb (Path B) which gave the more substituted 
and conjugated olefin 1.11.   
 
Scheme 1.4.  Base Induced Elimination of a Oxaspiro[2.2]pentane to form Vinyl 
Cyclopropanes. 
 
 
 This ring system has proven to be a useful intermediate in a number of syntheses 
of natural and unnatural products.  Since their last review12 oxaspiro[2.2]pentanes have 
continued to be valuable in the synthesis of other complex architectures.  This ring 
system has proved to be valuable for both the synthesis of new ligands, natural and 
unnatural products.   
 The first application of oxaspiro[2.2]pentanes is in the synthesis of carbocyclic 
analogues of the antibiotic/antiviral natural product oxetanocin (Scheme 1.5).17  Hsiao’s 
synthesis hinges on the construction of an optically active cyclobutanone 1.15.  Their 
O
Hb
Ha
N N
Path APath B
HO
Hb
HO
Ha
1.9 1.101.11
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approach to this ring system hinges on building an appropriate oxaspiro[2.2]pentane and 
its subsequent rearrangement to the corresponding cyclobutanone.  The synthesis begins 
with Feist’s acid 1.12 which is resolved utilizing quinine.  After resolution and a series of 
standard manipulations, they are able to obtain methylene cyclopropane 1.13 in good 
overall yield.  The substrate is now setup for the key oxidation/rearrangement sequence.  
This is accomplished by exposing methylene cyclopropane 1.13 to meta-
chloroperbenzoic acid (m-CPBA) and then subsequent rearrangement of the 
oxaspiro[2.2]pentane 1.14 with catalytic lithium iodide to give key cyclobutanone 1.15 in 
excellent yield over the two steps.  By use of a C2 symmetric substrate selectivity issues 
are bypassed in the oxidation step.  Cyclobutanone 1.15 could then be transformed into 
carbocyclic oxetanocin analogue 1.16. 
 
Scheme 1.5. Synthesis of a Carbocylic Oxetanocin Analogue. 
OTBDPS
OTBDPS
m-CPBA
CH2Cl2
OTBDPS
OTBDPS
O
HO2C
HO2C
LiI (cat.)
CH2Cl2(92%,
two steps)
O
TBDPSO
TBDPSO
HO
HO
N
N
N
N
NH2
1.12 1.13 1.14
1.15
1.16
 
 
 In addition to diastereoselective methods, enantioselective epoxidation methods 
have also proven to be effective in yielding optically active oxaspiro[2.2]pentanes in 
some cases.  This was applicable to the synthesis of both enantiomers of the 
sesquiterpene natural product α-cuparenone (Scheme 1.6).18  The synthesis of either 
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enantiomer of α-cuparenone begins with epoxidation of cyclopropene 1.17 under 
Sharpless conditions resulting in an aryl substituted oxaspiro[2.2]pentane 1.18 that 
rearranges to cyclobutanone 1.19 in modest yield and enantiomeric excess.  The primary 
alcohol is then converted to phenylsulfide 1.20 utilizing a two step protocol.  The 
cyclobutanone 1.20 is then desulfurated by the action of Raney nickel in acetone to yield 
methyl-cyclo butanone 1.21 in good yield.  This represents a formal total synthesis of α-
cuparenone (1.22) as this is a common intermediate in a previous synthesis.19  
 
Scheme 1.6  Synthesis of α-Cuparenone. 
OH
(+) or (-) DET, TBHP, Ti(Oi-Pr)4
CH2Cl2, 3A M.S., -50oC(76% yield, 79% ee)
OHO OH
O
i) MsCl, DMAP,
Et3N, CH2Cl2
ii)PhSNa, DMF,
(42%, two steps)
SPh
O
Raney Ni
acetone
(72%)
O O
1.17 1.18 1.19
1.20 1.21 (1.22)
 
 
 Perhaps one of the more complex uses of a oxaspiro[2.2]pentane is an elegant 
model study toward the synthesis of the architecturally intriguing natural products CP-
225,917 and CP-263,114.20, 21  After several steps cyclohexenone can be transformed into 
the advanced furan intermediate 1.23, which then undergoes silyl-deprotection  to alcohol 
1.24 and subsequent oxidation to ketone 1.25 (Scheme 1.7).  Ketone 1.25 provides a 
springboard to cyclobutanone 1.27 through the addition of cyclopropyl sulfonium 
tetrafluoroborate 1.26 and rearrangement to the cyclobutanone 1.27 under acidic 
conditions.  This sequence depicts one of the most complicated substrates utilized in the 
Trost cyclobutanone synthesis. 
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Scheme 1.7. Model Studies Toward the Synthesis of CP-225,917 and CP-263,114. 
O
TBS
HH
RO
OAc
Dess-Martin periodinane
CH2Cl2(85%, two steps)
1.23 R=TBS
1.24 R=HTBAF
O
TBS
HH
O
OAc
SPh2 BF4
KOH, DMSO
ii) then aq. HBF4, Et2O(56%)
i)
O
TBS
HH
OAc
O
1.25
1.26
1.27
 
 
 The diastereoselective synthesis of both the acetogenin natural product 
muricatacin and the pheromone japonilure have also been accomplished by the utilization 
of an oxaspiro[2.2]pentane as one of the intermediates.22  The first key reaction is the 
oxidation of methylene cyclopropane 1.28 to the corresponding oxaspiro[2.2]pentanes 
1.29 and 1.30.  The diastereoselectivity of this reaction proves to only be modest giving a 
70:30 mixture of diastereomers (Scheme 1.8).   
 
Scheme 1.8. Diastereoselective Oxidation of Methylene Cyclopropane 1.28. 
O
O
H
m-CPBA
CH2Cl2(70%) O
O
O
O
O
O
70:30
H H
1.28 1.29 1.30
 
 With oxaspiro[2.2]pentane 1.29 in hand, the next key reaction was the 
rearrangement to the cyclobutanone 1.31 (Scheme 1.9).  This reaction proved to be 
challenging, in that the identity of the Lewis acid proved to be key for the selectivity of 
the outcome of the reaction as has been previously noted.23  However, under the 
optimized conditions of lithium iodide in dichloromethane the reaction proved to be 
essentially selective for the desired diastereomer.  Interestingly, the other undesired 
 8 
diastereomer 1.32 could be obtained in good selectivity by using lithium perchlorate in 
place of lithium iodide hinting at a change in mechanism when lithium perchlorate is 
used.   
 
Scheme 1.9. Rearrangement of Oxaspiro[2.2]pentane 1.29. 
O
O
O
LiI
CH2Cl2(81%, >95:5)
H
O
O
O
O
O
O
H
H
H
HLiClO4
PhH
(85%, 90:10) 1.29 1.311.32
 
 
 After having accomplished the key oxidation-rearrangement reaction sequence, 
the subsequent steps toward the formal syntheses of muricatacin and japonilure are rather 
straightforward (Scheme 1.10).  Baeyer-Villiger oxidation of the cyclobutanone 1.31 to 
the corresponding γ-lactone 1.33 followed by deprotection of the acetonide to give diol 
1.34, provided a common intermediate in two syntheses of muricatacin (1.35).24, 25 
 
Scheme 1.10. Formal Synthesis of Muricatacin. 
O
O
O
H
H m-CPBA
CH2Cl2
O
O
H
HO
O
FeCl3
CH2Cl2
OH
OH
H
HO
O
C11H23
OH
H
HO
O
1.31 1.33 1.34 (1.35)
 
 
 Alternatively, diol 1.34 can be oxidatively cleaved to the aldehyde (Scheme 1.11).  
This unstable aldehyde is then reduced to the alcohol 1.36.  This represents a formal 
synthesis of japonilure (1.37).26 
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Scheme 1.11.  Formal  Synthesis of Japonilure. 
i)NaIO4, CH2Cl2
ii)NaBH4, MeOH
OH
OH
H
HO
O
OH
HO
O
HO
O
C8H17
1.34 1.36 (1.37)
 
 
 Not only have oxaspiro[2.2]pentanes found application in synthesis of natural and 
unnatural products but they have found application in the synthesis of structurally 
interesting compounds, i.e. polyspiranes, and ligands for catalysis.  While polyspiranes 
have been the subject of previous reviews2 and will therefore not be discussed, the later 
has not been included.  Although only an isolated synthesis exists, it illustrates the broad 
ranging applicability of this ring system and will be mentioned.   
Paquette showed that oxaspiro[2.2]pentanes can be applied in different arenas 
besides total synthesis.  This is exemplified in its utilization in the synthesis of a new set 
of chiral cyclopentadienide ligands.27 Paquette’s synthesis of these new chiral 
cyclopentadienide ligands begins with dicyclopentadiene 1.38, first by oxidation with 
selenium dioxide and then resolution with lipase P30 to give alcohol 1.40 along with 
acetate 1.39 in high optical purity.  This is followed by Jones oxidation of the alcohol to 
the corresponding α,β-ketone and subsequent reduction to the saturated ketone 1.41 
(Scheme 1.12). 
 
Scheme 1.12.  Synthesis of Ketone 1.41. 
1)SeO2,
dioxane/H2O
2)lipase P30
(36%)
H
OH
H
OAc
1)Jones Ox.
2)H2, 10% Pd/C(86%, two steps)
O
99% ee1.38 1.39 1.40 1.41
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 Ketone 1.41 is then subjected to the Trost cyclobutanone synthesis conditions by 
exposure to cyclopropyl diphenyl sulfoxonium tetrafluroborate 1.26 under basic 
conditions (Scheme 1.13).  Subsequent rearrangement with aqueous acid yields an 
inconsequential mixture of cyclobutanones 1.42 and 1.43.  The mixture of 
cyclobutanones 1.42 and 1.43 are then oxidized to the γ-lactones and exposed to the 
combination of phosphorous pentoxide and methane sulfonic acid to yield the α,β-
unsaturated ketone 1.44. 
 
Scheme 1.13.  Synthesis of Ketone 1.44. 
O
SPh2 BF4
KOH, DMSO
ii) then 1M HBF4(80%)
i)
O
O
1)30% H2O2, NaOH
2)P2O5, CH2SO3H
O
1.41 1.42 1.43 1.44
1.26
 
 
 The completed synthesis of the cyclopentadienide ligand was accomplished in 
three steps (Scheme 1.14).  The first step was the reduction ketone 1.44 to the alcohol.  
This was then eliminated under acidic conditions to yield a cyclopentadiene, which can 
then be deprotonated with n-butyl lithium to yield the desired cyclopentadienide 1.45. 
 
Scheme 1.14. Synthesis of Cyclopentadienide 1.45. 
O
Li
1.44 1.45
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The formal total synthesis of the steroid (+)-equilenin (1.46) was also 
accomplished utilizing oxaspiro[2.2]pentanes (Figure 1).28, 29  Ihara’s synthesis of 
equilenin (1.46) began with a naphthalene derivative 1.47, which was epoxidized under 
Jacobsen conditions in moderate yield and enantiomeric excess (ee) to yield the desired 
cyclobutanone 1.49 directly due to the oxaspiro[2.2]pentane’s 1.48 instability to the 
reaction conditions (Scheme 1.15).   
 
HO
O
H
 
Figure 1.1.  Structure of equilenin (1.46). 
 
Attempts to improve the optical purity of the cyclobutanone through the 
utilization of other epoxidation methods did not yield better results.  Shi epoxidation 
utilizing the fructose derived catalyst also resulted in low optical purity.  Attempts to 
improve this, through a variety of solvents and using the ‘catalyst’ in superstoichiometric 
amounts, did not improve the optical purities to sufficient levels.  This observed 
reduction of enantioselectivity is presumably due to the stabilization of the potential 
benzylic cation by the methoxy substituent leading to an unselective rearrangement to the 
cyclobutanone as optical purities increase drastically when the methoxy substituent is 
replaced by hydrogen, up to 93% ee.  The isoperenyl group was installed on the 
cyclobutanone 1.49 with cerium trichloride to give the precursor to the key cascade ring 
expansion reaction which took place with a full equivalent of palladium acetate to give 
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cyclopentanone 1.50 which could then be transformed to (+)-equilenin (1.46) after a few 
further transformations. 
 
Scheme 1.15.  Total Synthesis of (+)-equilenin. 
MeO
Jacobsen Epoxidation
(55%, 78% ee)
MeO
O
MeO
O
H
MeO
O
H
1) isoprenylmagnesium bromide, CeCl3, THF, -78oC, 82%
2) Pd(OAc)2, HMPA:THF (1:4), 60%, dr 73:27
MeO
O
1.47 1.48 1.49
1.49 1.50
 
 
 Paquette’s studies toward the synthesis of the trixikingolides illustrate the power 
of small rings in synthesis due to failure of the original plan to construct the 
cyclopentenone ring intermediate 1.52 through a Nazarov type cyclization.  Once the 
divinyl ketone 1.51 for the Nazarov cyclization was completed, it was found that 
cyclization under a variety of conditions did not lead to the desired cyclopentenone in 
sufficient yields to be synthetically useful.  Even the assistance of a silicon atom in the β-
position only led to low yields or mixtures of stereoisomers at the ring fusion (Scheme 
1.16). 
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Scheme 1.16.  Attempted Nazarov Cyclization. 
H
H
O
R
R=H, TMS
Conditions
H
H
O
1.51 1.52
   
 
 With these failures of more standard conditions, they next turned their attention to 
the construction of the cyclopentenone, via Trost’s annulation procedure, using a 
oxaspiro[2.2]pentane as an intermediate.  This protocol begins with ketone 1.53 
condensation with cyclopropyl sulfoxonium ylide 1.26 leading to oxaspiro[2.2]pentane 
derivative 1.54, which was used in the elimination step without purification to yield 
cyclopropane 1.55 (Scheme 1.17). 
 
Scheme 1.17.  Cyclopentenone Annulation via 1-Oxaspiro[2.2]pentane 1.54. 
H
O
H SPh2 BF4
KOH, DMSO
H
H
O
H
H
TMSO
LiNEt2
TMSCl
(58%, two steps)
1.26
1.53 1.54 1.55
 
 
 To complete the annulation cyclopropane 1.55 was flash vacuum pyrolyzed to 
yield the desired cyclopentanone as its silylenol ether 1.56 in excellent yield (Scheme 
1.18).  Unfortunately, attempts to utilize this strategy toward an ultimate synthesis of the 
trixikingolides (1.57) did not result in a complete synthesis. 
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Scheme 1.18.  Completion of Trost Cyclopentenone Annulation Protocol. 
H
H
TMSO
410oC
30 s
H
H
OTMSH
O
RO
O OR
H
H1.55 1.56 (1.57)
 
 
 In addition to access to numerous natural products and the synthesis of new chiral 
ligands, oxaspiro[2.2]pentanes have also provided access to substrates for interesting 
transformations.  An example substrate transformation is the rhodium catalyzed eight-
membered ring synthesis developed by Murakami (Scheme 1.19).30  In this 
transformation the desired o-styryl-cyclobutanones 1.60 were synthesized utilizing 
Trost’s cyclopropyl sulfoxonium ylide 1.26 procedure to generate the desired 
oxaspiro[2.2]pentane 1.59 which were subsequently rearranged under protic conditions to 
yield the desired cyclobutanone 1.60.   
 
Scheme 1.19. Synthesis of o-Styryl-Cyclobutanones. 
OO
SPh2 BF4
KOH, DMSO
then 1M HBF4 O
1.58
1.26
1.59 1.60
 
 
Cyclobutanone 1.60 was then exposed to a rhodium alkene complex in the 
presence of a phosphine ligand in refluxing m-xylene resulting in cyclooctenones 1.61 
and 1.62 (Scheme 1.20).  No reaction was observed with substitution on the vinyl group, 
however, substitution of the phenyl ring was tolerated with similar results.  
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Scheme 1.20.  Rhodium Catalyzed Synthesis of Eight-Membered Rings. 
O [Rh(cod)2]PF6,
MeO
P 3
m-xylene O O
~3:11.60 1.61 1.62
 
 
 The reaction proceeded by oxidative addition of the rhodium (I) catalyst to the 
cyclobutanone 1.60 to yield an acylrhodium intermediate 1.63 (Scheme 1.21).  The 
acylrhodium then went migratory insertion into the adjacent vinyl group to yield a 
rhodium bicycle 1.64 which has two potential options for β-elimination to yield the 
observed products.   
 
Scheme 1.21.  Proposed Mechanism for Eight Member Ring Synthesis. 
O O Rh
RhHb
Ha
O
O
O
[Rh]
b
a
1.60 1.63 1.64
1.61
1.62
  
 
1, 4-Dioxaspiro[2.2]pentanes 
Like the oxaspiro[2.2]pentanes, the more oxidized 1,4-dioxaspiro[2.2]pentanes 
1.65 display one primary mode of reactivity.  The reactivity of this the smallest example 
of a spiro-acetal, hinges on the relief of the strain energy contained in both epoxide rings 
to give α-nucleophile substituted α’-hydroxy ketones 1.66 as products (Scheme 1.22).  
These nucleophile additions are broad in scope and can be both intra- and inter-molecular 
in nature.   
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Scheme 1.22.  General Reactivity of 1, 4-Dioxaspiro[2.2]pentanes. 
O O
Nu+
R1 R2
HO
O
R1 R2
Nu
1.65 1.66
  
 
This interesting member of the spiro-acetals was first synthesized by Crandall in 
1966 and regained the interest of synthetic chemists in recent years. 31, 32  Crandall found 
that exposure of tetramethylallene to peracetic acid resulted in the formation of several 
oxidized products.  Although 1,4-dioxaspiro[2.2]pentane was not directly detected, 
several of the reaction products pointed to its formation, because it underwent an acid or 
thermal mediated rearrangement to give the observed products.  It was not until 1968 that 
Crandall succeeded in isolating a 1,4-dioxaspiro[2.2]pentane 1.68 by careful distillation 
of the oxidation products of allene 1.67 (Scheme 1.23).33   
 
Scheme 1.23. First Isolation of a 1,4-Dioxaspiro[2.2]pentane.  
•
AcOOH O
O
1.67 1.68
 
 
 It was still two decades before 1,4-dioxaspiro[2.2]pentanes found their way into 
more synthetically useful scenarios.34-36  This time gap was due to the lack of an efficient 
neutral and mild oxidizing reagent to effect this transformation.  This role was filled by 
the advent of dimethyldioxirane (DMDO) by Murray and co-workers.37  With a more 
general synthesis of 1,4-dioxaspiro[2.2]pentanes available, synthetic transformations 
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could be explored (Scheme 1.24).  It was found that exposure of diepoxide 1.70, available 
from allene 1.69, to various nucleophiles typically yielded substituted ketones of type 
1.71 and 1.72 depending on the steric demands of the nucleophile used, and whether the 
conditions were Lewis acidic in nature.  The more sterically demanding nucleophiles 
react to give preference for the formation of ketone 1.71 compared to less sterically 
demanding nucleophiles which yielded mixtures of both substituted ketones 1.71 and 
1.72.  Under acidic conditions preference was for the initial formation of ketone 1.72.   
 
Scheme 1.24. Nucleophile Additions to 1,4-Dioxaspiro[2.2]pentanes 
DMDO• O
O
Nu
OH
O
Nu
n-Bu
Nu
O
OH
n-Bu+
1.69 1.70
1.71 1.72
 
 
 Crandall and co-workers also found that intramolecular cyclizations were also 
possible with an appropriate pendant nucleophile (Scheme 1.25).35, 38  Thus, oxidation of 
allenic alcohols 1.74 containing one or two carbon atom tethers yielded 
tetrahydrofuranones 1.73.  The reaction proceeds by attack at the distal epoxide C-O 
bond with the alcohol to form the observed products.  When the tether is extended to 
three or four carbon atoms nucleophilic addition favors the proximal epoxide C-O bond 
to form tetrahydrofurans 1.75 and tetrahydropyrans 1.76, respectively.   
 
Scheme 1.25.  Synthesis of Cyclic Ethers via 1,4-Dioxaspiro[2.2]pentanes. 
•
HO
nn=1,2
DMDO
O
O
OH
n
O
O
HO
n=3,4
DMDO
1.73 1.74 1.75
O
HOor
O
1.76
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 In analogy to allenyl alcohols, protected amines also give cyclic heterocycles as 
products (Scheme 1.26).  Exposure of a tosyl protected allenyl amine 1.77 with a one or 
two carbon tether yielded amino-ketones 1.78 where nucleophilic attack of the amine 
occurred at the distal epoxide C-O bond.  Conversely, when the tether was lengthened to 
three carbon atoms 1.79, again in analogy to the alcoholic series, nucleophilic attack 
instead occurred at the proximal epoxide C-O bond.  Contrary to what was observed with 
the alcoholic substrates the amine substrates suffered from lower yields, 52% vs. 87%, 
due to competing oxidation at the nitrogen atom to give further oxidized by-products. 
 
Scheme 1.26.  Synthesis of Cyclic Amines from 1,4-Dioxaspiro[2.2]pentanes. 
1.79
•
TsHN
n
n=1,2
DMDO
TsN
O
OH
n
TsN
O
HO
n=3
DMDO
1.77
1.78 1.79
 
 
  Similarly, when allenic carboxylic acids 1.80 were employed as substrates the 
corresponding lactones were obtained as products (Scheme 1.27).39, 40  When the tether 
length was only one carbon atom δ-lactones 1.81 were obtained as the major product.  
Interestingly, when the tether was one carbon atom and sodium bicarbonate was added to 
the reaction to form the sodium carboxylate a β-lactone 1.82 and δ-lactone 1.81 were 
observed.  When acid was added the reaction gave the δ-lactone 1.81 as the major 
product. 
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Scheme 1.27.  Synthesis of Lactones Utilizing 1,4-Dioxaspiro[2.2]pentanes.  
•
HO2C
n
n=1,2,or 3
DMDO, additive
O
O
O
OH
OH
O
O O
n+
1.80
1.81 1.82
 
 
 Allenyl aldehydes were also explored as substrates in oxidative cyclizations  as an 
alternate to carboxylic acids as it is known that DMDO will oxidize aldehydes to the 
corresponding carboxylic acids (Scheme 1.28). 37, 41  However, with these substrates 
epoxidation proved to be competitive with oxidation of the aldehyde.  With this scenario, 
intramolecular cyclization becomes competitive with intermolecular oxidation of the 
aldehyde.  Thus, after oxidation of the aldehyde 1.83 the observed product is not the 
expected keto-lactone 1.85, but is in fact the acetal 1.84.  Utilizing scrupulously dry 
DMDO in the presence of a suitable alcohol an alkyl acetal can be obtained.   
 
Scheme 1.28. Oxidative cyclization of Allenyl Aldehydes.  
•
H
O
DMDO
O
O
OH
OH
O
O
OH
O
not observed
1.83 1.84
1.85
 
 
 Even though this ring system has been known since 1966, and several 
investigations into their reactivity with various nucleophiles have been conducted, it was 
thirty years until it was applied in the synthesis of a complex molecule.  The synthesis of 
betamethosone by Andrews and co-workers demonstrated the practicality of 1,4-
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dioxaspiro[2.2]pentanes (Scheme 1.29).42  Starting from allene 1.86 derived from 9α-
hydroxyandrost-4-ene-3,17-dione, oxidation with DMDO provided 1,4-
dioxaspiro[2.2]pentane derivative 1.87 which upon subjection to tetrabutylammonium 
acetate yielded acetate substituted ketone 1.88.  This could then be converted to 
betamethosone 1.89 by known conditions.43 
 
Scheme 1.29. Use of 1,4-Dioxaspiro[2.2]pentanes in Corticosteroid Synthesis.  
O
•
DMDO
O
O
O
TBA OAc
O
O
OAcOH
O
O
OHOH
F
HO
1.86 1.87
1.88 1.89
 
 
 The utility of this ring system is also highlighted in Williams’ modular synthesis 
of the selective proteosome inhibitor epoxomicin (1.92) (Scheme 1.30).44  Beginning with 
allene 1.90, which is derived from isovaleraldehyde, a successive sequence of oxidation 
with DMDO, azide addition and reduction of the unstable azido-ketone delivered the 
stable amino-ketone 1.91.  This route was chosen due to the low yield or instability of 
other amino-ketones derived from alternate nitrogen sources.  The completion of the 
synthesis was accomplished by successive peptide coupling, followed by the 
transformation of the tertiary alcohol into the requisite epoxide to produce epoxomicin 
(1.92).  This sequence proceded in excellent overall yield of 20% for all steps. 
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Scheme 1.30.  Synthesis of Epoxomicin. 
O
N
O
H
N
O
N
H
OH
H
N
O
O
O
O
H3N
OH
OTBS
TFA
•
H OTBS i)DMDOii)TBAN3
iii)Pd/C, H2, Boc2O
then TFA
(66%, three steps)1.90 1.91 (1.92)
 
 
 Nucleophilic additions to 1,4-dioxaspiro[2.2]pentanes are not limited to 
heteroatoms; carbon based nucleophiles can also provide substituted ketone products.  
The addition of cuprates to this ring system proved difficult at first, but could be made 
effective with the appropriate choice of reagent (Scheme 1.31).45  
 
Scheme 1.31.  Addition of Cuprates to 1,4-Dioxaspiro[2.2]pentanes. 
•
n-Bu
n-Bu i-Bu
H
i)[O]
ii)RnCuX
O
i-Bu
OHn-Bu
n-Bu
O
i-Bu
OHn
-Bu
n-Bu+
1.93 1.94 1.95
 
 
  The choice of typical dialkyl cuprates derived from alkyl lithiums provided some 
of the desired addition product 1.94 along with ketone 1.95 as the major product.  The 
production of hydroxyl-ketone 1.94 proved to be surprising but not unfounded.46  This 
reaction presumably occured through oxidative addition of the Cu(I) species to the 
epoxide 1.96, to give an intermediate α-Cu(III) ketone 1.97 and which provided two 
divergent reaction pathways (Scheme 1.32).  First, ‘normal’ reductive elimination yielded 
the desired substituted product 1.98.  Whereas, isomerization to the corresponding 
enolate 1.99 would lead to observed ketone 1.100.   The second reaction manifold was 
avoided by the use of alkylcyano cuprates. 
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Scheme 1.32.  Two Reaction Pathways for Cuprate Addition. 
O O R2CuI
O
O CuIIIR2
O
O
CuIIIR2
O
RHO
O
HHO
1.96 1.97
1.98
1.99
1.100
 
 
 With this methodology in hand, it was then applied to the synthesis of a precursor 
towards the antibiotic erythromycin (Scheme 1.33).  Oxidation of allene 1.101 with 
subsequent exposure to methylcyanocuprate yielded ketone 1.102 in good 
diastereoselectivity, 8:1.  This was then transformed to the known protected tetrol 1.103 
by standard methods.47 
 
Scheme 1.33.  Synthesis of a Precursor to Erythromycin. 
•
H
OTBS
OTBS TBSO
OH
O
OTBS
i)DMDO
ii)MeCu(CN)Li
TBSO
OBn
O O
PMB
1.101 1.102 1.103
 
 
 In 2004, the selective anti-tumor agent psymberin was isolated from a sponge off 
the coast of Papua New Guinea.48  The tetrahydropyran of this natural product lends itself 
to be constructed utilizing Crandall’s methodology (Scheme 1.34).  Advanced allene 
1.104 was subjected to oxidation, in the presence of DMDO, to give the intermediate 1,4-
dioxaspiro[2.2]pentane which cyclized to dihydropyranone 1.105 upon the addition of 
methanol.  The dihydropyranone 1.105 could then be transformed into a known 
intermediate in the synthesis of psymberin (1.106). 
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Scheme 1.34.  Synthesis of the Dihydropyran of Psymberin. 
O
OH
OH
O
OH
O
OH
N
H
OMeO
OH
OMe
•
H
TBDPSO
H
HO O
O
OTBDPS
OH
DMDO
CHCl3
then CH3OH(72%)1.104 1.105 (1.106)
 
 The unusual necessity of methanol to bring about cyclization can be explained by 
looking at the conformations of the 1,4-dioxaspiro[2.2]pentane and its diastereomer 
(Scheme 1.35).  If the opposite stereochemistry of the alcohol was used in the oxidative 
cyclization, it spontaneously cyclized to give the cis-dihydropyranone.  This is due to the 
destabilization of the unproductive hydrogen-bonded conformation 1.107 due to steric 
interactions, which promotes the formation of the productive conformation 1.108 and 
leads to cis-dihyropyranone 1.109.  Conversely, the other diastereomer forms a stable 
hydrogen-bonded complex 1.110, due to a lack of the destabilizing interactions.  The 
productive conformation 1.111 is destabilized due to interactions between the alkyne and 
the epoxide.  In order to break up this stable hydrogen-bonded complex, a protic solvent 
is added which drives the formation of conformer 1.111 and thus formation of the desired 
trans-dihydropyran 1.105. 
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Scheme 1.35.  Conformational Analysis Leading to the Two Diastereomeric Pyrans. 
O O
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Me
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O
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1.110 1.111
 
 
 A very elegant synthesis of the A-B ring system of pectenotoxin 4 by Williams 
was also devised using a 1,4-dioxaspiro[2.2]pentane as a key intermediate (Scheme 
1.36).49  Keto-allene 1.112 is oxidized by DMDO to the bis-epoxide, which is then 
captured by the pendant ketone and generates an oxocarbenium ion.  This cation is then 
captured by the alcohol to give the A-B ring system of pectenotoxin 4 1.114 in good 
yield.  Additionally, the diastereoselectivities for both oxidations is good, >20:1 for the 
C12 alcohol and 7:1 for the C10 center.  This cascade reaction sequence could be 
extended by a further reaction by the use of PMB protected alcohol 1.113, in that DMDO 
also can be used to remove the PMB group. 
 
Scheme 1.36.  Synthesis of the A-B ring System of Pectenotoxin 4. 
•
OOR
TBDPSO OTBDPS
OTBDPS1.112 R=H
1.113 R=PMB
O
O
TBDPSO
O
OH
OTBDPS
OTBDPS
10
i)DMDO, MeOH, CHCl3
ii)TsOH
12
R=H, 89%
R=PMB, 72%1.114
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1-Oxaspiro[2.3]hexanes 
 Similarly to the previously described ring systems, the construction of 1-
oxaspiro[2.3]hexanes is analogous.  Although many methods exist, oxidation of 
methylene cyclobutanes by agents such as DMDO or peracids are the most prevalent.  
This ring system has also been constructed by the addition of α-lithio selenocyclobutanes 
to carbonyl compounds,50, 51 addition of sulfur ylides to cyclobutanones,52  oxidation of 
methylene cyclobutanes with N-bromosuccinimide in water,53 transition metal mediated 
epoxidations of cyclobutenes,54  and oxidation of methylenecyclobutanes with chiral 
versions of DMDO.55, 56 
Oxaspiro[2.2]pentanes and 1-oxaspiro[2.3]hexanes 1.115 have similar reactivity 
patterns (Scheme 1.37).  When the ring system was functionalized with an aryl or alkyl 
group, it underwent a facile ring expansion to cyclopentanones  1.116 under Lewis acidic 
conditions exhibited similarly with oxaspiro[2.2]pentanes.52, 57  Likewise this ring 
expansion was driven by the release of the strain energy of both rings, and the presence 
of an aryl group would likely stabilize the forming carbocation necessary for the 
rearrangement.  Conversely, nucleophiles were added to make substituted cyclobutanes 
1.117 when the ring system was functionalized with an appropriate electron withdrawing 
group.  This was presumably due to the destabilization of the cation, which was necessary 
for the rearrangement and preference of reaction at the distal cyclobutyl C-O bond. 
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Scheme 1.37.  General Reactivity of 1-Oxaspiro[2.3]hexanes. 
R
O R=Aryl or alkylR=EWG O
R
R
OH
Nu
Nu Lewis acid
1.115 1.1161.117
 
 
 The first application of 1-oxaspiro[2.3]hexane in synthesis was the attempted 
construction of an aldosterone derivative (Scheme 1.38).58  Steroid 1.118, which was 
obtained after several steps from pregnenolone acetate, was oxidized by the action of m-
CPBA to give 1-oxaspiro[2.3]hexane 1.119.  The 1-oxaspiro[2.3]hexane 1.119,  was then 
eliminated with lithium diethylamide to give cyclobutene 1.120.  This reaction sequence 
worked well when R=H, however when R≠H the elimination essentially did not proceed.  
With these disappointing results this route was abandoned for a more productive 
pathway. 
 
Scheme 1.38.  Application of 1-Oxaspiro[2.3]hexanes Toward an Aldosterone. 
O O
O
RR
m-CPBA Et2NLi
(69%)
O
R
OH
1.118 1.119 1.120
 
 
 The aromatic sesquiterpene natural product herbertene, isolated from the liverwort 
Herberta adunca, is another early example of the use of 1-oxaspiro[2.3]hexanes in 
natural product synthesis (Scheme 1.39).52  The synthesis of the key 1-
oxaspiro[2.3]hexane 1.122 begins with cyclobutanone 1.121; this was made from a 
toluene derivative and dimethyl ketene via thermal cyclization.  Cyclobutanone 1.121 is 
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then condensed with trimethylsulfonium bromide, under basic conditions, to yield the 
desired spirosystem 1.122.  Upon exposure to catalytic lithium iodide, this spirosystem 
rearranges to an inconsequential mixture of carbonyl isomers 1.123 and 1.124.  The 
synthesis is completed by reduction of the carbonyl to the methylene in herbertene 
(1.125) by the Huang-Minlon reduction.59  This concise synthesis of herbertene (1.125) 
proves to be efficient with an overall yield of ~30%.  
 
Scheme 1.39.  Synthesis of Herbertene. 
O S Br t-BuOK O
O
O
+
H2NNH2, KOH
∆
LiI
1.121 1.122
1.123 1.124 (1.125)
 
 
 Triquinane natural products have been a long standing proving ground for 
methodology as is also the case with 1-oxaspiro[2.3]hexanes.  Both isocomene and β-
isocomene could be synthesized from a common 1-oxaspiro[2.3]hexane (Scheme 1.40).60  
The synthesis of key 1-oxaspiro[2.3]hexane 1.127 derives from cyclobutene 1.126 by 
hydroxyl directed epoxidation with m-CPBA to give a single epoxide 1.127 in good 
yield.  Rearrangement gave cyclopentanone 1.128, by the action of lithium bromide with 
hexamethylphosphoramide (HMPA), gave a single regioisomer again in good yield.  This 
cyclopentanone 1.128 was then transformed into β-isocomene (1.129) after several steps 
to isocomene (1.130).  
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Scheme 1.40.  Synthesis of Isocomene and β-Isocomene via an 1-Oxaspiro[2.3]hexane. 
OH OH
O
m-CPBA
(70%) OH
LiBr, HMPA
(81%)
O
1.126 1.127 1.128
(1.129) (1.130)
 
 
 A particularly elegant use of a 1-oxaspiro[2.3]hexane is Tobe’s synthesis of 
marasmic acid (Scheme 1.41).61, 62  In this synthesis cyclobutene 1.131 is oxidized with 
m-CPBA to give the epoxide 1.132.  Epoxide 1.132 then undergoes a cascade 
rearrangement with sulfuric acid to give lactone 1.133, which is a precursor to marasmic 
acid. 
 
Scheme 1.41.  Use of a Cyclobutyl-Cyclopropylcarbinyl Rearrangement in the Synthesis 
of Marasmic Acid. 
OHO
CO2Me
HO
CO2Me
m-CPBA
(89%)
O
O
O
H2SO4
(80%)
1.131 1.132 1.133
 
 
 The mechanism of this cascade rearrangement is depicted in simplified version, 
the cyclopentane was omitted for clarity, in Scheme 1.42.  Protonation of epoxide 1.134 
leads to the formation of cyclobutyl cation 1.135, which then underwent a bond migration 
that gave the new cyclopropylcarbinyl cation 1.136.  This cation then underwent a 1,2-
hydride shift that gave the observed product after lactonization 1.137. 
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Scheme 1.42.  Mechanism for the Cascade Rearrangement of the Epoxide 1.134 to 
Lactone 1.137. 
HO
HO
CO2Me
OH
CO2Me
H
OHO
CO2Me
O
O
OOH
1.134 1.135 1.136 1.137
 
 
 The use of 1-oxaspiro[2.3]hexane ring expansion also proved to be particularly 
effective for the synthesis of pentalenolactone E and G methyl esters (Scheme 1.43).54  
Cyclobutene 1.138 was constructed by a photo [2+2] cycloaddition from the 
corresponding allene and enone.  Alkene 1.138 was then epoxidized in a hydroxyl 
directed fashion by the use of V(O)(acac)2 in the presence of tert-butylhydroperoxide 
(TBHP) to give epoxide 1.139 in excellent yield and selectivity.  Alcohol 1.139 was then 
deoxygenated using the Barton protocol.63  Next, epoxide 1.140 underwent ring 
expansion to give cyclopentanone 1.141 in near complete regioselectivity.  
Cyclopentanone 1.141 could then be converted to pentalenolactone E methyl ester 1.142 
after a few additional steps.  Pentalenolactone G methyl ester was also accessed utilizing 
a similar strategy. 
 
Scheme 1.43.  Synthesis of Pentalenolactone E Methyl Ester. 
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O
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 Amino-substituted 1-oxaspiro[2.3]hexanes are also accessible via a two step 
process in good optical purities (Scheme 1.44).64, 65  The amino-cyclobutanones 1.143 are 
available directly from the [2+2] cycloaddition of keteniminium salts and disubstituted 
olefins.  These cyclobutanones 1.143 can then be condensed with sulfur ylides to yield 
the corresponding epoxide 1.144 and 1.145 in good yield and poor diastereoselectivities. 
 
Scheme 1.44.  Synthesis of Aminosubstituted 1-Oxaspiro[2.3]hexanes. 
H
H NTsMe
O S
H
H NTsMe
O H
H NTsMe
O
+
1.5:11.143 1.144 1.145
 
 
 These amino-substituted 1-oxaspiro[2.3]hexanes could then be converted to the 
subsequent cyclopentenones by exposure to either a catalytic or stoichiometric amount of 
lithium iodide (Scheme 1.45).  The exo-isomer 1.145 underwent a more facile 
rearrangement as only a catalytic amount of lithium iodide is necessary.  However, the 
endo-isomer required more forcing conditions demanding a full equivalent of lithium 
iodide.   Both isomers presumably gave the same intermediate β-amino cyclopentanone 
1.146, but under the reaction conditions β-aminocyclopentanone 1.146 eliminated to give 
the observed cyclopentenone 1.147.  The regioselectivity of the rearrangement of the 
endo-isomer 1.144 was not as selective as the exo-isomer 1.145.  This resulted in the 
formation of two products, α-aminocyclopentanone 1.148 and cyclopentenone 1.147.  
This process proved, in most cases, to preserve the optical purity of the starting epoxide 
in all of the products as the enantiomeric excess was preserved in all products.  
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Scheme 1.45.  Rearrangement to form Cyclopentenones. 
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 One of the main advantages of 1-oxaspiro[2.3]hexanes is their facile 
rearrangement to the corresponding cyclopentanones.  Addition of diazomethane to 
cyclobutanones can give the same products, however they are often as a mixture of 
regioisomers.  An example of the use of this ring system to bring about a more selective 
rearrangement compared to a similar reaction with diazomethane is the synthesis of 
carbovir 1.153 by Hegedus and co-workers (Scheme 1.46).66  The substrate 
cyclobutanone 1.149, for the rearrangement, was constructed using a photolytic reaction 
of a chromium carbene with an ene-carbamate.  Upon reaction with dimethylsulfoxonium 
methylide the intermediate 1-oxaspiro[2.3]hexane 1.150 was formed, and then exposed to 
scandium triflate triggers a rearrangement to cyclopentanone 1.151.  Other Lewis acids 
brought about elimination of the β-ethoxy group in addition to rearrangement.  In a 
second step, the ethoxy group was eliminated under basic conditions to give 
cyclopentenone 1.152 which was then transformed to carbovir 1.153 after several steps. 
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Scheme 1.46.  Synthesis of the Antiviral Agent (+)-Carbovir. 
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 The propensity of 1-oxaspiro[2.3]hexanes to open to cyclobutylcarbinyl cations 
under Lewis acid conditions, and subsequent rearrangement, can be thwarted with the 
attachment of an appropriate electron withdrawing group.  The two step protocol to 
generate sulfoxyl substituted epoxides is an example of a synthesis of this type of 
substrate (Scheme 1.47).67, 68  Cyclobutanone 1.154 reacted with chloromethyl substituted 
sulfoxide 1.155 under the action of LDA to give an intermediate alcohol that could be 
cyclized to the corresponding epoxide 1.156.  Nucleophiles, such as azide, could be 
added to the distal carbon of the epoxide 1.156 would gave an azido-aldehyde, which was 
directly oxidized to the methyl ester 1.158 by the use of basic iodine in methanol.  The 
azido ester 1.157 could then be reduced to the corresponding amine by catalytic 
hydrogenation.  While this procedure proved effective in the racemic sense for a variety 
of substrates the analogous process with a chiral sulfoxide was only demonstrated for a 
select few substrates. 
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Scheme 1.47.  Synthesis of α-Quaternery Amino Acids Using Ketones. 
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4-Oxaspiro[2.3]hexanes 
 Even though 4-oxaspiro[2.3]hexanes have been the subject of several syntheses, 
their application to the synthesis of natural and unnatural products has yet to be 
envisioned.  Presumably due to the lack of scope in their syntheses, very few applications 
have been undertaken, and their synthesis will only be covered in brief.   
 The first construction of this ring system was by Turro in the late 1960’s (Scheme 
1.48).69, 70  While the cycloaddition between cyclopropanone 1.159 and ketene 1.160 
proceeded in modest yields of cycopropane 1.161, it proceeded in excellent yield for the 
dimethyl acetal of ketene 1.162 to give orthoester 1.163, 90%.  It still suffered from the 
lack of adequate syntheses of the requisite cyclopropanones to be broadly applicable.  
 
Scheme 1.48.  Themal [2+2] Cycloaddition of Cyclopropanone and Alkenes.   
O
O
•
OMe
OMe
O
O
O OMe
OMe
1.159
1.160
1.161
1.162 1.163
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 Perhaps one of the more broadly applicable syntheses of 4-oxaspiro[2.3]hexanes 
is the decomposition of diazo-compounds in the presence of diketene 1.164 (Scheme 
1.49).71-74  A variety of diazocompounds 1.165 bearing an electron withdrawing group in 
the form of a phosphonate or ester did give the 4-oxaspiro[2.3]hexanes 1.166 with 
varying degrees of success.  The identity of the subtituents appears to be crucial to the 
outcome of the reaction.  However, both light mediated and transition metal mediated 
decomposition of the diazocompounds gave similar results. 
 
Scheme 1.49.  Diazo Decomposition to Form Cyclopropyl-β-Lactones. 
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 One of the major reactions of this highly strained system is the thermal 
rearrangement to give furanones of type 1.169 or 1.170 as the products (Scheme 1.50).  It 
is thought that this reaction proceeds via cleavage of one of the cyclopropyl C-C bond 
and the C-O bond of the β-lactone to give a zwitterion intermediate 1.168.  This, then 
undergoes ring closure to give the initial product 1.169 which partially or completely 
isomerizes to furanone 1.170, under the reaction conditions. 
 
Scheme 1.50.  Thermal Rearrangement of 4-Dioxaspiro[2.3]hexanes. 
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 The most general synthesis to date is that of cyclopropanation of 2-methylene 
oxetanes.  2-Methylene oxetanes 1.171, which are available from the corresponding β-
lactones by the method of Howell75, under went a Simmons-Smith cyclopropanation to 
give 4-diaoxaspiro[2.3]hexanes 1.172 (Scheme 1.51).  The only accessible structural 
variation is where the substituents are on the oxetane ring.  Cyclopropanation does 
proceed in good yields for a variety of substrates. 
 
Scheme 1.51.  Use of Simmons-Smith Reaction for the Construction of 4-
Oxaspiro[2.3]hexanes. 
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 With a more general synthesis in hand, attention could be turned to the reactivity 
of the ring system (Scheme 1.52).  Depending on the substrate, exposure to Lewis acid 
gave a variety of different structures, unfortunately the yields for these reactions were 
very moderate, limiting their potential in synthesis. 
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Scheme 1.52.  Lewis Acid Mediated Rearrangements. 
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 In addition to the above described procedures, 4-oxaspiro[2.3]hexanes have been 
observed as products, by-products or intermediates in several other more exotic reactions.  
This ring system was isolated in low yields from photochemical reaction between 
carbonyl compounds and olefins.76, 77  They have also been constructed by 
cylcopropanation of alkylidene oxetanes with dichlorocarbene.78  4-Oxaspiro[2.3]hexanes 
are also an intermediate in the synthesis of a polyspirane,79 but the most current example 
of their synthesis is an isolated report of the fragmentation of a benzylidene acetal to 
yield a 4-oxaspiro[2.3]hexane.80  
1,5-Dioxaspiro[3.2]hexanes 
 The first example of 1,5-dioxaspiro[3.2]hexanes was initially synthesized by 
chance.81 In an exploration of the oxidation of cumulene with peracids, Crandall found 
that exposure of cumulene 1.179 to an excess of m-CPBA yielded several products, one 
of them was 1,5-dioxaspiro[3.2]hexane 1.180 (Scheme 1.53).   
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Scheme 1.53.  Oxidation of a Cumulene to Yield a 1,5-Dioxaspiro[3.2]hexane. 
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While this type of reaction did provide the desired ring system; it was not 
synthetically practical given the starting material.  However, a synthetically viable route 
was not developed until more than a decade later that.  Howell and co-workers have 
shown that methyleneoxetanes can yield 1,5-dioxaspiro[3.2]hexanes in good yields and 
modest to good diastereoselectivity in most cases.82  Additionally, the methyleneoxetanes 
can be readily accessed from β-lactones, which in turn can be made by a variety of 
methods.  This particular method is also tolerant of a variety of functional groups which 
should prove useful in the synthetic arena.   
 In contrast to the previously described heterocycles, 1,5-dioxaspiro[3.2]hexanes 
1.181 display varied reactivity depending on conditions employed (Scheme 1.54).  Given 
the ring system, there are three possible modes of reactivity.  Most probable reaction is 
path ‘a’, because nucleophilic attack is at the least hindered C6 that completely unravels 
the entire ring system with relief of all ring strain, to yield α-substituted ketones 1.182.  
The next most probable is reaction pathway ‘b’, which is attack at C2, to relieve all ring 
strain yielding β-substituted ketones 1.183.  Finally, the least probable reaction pathway 
‘c’, in which a nucleophile adds to C4 to give substituted oxetanes 1.184 as products.  
Pathway ‘a’ seemed the most likely due to the unsterically hindered attack of a 
nucleophile.  Pathway ‘c’ was initially precluded due to the increased basicity of the 
oxetane oxygen over the epoxide oxygen, which would increase its lability.   
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Scheme 1.54.  Reactivity of 1,5-Dioxaspiro[3.2]hexanes Towards Nucleophiles.  
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 Howell and co-workers discovered many interesting things during their initial 
investigation of the reactivity of this poorly studied ring system.83, 84  Initially, most 
nucleophiles would add to the least hindered C6 position and follow reaction pathway ‘a’ 
to yield α-substituted ketones.  These nucleophiles were quite diverse and included 
examples such as alcohols, acetate and sodium thiophenoxide.  Contrary to these results, 
when DIBAl-H, Me3Al, or TMSN3 were utilized as nucleophiles the major product 
observed switched to that from addition to C4 yielding substituted oxetane products.  
This was initially attributed, to the Lewis acidic aluminum or silicon atom which facilited 
the ring opening of the epoxide.  Later it was found that heterocyclic nucleophiles, with 
acidic protons that have a pKa of greater than 10 would yield the α-substituted ketones as 
products 1.186, while those below a pKa of ~10, would yield the same substituted 
oxetanes 1.187 as product (Scheme 1.55). 
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Scheme 1.55.  Influence of Acidity on the Reactivity of 1,5-Dioxaspiro[3.2]hexanes. 
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 Computational analysis was also performed on these reaction pathways.  It was 
found that with anionic nucleophiles there is a small preference for attack at C6.  This 
mode of attack then results in a highly exothermic, 59.9 kcal/mol, unraveling of both 
rings to yield the observed product.  Conversely, when in an acidic solution there is no 
preference for protonation at the oxetane or the epoxide oxygen, rather it is the stabilities 
of the generated oxonium ion.  Obviously, the preference at this stage is for opening of 
the epoxide ring with generation of an oxetane oxonium, which is more stable than the 
corresponding epoxide oxonium by 18.8 kcal/mol. 
 In synthesis, the 1,5-dioxaspiro[3.2]hexane ring system proved to be a versatile 
building block toward the cell signaling and immunomodulatory molecules 
dihydrosphingosines, sphingosines, and phytosphingosines.85-87  Scheme 1.54 was 
illustrative of this versatility by the synthesis of D-erythro-sphinganine.  Methylene 
oxetane 1.188 derived from serine was first oxidized to the 1,5-dioxaspiro[3.2]hexane 
1.189 by DMDO in quantitative yield.  The ring system is then exposed to a higher order 
cuprate to yield ketone 1.190 in good yield.  The ketone 1.190 was selectively reduced by 
the action of lithium tri-t-butoxy aluminum hydride in excellent yields to give the alcohol 
1.191.  The synthesis was completed by deprotection of the Boc-group with 
trifluoroacetic acid to afford D-erythro-sphinganine (1.192). 
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Scheme 1.54.  Synthesis of D-Erythro-Sphinganine. 
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 With the recent advances in the synthesis of small rings, there has been several 
new spiro-heterocycles that have been accessed.  The construction of these ring systems 
allowed access to not only molecules of theoretical interest but also synthons for a variety 
of natural and unnatural products.  These ring systems have also proven useful as they 
can undergo rearrangements with high selectivity, while the more traditional methods 
have proven to be less selective.  With the combination of reactivity and selectivity there 
is no doubt that there will be continued interest in these spiro-heterocycles for a long time 
to come. 
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CHAPTER II 
STUDIES TOWARD THE HATERUMALIDES:  THE SYNTHESIS AND 
STRUCTURE OF SPIROEPOXY-β-LACTONES88 
 
Isolation and Biological Activity of the Haterumalides 
 Chemical entities derived from natural sources have been a continual source of 
novel structures and biological activities.  Natural products have also been the mainstay 
for drug development as more than half of the current chemical entities from 1981-2002  
have been derived in some fashion from natural products.89 In particular, marine sources 
have been a continual pool of architecturally intriguing and potent molecular structures. 
Such a group of natural products that proves to be both structurally and biologically 
interesting are the haterumalides (Figure 2.1) 
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Figure 2.1.  Structures of the haterumalides. 
 
 Haterumalides NA-NE (2.1-2.5) belong to a class of natural products that have 
been isolated from a marine sponge Ircinia sp. the source of haterumalides NA-NE (2.1-
2.5)90 and the source of haterumalide B (2.7) was identified as a marine ascidian 
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Lissoclinium sp.91  One additional haterumalide, X (2.6), along with haterumalides NA 
(2.1), B (2.7), and NE (2.5) were isolated from the soil bacterium Serratia liquefaciens.92 
The haterumalides contain several interesting structural features which make them 
attractive targets for total synthesis.  First is their trans-tri-substituted tetrahydrofuran 
ring, and second is the skipped diene containing a Z-chloro-alkene moiety.  It should also 
be noted that the initially proposed stereostructures were corrected as a result of total 
syntheses.93-96 
 In addition, to their interesting structures the haterumalides display a variety of 
interesting biological activities including varying degrees of cytotoxicity with 
haterumalide NA (2.1) displaying an IC50 value of 68 nM against the leukemia cancer 
cell line P388.90  Haterumalide B inhibits the first division of fertilized sea urchin egg cell 
at concentrations as low as 18 pM.91   
Previous Syntheses of Haterumalide NA 
 There have been two previously reported syntheses of ent-haterumalide NA (2.1) 
and one synthesis of the natural enantiomer.  Kigoshi and co-workers published the first 
synthesis of the enantiomer of the methyl ester of ent-haterumalide NA (2.1).93  The 
synthesis of the tetrahydrofuran core began with a threitol derivative 2.8, the primary 
alcohol was converted to the iodide via a two step procedure (Scheme 2.1).  The iodide 
was then homologated by one carbon by the use of the anion generated from FAMSO, 
methyl methylsulfinylmethyl sulfide, to give acetal 2.9.  After a two step deprotection of 
both the 1,2-diol and the aldehyde, a Wittig reaction gave α,β-unsaturated ester 2.10.  
The tetrahydrofuran (THF) ring was then constructed by a Michael addition of the free 
alcohol to the α, β-unsaturated ester.  The remaining alcohol was protected as its TBS 
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ether, and the ester was completely reduced to the alcohol.  Conversion of the primary 
alcohol to the bromide via the tosylate gave THF 2.11. 
 
Scheme 2.1.  Kigoshi’s Synthesis of the Tetrahydrofuran Core of Haterumalide NA. 
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 With the THF core 2.11 in hand, Kigoshi next moved toward the coupling of the 
skipped diene fragment and THF 2.11 (Scheme 2.2).  The synthesis of the western 
hemisphere fragment began with protection of the primary alcohol of 3-butyn-1-ol 2.12 
as the THP acetal and protection of the acetylenic position with a trimethylsilyl group.  
Alkyne hydroalumination with bromine quench gave the corresponding (E)-alkenyl 
bromide which was then photoisomerized to give (Z)-alkene 2.13 which is ready for 
coupling.  Treatment of alkene 2.13 with sec-butyl lithium afforded the corresponding 
vinyl lithium reagent which was added to bromide 2.11 to give olefin 2.14.  The silyl 
group was then exchanged for chlorine by the action of N-chlorosuccinimide concurrent 
with isomerization of the alkene to the desired Z-alkene geometry.  After deprotection 
and oxidation of the alcohol, a Still modified Horner-Wadsworth-Emmons olefination 
with phophonate 2.15 was employed to give diene 2.16.   
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Scheme 2.2.  Coupling of the Western Hemisphere to the THF Core 2.11. 
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 The next key step was a Reformatsky-type reaction to provide the macrocycle 
(Scheme 2.3).  The macrocyclization precursor was made in several straightforward steps 
from ester 2.17.  Reduction of the ester to the alcohol and temporary trityl protection 
followed by deprotection and acylation with bromoacetyl bromide gave macrocycle 
precursor 2.18.  Allylic alcohol oxidation and then submission to Reformatsky-type 
reaction conditions gave macrocycle 2.19 in very poor yield.  The yield of this reaction 
could not be improved under a variety of conditions that were explored due to olefin 
isomerization.  The MPM group is then removed and the alcohol oxidation to the 
aldehyde which was utilized in a Nozaki-Hiyama-Kishi reaction to append on the side 
chain 2.20, thus completing the first synthesis of the enantiomer of haterumalide NA as 
its methyl ester 2.21. 
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Scheme 2.3.  Completion of the Synthesis of ent-Haterumalide NA. 
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 The second synthesis of ent-haterumalide NA (2.1)  was accomplished later that 
year by Snider and co-workers.94  Their synthesis of the THF core begins with allylic 
alcohol 2.22 which can be obtained through a vinylogous aldol reaction (Scheme 2.4).  
Alcohol 2.22 was first deprotected to unveil the ketone which was reduced to give diol 
2.23.  Diol 2.23 was then protected as its acetonide and the ester was completely reduced 
to the alcohol.  This primary alcohol was converted to iodide 2.24 via the mesylate.  
Lithio-acetylene 2.25 was then coupled and following deprotection of the acetonide gave 
diol 2.26.  Finally, an iodo-etherification procedure gave THF 2.27 in good yield. 
 
Scheme 2.4.  Snider’s Route to the THF Core of Haterumalide NA. 
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 The alcohol of THF 2.27 was then acylated and the iodide oxidized to the 
corresponding iodoso compound (Scheme 2.5).  Potassium carbonate hydrolyzed both the 
iodoso and the ester functionalities to give diol 2.28.  The two alcohols were protected as 
their acetonide and the TBS group was removed with fluoride.  Hydroalumination of the 
intermediate alcohol with Red-Al and the oxidation of alkenyl aluminium by N-
chlorosuccinimide provided the chloro-alkene.  The allylic alcohol was then transformed 
into allyl chloride 2.29 by the use of mesyl chloride in conjunction with lithium chloride. 
 
Scheme 2.5.  Synthesis of Allyl Chloride 2.29. 
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 Synthesis of the Stille coupling partner for allyl chloride 2.29 began with known 
alcohol 2.30, which was oxidized to the aldehyde and then underwent an aldol reaction in 
the presence of chiral Lewis acid 2.31 to give alcohol 2.32 (Scheme 2.6).  Alcohol 2.32 
was protected as its TBS ether, and the iodine was exchanged for a trimethylstannyl 
group under palladium catalysis to give vinyl stannane 2.33.  With both coupling partners 
in hand, the Stille coupling between vinyl stannane 2.33 and allyl chloride 2.29 was 
undertaken to give THF 2.35 in good yield.  Next deprotection of the acetonide under 
acidic conditions followed by trityl protection of the primary alcohol and basic hydrolysis 
of the phenolic ester gave acid 2.36 ready for macrocyclization.  Macrocyclization is 
accomplished using a two step Yamaguchi protocol to afford macrocycle 2.37.  
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Completion of the synthesis of haterumalide NA methyl ester is brought about by 
deprotection of the hydroxyl at C3 and acylation followed by coupling with the side chain 
by the method developed by Kigoshi. 
 
Scheme 2.6.  End Game of Snider’s Synthesis of ent-Haterumalide NA Methyl Ester. 
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 The only synthesis of the correct enantiomer of haterumalide NA (2.1) was 
carried out by Hoye and co-workers.95  Hoye’s synthesis began with advanced silane 2.38 
which was available in several steps by methodology developed by  
Roush and Micalizio (Scheme 2.7).97  A protecting group switch from silyl ether 2.38 to 
acetonide 2.39 was uneventfully accomplished in two steps.  Tamao-Fleming oxidation 
of the silane 2.39 to the alcohol and subsequent inversion using the Mitsunobu protocol 
yielded acetonide 2.40 after hydrolysis and protection as the silyl ether.  DDQ removal of 
the PMB group followed by exposure to iodine in the prescence of triphenylphosphine 
 48 
gave iodide 2.41.  Homologation of iodide 2.41 by three carbon atoms was accomplished 
by a radical process to give alkene 2.42. 
 
Scheme 2.7.  Synthesis of THF 2.42. 
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 Alkene 2.42 was then converted to the corresponding alkyne by a two step 
procedure.  First, ozonolysis of the alkene to the aldehyde and then alkynylation with 
diazophosphonate 2.44 gave alkyne 2.45 (Scheme 2.8).  The acetonide of alkyne 2.45 
was removed under acidic conditions and the resulting diol was oxidatively cleaved to the 
aldehyde.  This aldehyde was then reduced with sodium borohydride and the resulting 
alcohol was then protected to give alkyne 2.46.  Next, the TIPS group was removed by 
the action of fluoride and coupling with acid 2.47 which gave ester 2.48.  The key alkyne 
haloallylation reaction was carried out by reaction of alkyne 2.48 with a palladium 
catalyst to obtain the macrocycle in good overall yield as a 1.4 to 1 mixture of 
geometrical isomers and unfortunately, the desired (Z)-olefin was the minor product 2.50.  
This macrocycle however was carried forward in a similar sequence to that of Kigoshi 
and Snider to finish the synthesis of the natural enantiomer of haterumalide NA (2.1). 
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Scheme 2.8.  Completion of the Synthesis of (-)-Hateumalide NA. 
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Retrosynthetic Analysis of the Haterumalides 
The combination of interesting structure and biological activity initially drew our 
attention to this class of natural products.  In our original retrosynthesis, we envisioned 
that haterumalide NA could be constructed via three major disconnections (Scheme 2.9).  
We envisioned that the C8-C9 bond could be constructed through a transition metal 
catalyzed coupling.  The macrolactone could be formed from a β-lactone derived from 
diene 2.52 as the hydroxyl at C12 is somewhat hindered and would require a reactive 
acylating agent.93, 98  Finally, the side chain could be appended by an appropriate 
olefination reaction with the aldehyde derived from ester 2.53. 
 
Scheme 2.9.  Retrosynthetic Analysis of Haterumalide NA. 
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 We next envisioned that the tetrahydrofuran core 2.53 of the haterumalides could 
be prepared from an appropriately functionalized cis-β-lactone such as 2.54 (Scheme 
2.10).  This β-lactone would give rise to the desired tetrahydrofuran 2.53 by a Lewis acid 
mediated cyclization developed by Mead.99  Reduction of the intermediate oxocarbenium 
ion is predicted to give the trans-tetrahydrofuran using the model developed by Woerpel 
for similar substrates.100  While the construction of cis-β-lactones are well 
documented101, γ-siloxy-cis-β-lactones have not been previously described.  The lack of 
routes to γ-siloxy-cis-β-lactone such as β-lactone 2.54 led us to consider the development 
of methods for their preparation and in particular we were attracted to studying the 
potential for regio- and diastereoselective reduction of spiroepoxy-β-lactones 2.55.   
 
Scheme 2.10.  Retrosynthesis of THF 2.53. 
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 Calter demonstrated that ketene homo-dimers can be prepared by cinchona 
alkaloid catalyzed dimerizations in good yields and with high enantioselectivities.102  
This method could potentially be applied to the construction of β-lactone 2.54 by 
oxidation of the olefin present in hetero-ketene dimer 2.56 (Scheme 2.11).  We predicted 
that oxidation of the olefin would take place opposite to the α-substitutent due to steric 
interactions between the oxidant and the substituent.  To explore the viability of this route 
we set out to explore a model study using ketene-homo dimers as substrates. 
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Scheme 2.11.  Retrosynthesis of β-Lactone 2.54. 
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Model Studies Toward the Oxidation of Ketene-Homo Dimers  
Our attention focused on developing appropriate oxidation conditions that would 
provide the desired γ-oxygenation while leaving the β-lactone nucleus intact (Scheme 
2.12).103 It was assumed that epoxidation would result in an intermediate spiroepoxy-β-
lactone 2.58 that might be highly unstable and therefore be reduced in situ to the desired 
β-lactone 2.60.  Reduction would favor formation of an oxocarbenium ion such as 2.59 
over that generated from the epoxide based on ring strain considerations.   
 
Scheme 2.12.  Epoxidation and Reduction of Ketene-Homo Dimers. 
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 We next set out to explore oxidation conditions and the first oxidant that was 
explored was m-CPBA.  Not surprisingly acidic m-CPBA even with buffering conditions 
gave multiple products.  It was obvious from this result that the oxidation would 
necessitate milder conditions.  The next oxidant chosen to fit these requirements was 
DMDO, a mild non-nucleophilic and neutral oxidant. 37  However, exposure of dimer 
2.61 to DMDO at low temperatures lead to no reaction (Table 2.1, entry 2).  We were 
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pleased to find that exposure of dimer 2.61 to freshly prepared DMDO at ambient 
temperature led to the production of a single product.  Secure assignment of the structure 
of this compound as spiroepoxy-β-lactone 2.62 was delayed stability to silica gel 
chromatography but tentatively assigned at this point based on NMR, MS, and IR.  
 
Table 2.1.  Exploration of Epoxidation Conditions of Ketene-Homo Dimers. 
O
O
O
O
OConditions
2.61 2.62
 
Entry Conditions Outcome 
1 m-CPBA, NaHCO3, CH2Cl2, 0oC Multiple products 
2 DMDO, CH2Cl2, -78oC No reaction 
3 DMDO, CH2Cl2, 23oC Single stable product 
 
 
 To give further support to the structural assignment of the oxidation product 
structure as that of spiroepoxy-β-lactone 2.62, we explored the scope of this oxidation 
Table 2.2).  Both straight chain alkyl substituents 2.62 and carbocycles 2.64a were 
tolerated with good yields and diastereoselectivities (entries 1 and 2).  Aromatic groups 
2.64b were also tolerated but with reduced yields.  Additional functionality in the form of 
protected alcohols 2.64c was also tolerated but with reduced yield but high 
diastereoselectivity.  Finally an azido functionality in adduct 2.64d was also tolerated in 
moderate yield and good diastereoselectivity (entry 5).   
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Table 2.2.  Substrate Scope of the Epoxidation of Ketene-Homo Dimers. 
                   
R
O
O
R
DMDO, MgSO4,
23oC,CH2Cl2 R
O
O
R
O
R
O
O
R
O+
2.63 2.64 2.65
 
 
  
During this exploration of substrate scope, we were pleased to find that 
spiroepoxy-β-lactone 2.64a was a crystalline solid suitable for X-ray diffraction analysis.  
The X-ray structure of spiroepoxy-β-lactone 2.64a revealed several interesting physical 
features (Table 2.3).  First, the C11-O3 bond is slightly lengthened to 1.486 Å when 
compared to the average bond length from crystallographic data that was deposited with 
the Cambridge Crystallographic Data Centere, from a more typical length of 1.446 Å .104  
Additionally, the C10-O3 bond of the epoxide spiro-center has been significantly 
shortened to the observed 1.380Å from the average of 1.446 Å.  Finally the C10-O1 bond 
is slightly shortened to 1.448 Å from the more typical 1.492 Å.  Taken together this data 
could have two possible explanations for the observed bond lengths.   
 
 
 
 
 
 
Entry Dimer Yield dr (2.64:2.65) Product 
1 n-Bu 80 14:1 2.62 
2 CyCH2 76 10:1 2.64a 
3 PhCH2 57 24:1 2.64b 
4 TIPSO(CH2)4 40 17:1 2.64c 
5 N3(CH2)4 61 16:1 2.64d 
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Table 2.3.  X-ray Structure of Spiroepoxy-β-Lactone 2.64a and Selected Bond Lengths. 
 
Entry Bond Observed Length Average Length 
1 C11-O3 1.486 1.446 
2 C10-O3 1.380 1.446 
3 C10-O1 1.448 1.492 
 
 
 One explanation is due to the unusual bonding observed with small rings.  Due to 
the increased strain associated with three and four membered rings the hybridization at 
the atoms within the ring have an increased p-orbital character to help alleviate some of 
this strain.  With this increase in p-orbital character within the ring there is an increase in 
s-orbital character in the exocyclic bonds and thus an associated shortening.105  To 
address the possibility that the observed shortening is due to hybridization effects the 
optimized structures of this and related ring systems were calculated at the B3LYP/6-
31+G**+zpe level of theory.106  As can be seen from Table 2.4, the hybridization effects 
do account for some of the shortening observed in the ring system.  However, based on 
calculations hybridization effects do not account for all of the observed bond shortening. 
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Table 2.4.  Observed and Calculated Bond Lengths (Å) for Spiroepoxy-β-Lactone 2.64a 
and Related Ring Systems. 
Ring 
System 
Bond 
O
O
O1
46
 
O
O1
4
 
O6
 
O
1
4
 
O
O
1
46
 
O
O1
46
 
O
1
4
6
 
X1-C4 1.448a 1.492b - 1.452b 1.415c 1.458c 1.531c 
C4-X6 1.380a - 1.446b - 1.399c 1.487c 1.423c 
C4-C5 1.437a - 1.466b - 1.461c 1.487c 1.467c 
C5-X6 1.486a - - - 1.464c 1.527c 1.445c 
aObserved bond lengths for spiroepoxy-β-lactone 2.63a.  bAveraged bond lengths from 
those available in the Cambridge Crystallagraphic Data Centre.104  cCalculated bond 
lengths for optimized structures. 
 
 Since the observed bond shortening cannot be accounted for by hybridization 
effects alone another phenomenon must also be present to explain these results.  Given 
that this ring system is an acetal, one such phenomenon that could explain these results is 
the anomeric effect.   
 The anomeric effect is a phenomenon that is observed in systems in which one of 
the carbon atoms bears two heteroatoms, typically oxygen but most heteroatoms will 
participate to varying degrees.107  Due to the lone pairs of electrons on the heteroatom 
and the polarization of the other carbon-heteroatom bond, there is a donation of the non-
bonding lone pair of electrons into the σ* anti-bonding orbital of the geminal carbon-
heteroatom bond.  The result of this donation of electron density is simplistically depicted 
in Scheme 2.13 structure 2.68.  Namely, there is a pronounced increase in double bond 
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character in the first carbon heteroatom bond and thus a bond shortening is observed.  
The other carbon-heteroatom bond is weakened due to donation into the anti-bonding 
orbital resulting in an observed bond lengthening.  
 
Scheme 2.13.  Depiction of the Anomeric Effect. 
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 We considered whether simple anomeric effects could account for the observed 
differences in the bond lengths seen in the crystal structure of spiroepoxy-β-lactone 
2.64a.  First, a distinct bond shortening of the C10-O3 bond would be expected 
concurrently with a bond lengthening of the C10-O1 bond.   However, this still does not 
explain the observed results as the C10-O3 bond is shortened, but the C10-O1 bond is not 
lengthened but rather shortened to some degree, 0.044 Å.  Therefore, the best description 
of this ring system is one in which there is not one anomeric effect but in fact two 
anomeric effects.  This would explain the observed bond shortening of the C10-O3 bond 
and the bond shortening of the C10-O1 bond.   This is surprising given the increased 
strain that would be accompanied by the increase in double bond character of the epoxide 
ring.   This effect may be a consequence of the constrained geometry of the ring system 
which leads to the observed anomeric effects.   
Conclusions 
 In conclusion, we oxidized ketene-homo dimers to their corresponding 
spiroepoxy-β-lactones.  Oxidation was accomplished by using the mild, neutral, and non-
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nucleophilic oxidizing agent DMDO in moderate to good yields for a variety of 
functionalized substrates.  We obtained a crystal structure of this novel ring system and 
several interesting physical characteristics were gleaned from analysis of the structure 
and comparison to related spiro ring systems.  Finally, through the use of calculations, we 
determined that this ring system likely possesses a double anomeric effect which would 
account for the observed physical features observed in the crystal structure.  The 
observed physical data hints at the possible reactivities that will be observed. 
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CHAPTER III 
A SURVEY OF THE REACTIVITY OF SPIROEPOXY-β-LACTONES AND 
STUDIES TOWARD MACULALACTONE A88 
  
Introduction 
 Several other spiro-acetals have been recently shown to have an interesting and 
varied reactivity profile (See chapter I).  This inspired us to conduct a similar 
investigation into the reactivity of the novel ring system 1,4-dioxasprio[2.3]hexanone 3.1 
ring system.  Considering the functionalities present in this ring system there are four 
possible modes of reactivity with a nucleophile that were envisioned (Scheme 3.1).  The 
first mode is addition to the distal epoxide C-O bond, pathway ‘a’.  This mode of addition 
would lead to a γ-substituted β-keto-carboxylate 3.2 as an initial product.  This product 
would likely undergo a facile decarboxylation to yield α-substiuted ketones 3.3 as the 
ultimate product.  The second mode involves addition to an oxocarbenium derived from 
cleavage of the epoxide ring at the spirocenter.  This would result in a γ-hydroxy-β-
lactone 3.4 which was the initially desired reaction manifold to obtain the requisite β-
lactone for haterumalide synthesis.  Alternatively, a nucleophile could add to an 
oxocarbenium derived from cleavage of the β-lactone ring at the spirocenter instead of 
the epoxide (pathway ‘c’).  This cleavage would result in the formation of an epoxy-acid 
3.5 as the product.  The final mode involves nucleophilic addition at the β-lactone 
carbonyl leading to acylation and cleavage of both rings to initially yield a γ-hydroxy-β-
keto-acid 3.6.  With these possible reaction manifolds in mind we set out to explore a 
variety of nucleophiles and reaction conditions to ascertain the preferred reaction 
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pathways for a given nucleophile.  Ultimately we epected to apply discovered conditions 
leading to reaction manifold type ‘b’ to the synthesis of the tetrahydrofuran of the 
haterumalides. 
 
Scheme 3.1.  Modes of Nucleophilic Addition to 1,4-Dioxaspiro[2.3]hexanones. 
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 When spiroepoxy-β-lactone 2.64a was exposed to tetrabutylammonium chloride, 
the major isolated product was α-chloroketone 3.7 in low yield.  Similarly, when the 
same spirocompound was exposed to sodium azide in a THF/H2O mixture α-azidoketone 
3.8 was obtained in low yield.  These reactions are examples of nucleophilic addition by 
pathway ‘a’. 
 
Scheme 3.2.  Nucleophilic Additions to Spiroepoxy-β-Lactone 2.64a (Pathway ‘a’). 
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 The proposed mechanism fro these additions is outlined in Scheme 3.3.  Attack of 
the nucleophile to the distal epoxide C-O bond would result in hemiketal 3.9 which 
would collapse to give the intermediate keto-carboxylate 3.10.  This intermediate likely 
undergoes facile decarboxylation to yield enolate 3.11 and ultimately ketone 3.7 after 
protonation. 
 
Scheme 3.3.  Proposed Mechanism of Chloride and Azide Addition. 
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 The reaction of spiroepoxy-β-lactone 2.64a with water over protracted periods of 
time led to α-hydroxy ketone 3.12.  Mechanistically, there are two routes that could 
provide the same ketone product.  In an effort to distinguish between these two different 
reaction pathways, the reaction was repeated with isotopically enriched water containing 
90% O18.  The two reaction pathways are: (1) addition through reaction pathway ‘a’ 
which would result in the product incorporating and retaininig the oxygen-18 isotope, 
ketone 3.12 (Scheme 3.4) (2) addition to the β-lactone carbonyl (pathway ‘d’), which 
would result in the incorporation of the oxygen-18 into the carbon dioxide derived from 
decarboxylation and thus no isotope incorporation into ketone 3.11 (Scheme 3.4).   
 
 61 
Scheme 3.4.  Possible Pathwarys for Addition of Water to Spiroepoxy-β-Lactone 2.64a. 
O O
O
18OH
O
H2O18/THF
OH
OH2O18/THF
C
O18
O
C
O
O
Path 'a' Path 'd'
2.64a3.12 3.13
+ +
 
 
 Pathway ‘d’ would result in loss of labeled carbon dioxide by a process outlined 
in Scheme 3.5.  Addition of labeled water to the carbonyl of the β-lactone ring  of 2.64a 
would result in tetrahedral intermediate 3.14 would then undergo cleavage of both rings 
to generate keto-acid 3.15.  Keto-acid 3.15 can then lose carbon dioxide, containing the 
label, and yield enol 3.16 which tautomerizes to ketone 3.13. 
 
Scheme 3.5.  Mechanism involving Acyl Addition/Decarboxylation (pathway ‘d’). 
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 After conducting this reaction it was necessary to analyze the outcome via two 
methods, namely mass spectrometry by electrospray ionization and 13C NMR.  Although 
mass spectrometry did show an increase of two amu over the control experiment for the 
ketone 3.12, 13C NMR would ensure the position of the label as it is well-known that 
oxygen can be incorporated into  ketones through exchange with water molecules under 
 62 
both acid and base catalysis.108, 109  13C NMR studies were undertaken to determine the 
site of oxygen-18 incorporation by observation of the slight shielding effect of the 18O 
isotope versus 16O on a 13C atom.110 
   Analysis of this shielding effect by 13C NMR would distinguish incorporation of 
18O at the alcohol carbon or the carbonyl carbon.  As seen in Figure 3.1a, an upfield shift 
is observed for the labeled a-hydroxyl bearing 13C with a small shoulder corresponding to 
residual H216O incorporation.  A ~1:1 mixture of 13C derived from addition of a ~1:1 
mixture of 18O enriched and and normal water confirms the labeling of this position 
(Figure 3.1b).  Expansion of the carbonyl region did not show shift differences epected 
for incorporation of 18O at the carbonyl carbon.   
 
 
   (a)                         (b) 
Figure 3.1.  13C NMR spectral expansion of carbinol region of α-hydroxy ketone 3.12 
following: (a,) reaction with 90% atom H218O.  (b) reaction with ~1:1 mixture of 18O 
enriched and normal H216O water above in Figure. 
 
 Reduction of the spiroepoxy-β-lactone 2.64a with lithium aluminum hydride gave 
the corresponding triol 3.17 in excellent yield (Scheme 3.6).  The nucleophilic addition of 
hydride is a result of initial addition to the carbonyl carbon, (pathway ‘d’) since no 
Residual 16O  
Incorporation 
16O 18O 
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deoxygenation is observed at C4 or C5 and this is also consistent with reduction of β-
lactones with metal hydrides leading to acyl C-O versus C-O alkyl cleavage.  Also, the 
product reduction of the β-lactone carbonyl reveals an α-hydroxy ketone which is then 
reduced to the observed triol 3.17.  Attempts to effect the desired reduction for 
haterumalide under Lewis acidic condtions, ZnCl2, BF3.OEt2, etc. in combination with 
reducing agents led to either no reaction or complex mixtures of products.   
 
 Scheme 3.6.  Metal Hydride Reduction of Spiroepoxy-β-Lactone 2.64a. 
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O
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OHLiAlH4
(92%) 3.172.64a
 
 
 Spiroepoxy-β-lactone 2.64a also reacts with base in the presence of Lewis acid to 
provide a small amount of α,β-unsaturated ketone 3.18 in low yield (Scheme 3.7).  This 
reaction represents a different reaction pathway than those outlined in Scheme 3.1, but 
not uncommon to similar systems (cf. Chapter I). 
 
Scheme 3.7.  Elimination of Spiroepoxy-β-Lactone 2.64a. 
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i -Pr2NEt
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 The proposed mechanism for this elimination is outlined Scheme 3.8.  Activation 
of the carbonyl of the β-lactone ring, such as Lewis acid complex 3.19, leads to 
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deprotonation with the amine present and loss of both rings to yield keto-carboylate 3.20.  
Upon workup the carboxylate is protonated to give keto-acid 3.21 which decarboxylates 
to yield enol 3.22.  Tautormization of enol 3.22 leads to the observed α,β-unsaturated 
ketone 3.18.   
 
Scheme 3.8.  Mechanism of Lewis Acid Induced Elimination of Spiroepoxy-β-Lactone 
2.64a.   
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 Exposure of a single diastereomer of spiroepoxy-β-lactone 2.64a to two different 
amines two different reaction manifolds were observed.  Reaction with the less sterically 
hindered diethylamine resulted in a single diastereomer of a β-keto-amide 3.23 resulting 
from simple nucleophilic addition through pathway ‘d’ (Scheme 3.8).  However, when 
spiroepoxy-β-lactone 2.64a was exposed to a more sterically hindered amine, 
diisopropylamine, it surprisingly resulted in an essentially 1:1 mixture of diastereomeric 
keto-amides 3.24.  While this initial result was intriguing our only viable initial 
hypothesis was that the reaction had to proceed through an intermediate in which the α-
stereocenter was lost prior to or as a result of nucleophilic addition of the amine.  This 
was assumed due to A1,3 strain which severly retard the epimerization of α-substituted β-
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ketoamides.111  In fact it was found that exposure of a single diastereomer of diethyl 
amide 3.23 to deuterated diisopropylamine led to no incorporation of deuterium 
suggestive of no epimerization of that center over 4 h. 
 
Scheme 3.8.  Reaction of Spiroepoxy-β-Lactone 2.64a with Amines. 
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 Interestingly, when spiroepoxy-β-lactone 2.64a was exposed to the tertiary base 
diazabicycloundecane (DBU), the tetronic acid derivative 3.24 was obtained as the sole 
product (Scheme 3.9).  The structure was confirmed by X-ray structure.  This result 
inconjunction with the previous results with secondary amines intrigued us and required a 
mechanistic rationale. 
 
Scheme 3.9.  Base-Induced Rearrangement of Spiroepoxy-β-Lactones. 
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 With these results in hand, we considered two possible explanations for the 
observed results.  The first possibility is that the amine directly deprotonates spiroepoxy-
β-lactone 3.25 with loss of the epoxide ring to form oxet-3-en-2-one intermediate 3.26 
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(Scheme 3.10) which may undergo a retro[2+2] reaction to form keto-ketene intermediate 
3.27.  The formation of keto-ketene 3.27 rationalizes the loss of relative stereochemistry 
which is observed during generation of tertiary amide 3.28. 
Scheme 3.10.  One Possible Mechanism for the Observed Outcomes.  
R
O
R
O
O H
NR3
R
O
R
O
O O
O
O
•
R R
HN(i-Pr)2
OH
O O
R
R
N(i-Pr)2
3.25 3.26 3.27 3.28
 
 
  An alternative mechanism involves deprotonation at the α-position of the β-
lactone leading to the formation of enolate 3.29, which then undergoes ring cleavage to 
form tetrahedral intermediate 3.30 (Scheme 3.11).  Subsequent epoxide ring cleavage 
would yield the previously described keto-ketene intermediate 3.27 which ultimately 
leads to β-keto-amide 3.31 with loss of the stereochemistry at the α-carbon. 
 
Scheme 3.11.  Alternative Mechanism Leading to Amide 3.24. 
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 In order to provide support for one of these mechanistic possiblities, we set out to 
study this reaction by in situ IR since ketenes produce a very easily discriminated 
absorption band in the infared spectrum, at 2100 cm-1.  Unfortunately, we were unable to 
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observe this intermediate at ambient or low temperatures which does not exclude the 
possibility of a ketene intermediate as it may simply be a short-lived intermediate and 
thus not readily detected by IR.   
 An alternative method to provide evidence for a keto-ketene 3.27 as an 
intermediate is through direct trapping of a putative ketene intermediate with  
reagentsknown to react rapidly with ketenes such as TEMPO which leads to esters 
containing two TEMPO molecules.112 However, it should be noted that we recognized 
that this would be challenging as we were attempting to trap an intermediate in an 
intermolecular fashion which must be competitive with intramolecular cyclization of the 
same ketene intermediate.  Several attempts led only to the expected rearrangement to a 
butenolide and the production of small quantities of α-hydroxy ketone 3.12 due to 
residual water in TEMPO. 
 We were interested in exploring nucleophiles that might add to alkyl C-O bonds 
in these systems which led us to study sulfur nucleophiles.  When spiroepoxy-β-lactone 
2.64a was treated with benzyl thiol at low temperatures, -78→-20 oC, no reaction was 
observed and no change was observed when warmed to room temperature, 23 oC, for 
protracted time periods.  However, when exposed to a combination of benzyl thiol and 
boron trifluoride diethyl etherate at -78 oC a reaction ensued which was completed in 30 
min to give a moderate yield of tetronic acid 3.24 (Scheme 3.12).   
 
Scheme 3.12.  Reaction of 2.64a with Thiol and Lewis Acid. 
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 Having found this dichotomy between the reactivity of thiols with and without 
Lewis acid we set out to explore this further.  A control experiment with only boron 
trifluoride diethyl etherate also gave tetronic acid 3.24 in good yield (79%) indicating that 
Lewis acid was responsible for the rearrangement. Other Lewis acids, Zn(OTf)2, 
Sn(OTf)2, and In(OTf)3 gave similar results.   While the mechanism is unclear at this time 
it presumably involves cleavage of one of the spiro C-O bond to form an oxycarbenium 
intermediate which then drives the rearrangement to the tetronic acid. 
 The facile production of tetronic acid derivatives from these spiroepoxy-β-
lactones led us to explore the possibility that this ring system might provide facile access 
to tetronic acid derivatives or butenolide motifs, which are common motifs in natural 
products.113  This led us to consider the natural product maculalactone A which possesses 
an interesting tribenzyl tetronic acid-like structure that might be accessible via a 
spiroepoxy-β-lactone. 
Isolation and Biological Activity of the Maculalactones 
 Maculalactones A-M (3.32-3.44) were isolated from the marine cyanobacterium 
Kyrtuthrix maculans (Figure 3.2)  and are a group of γ-lactone containing natural 
products with maculalactone A (3.32) being the simplest member of the family with 
complexity increasing in the more oxidized versions such as maculalactone K (3.42).114-
117
  Of all of the members, only maculalactone A (3.32) has shown any significant 
biological activity.  Maculalactone A (3.32) has been shown to inhibit the growth of 
marine bivalves on rock surfaces were Kyrtuthrix maculans grows.  Due to this biological 
activity it is being explored as an additive to paints as an anti-fouling agent. 
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Figure 3.2.  Structures of maculalactones A-M (3.32-3.44). 
 
Previous Syntheses of Maculalactone A 
 Maculalactones A-C (3.32-3.34) has also attracted the attention of synthetic and 
to date there have been two syntheses of each of these natural products, including one 
enantioselective synthesis of maculalactone A (3.32).  
 The first synthesis by Brown began with Stobbe condensation of benzylaldehyde 
3.45 and ester 3.46 followed by anhydride formation to give dienoate 3.47 in poor yield 
over the two steps (Scheme 3.13).118  This route was chosen due to its amenability to 
large scale in spite of the poor yield.  Hydrogenation of anhydride 3.47 followed by 
addition of a benzyl Grignard reagent led to the production of alcohol 3.48.   Exposure of 
alcohol 3.48 to diazomethane leads to ring opening and the formation of ketone 3.49 
which was then reduced with catachol borane in the presence of chiral Lewis acid 3.50 in 
good yields and good enantiomeric excess.   
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Scheme 3.13.  Brown’s Synthesis of Maculalactone A (3.32). 
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 Argade’s synthesis of maculalactones A (3.32) and B (3.33) begins with bromide 
3.51 which is derived from citraconic anhydride (Scheme 3.14).119  Addition of a benzyl 
group in a 1,4 fashion lead to diacid 3.52 after hydrolysis of both esters.  The alkene was 
then brominated and the anhydride 3.53 was formed by use of acetic anhydride.  The 
bromide was then displaced with phenyl cuprate followed by complete reduction of the 
carbonyl to the corresponding methylene to give γ-lactone 3.54.  Following condensation 
with benzyaldehyde to yield maculalactone B (3.33) was obtained.  Finally, catalytic 
hydrogenation of maculalactone B (3.33) then gave racemic maculalactone A (3.32). 
 
Scheme 3.14.  Argade’s Synthesis of Maculalactone A and B. 
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Retrosynthesis of Maculalactone A 
 Our reterosynthesis of maculalactone A (3.32) begins with disconnection of the 
C4 benzyl group, which could be accomplished with the aid of a transition metal 
coupling from enol triflate 3.55 (Scheme 3.15).  This triflate 3.55 could in turn be made 
from the corresponding tetronic acid derivative which would be derived from optically 
active spiroepoxy-β-lactone 3.56.  
 
Scheme 3.15.  Retrosynthesis of Maculalactone A (3.27). 
Ph
Ph
O
O
Ph
Ph O
O
PhTfO
OO
O
(3.32) 3.55 3.56
 
 
Coupling Route to Maculalactone A 
 Our synthesis of the required triflate 3.55 begins with optically active spiroepoxy-
β-lactone 3.56, obtained from the optically active dimer synthesized with TMSO-
quinine.120, 121  Rearrangement with N,O-dimethylhydroxyamine gave the tetronic acid 
3.57 (Scheme 3.16).  N,O-dimethylhydroxyamine was used in the rearrangement as it 
seemed that tetronic acid 3.57 could be prone to epimerization.  Due to the difficulty in 
purifying tetronic acid 3.57 the crude reaction mixture was then converted to the triflate 
3.55 in modest yield over two steps.  The position of the triflate was also confirmed by 
X-ray analysis. 
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Scheme 3.16.  Synthesis of Triflate 3.55. 
Ph Ph
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O
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CH2Cl2
Tf2O, (i-Pr)2NEt
CH2Cl2(52%, two steps)3.56 3.57 (+) 3.55
 
 
 Unfortunately, the coupling reaction necessary to finish the synthesis proved to be 
quite difficult.  Attempts to couple triflate 3.55 with hypervalent tin reagents, which have 
been shown to be effective in sterically hindered settings, only resulted in hydrolysis of 
the triflate.122  Attempts using other transition metal catalysts, such as copper or iron, also 
met with failure. 
 As tetronic acids are veiled β-keto-lactones it was expected that revealing this 
functionality would be a more viable route maculalactone A (3.32) (Scheme 3.17).  To 
accomplish the tetronic acid 3.57 was converted to enol ether 3.58.123  This ketone was 
then treated with a variety of different benzyl-metal reagents, including lithium, 
magnesium, cerium, however these all returned starting material.  This may be due to 
deprotonation to form a furan type intermediate, which would not react further.  
 
Scheme 3.17.  Alternate route to Maculalactone A (3.32). 
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O
PhHO
Ph O
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PhO
Me3O BF4
CH2Cl2
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O
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3.57 3.58 (3.32)
 
 In conclusion we explored the reactivity of spiroepoxy-β-lactones under a variety 
of conditions.  Out of the four possible reaction manifolds considered, it appears that the 
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majority of nucleophiles react through pathways ‘a’ or ‘d’ involving acyl C-O or distal 
epoxide C-O bond cleavage respectively.  We have also shown that under basic 
conditions, an achiral intermediate is likely formed, possibly a keto-ketene intermediate 
which however could not be detected, but can undergo an intramolecular cyclization to 
form tetronic acid derivatives.  Additionally, Lewis acid also led to tetronic acid 
derivatives through cleavage of one of the spiro C-O bonds to form an oxycarbenium 
intermediate which then rearranges to give the observed product.  Finally, we have 
attempted to make the marine natural product maculalactone A by taking advantage of 
these reactivities. 
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CHAPTER IV 
TRANS-SELECTIVE COUPLINGS OF 1,1-DICHLOROALKENES 
 
Introduction 
The stereoselective synthesis of trisubstituted alkenes under mild conditions 
remains a challenging problem in synthesis.  Further difficulty is added when one of the 
three substitutents is a halogen atom.  In pursuit of a solution to this problem, methods 
have been developed for the synthesis of bromo and iodo alkenes utilizing either a trans-
selective cross coupling in the case of 1,1-dibromo-alkenes124 or modified Wittig 
reactions (e.g. Stork-Zhao olefination125).  However, few highly stereoselective methods 
exist for the corresponding reaction incorporating chlorine which would be useful due to 
the presence of vinyl chloride moieties in a variety of  recently isolated natural products 
including pinnaic acid (4.1), tauropinnaic acid (4.2)126, the aurantosides (4.3)126 (e.g. 
aurantoside A), halichlorine (4.4)127 , and the haterumalides (2.1)90 (e.g. haterumalide 
NA) (Figure 4.1).   
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Figure 4.1.  Structure of Z-chloro-dialkyl-alkene containing natural products. 
 
All of these natural products contain a trisubstituted alkene incorporating a 
chlorine atom as one of the substituents.  Additionally the two alkyl groups bear a trans 
relationship to one another.  This re-occurring motif led us to explore the feasibility of a 
trans-selective cross-coupling between a suitable nucleophile and a 1,1-dichloro-alkene 
under palladium catalysis.  We hoped that this coupling could be used in a 
macrocyclization  toward haterumalide NA (Scheme 4.1).   Such that intramolecular 
coupling of skipped diene 4.5 to give macrocycle 4.6.  At the onset of our endeavor there 
was only one paper detailing a similar reaction.128   However, recently there have been a 
few reports detailing an isolated coupling and two papers have recently appeared that 
explore the type of coupling in a broader context.129, 130 
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Scheme 4.1  Proposed Coupling for Haterumalide NA. 
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Encouraged by the fact that great strides have recently been made with palladium 
catalysis as applied to a variety of very challanging substrates, i.e. aryl chlorides.  These 
studies have led to the development of cross-coupling conditions employing a multitude 
of new catalysts and conditions.131, 132  We therefore embarked on screening catalysts for 
their ablility to promote cross-coupling of dichlorolefins with nucleophiles.  After 
screening several phosphine ligands we were very pleased to to find that bis-(tri-tert-
butylphosphine) palladium (0), recently utilized for cross-coupling with arly chlorides, 
provided an initial hit for this reaction by coupling dichloroolefine 4.8 with alkyl zinc 
reagent 4.7 to give olefin 4.9.133   
 
Scheme 4.2  Initial successful coupling of dichloroolefin 4.8 with zincate 4.7. 
ZnBr
O
EtO H
Cl
O
OEtClCl Pd(Pt-Bu3)2
NMP
µW, 120 oC
(66%)4.7 4.8 4.9
 
 
Optimzation of the Coupling 
 These initial studies with bis-(tri-tert-butylphosphine) palladium (0) coupling of 
1,1-dichloroolefin  and a zinc reagent derived from tert-butyl 4-bromobutanoate required 
optimization of the conditions to improve the yield of this process.  Our interest in 
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applying this coupling in the arena of natural product synthesis dictated several 
requirements for this reaction.  The first was that the zinc reagent used in the reaction had 
to be formed under mild conditions to allow for the complex functionality present in 
possible natural product total synthesis schemes.  Additionally, we hoped to minimize the 
reaction times nessecary since as coupling reactions especially with deactivated systems 
like 1,1-dichloroolefins are known to have protracted reaction times.  The geminal 
chlorine has a deactivating effect on the intial insertion step into the C-Cl bond and 
subsequently the trisubstituted olefin has greater reactivity, devoid of the geminal 
chloride, this causing double substitution a potential problem in the process.129   With 
these requirements and challenges in mind, we set out to find a procedure that would be 
amenable to complex settings.   
Addressing the first requirement was relatively easy as there are a number of very 
efficient and mild protocols that have been developed for the synthesis of alkyl zinc 
reagents from alkyl bromides.134  One procedure for the mild convertion of alkyl 
bromides to alkyl zincs and that was applied to a similar coupling employed recently by 
Fu involves a modified Knochel procedure, using the highly polar solvent N,N-
dimethylacetamide.  Use of this solvent is thought to facilitate insertion of metallic zinc 
into a carbon bromine or iodine bond at 80 oC and room temperature respectively.135  
Given that the reaction temperature an time are relatively mild we decided this would fit 
our requirements.  Additionally, it was very attactive to use a direct metal insertion, as 
transmetalation conditions typically use excesses reactive lithium reagents which are not 
compatible with a number of functional groups that might be present in a total synthesis.  
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With the requirement of a functional group friendly method for generation of the zinc 
reagent we next turned our attention to minimize the duration of the reaction. 
 The advent of the microwave oven and its drastic reduction in the time it takes to 
cook foods, intrigued chemists for its use as a potential alternatitive to other heating 
methods including oil baths and heating mantles.  However, it was not until 1986 that the 
first microwave assisted reaction was reported.136  Since that time there as been an 
explosion of literature using microwaves to heat reactions.136  The vast majority of these 
reactions exhibit an increased rate of reaction and thus significant shortening of reaction 
times. With this precedent and given that microwave heating had been used in similar 
context, the use of microwave heating was considered for the planned coupling of 
1,1dichloroolefins and alkyl zinc reagents.137   Initally, optimization of the temperture of 
the reaction was studied for the coupling of dichloroolefin 4.8  and alkyl zinc 4.10 and as 
can be seen, at lower temperature of the conversion is minimial (Table 4.1, entries 1and 
2).  However there is sharp increase in conversion when the reaction is run at 100 oC, and 
then a decrease when the temperature is further increased to 120 oC.  These results are 
suggestive that the optimal temperature is ~100 oC and possibly reactions above this 
temperature result in rapid catalyst or reagent decomposition. 
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Table 4.1.  Optimization of Reaction Temperature for Coupling of 4.8 and 4.10. 
ZnBr
O
O H
Cl
O
OClCl
Pd(Pt-Bu3)2
DMA/THF
conditions4.84.10 4.11
 
Entry Temperature (oC) Conversion
a
 
1 80 5% 
2 90 10% 
3 100 50% 
4 120 18% 
aConversition was monitored by 1H NMR. 
 
 We next explored the reaction time and found that with only 15 minutes of 
heating only 14% conversion was observed (Table 4.2).  However when the reaction time 
was increased to 2 h 52% conversion was obtained. 
   
Table 4.2.  Optimization of Reaction Time for Coupling of 4.8 and 4.10 by Microwave 
Heating. 
ZnBr
O
O H
Cl
O
OClCl
Pd(Pt-Bu3)2
DMA/THF
conditions4.10 4.8 4.11
 
Entry Time Conversiona 
1 15 minutes 14% 
2 1 hour 19% 
3 2 hours 52% 
aConversition was monitored by 1H NMR. 
 
The remaining variable to be explored was the number of equivalent of zinc 
reagent necessary for the reaction.  It was found that the utilization of 1.5-2.5 equivalents 
of zinc reagent led to relatively poor conversitions (entries 1-3, Table 4.3).  Interestingly, 
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an increase to 3.0 equivalents of zinc reagent led to complete conversion.  The need for a 
large excess of zinc reagent is unclear.  The quality of the zinc reagent appeared good  as 
1H NMR showed complete conversion to the alkyl zinc reagents and reaction with iodine 
confirmed this, the necessity of excess zinc reagent was reproducible with different 
batches of zinc reagent. 
 
Table 4.3.  Varying the Equivalents of Zinc Reagent for the Coupling of 4.8 and 4.10 by 
Microwave Heating. 
ZnBr
O
O H
Cl
O
OClCl
Pd(Pt-Bu3)2
DMA/THF
conditions4.10 4.8 4.11
 
Entry Equivalents Conversiona 
1 1.5 18% 
2 2 29% 
3 2.5 35% 
4 3 100% 
aConversition was monitored by 1H NMR. 
 
We then set out to explore the scope of the reaction using our optimized 
conditions described above (Table 4.4).  With alkyl zinc reagents that contain a 
heteroatom that is 4-5 atoms away from the Zn species, the coupling reaction proceeds in 
moderate yield to give the monocoupled products using the standardized conditions 
(entries 1-4).  However, when the heteroatom is absent or protected with a bulky 
protecting group that would prevent chelation, the reaction does not provide coupled 
adduct (entries 5-6).  This may suggest the requirement for chelation leading to 
stablization of the alkyl zinc reagent at the conditions required for the reaction or leading 
to a more reactive zinc reagent.  Another observation was made concerning the allowed 
 81 
water content of N,N-dimethylacetamide employed as solvent.  If the water content was 
>100 ppm, as determined by Karl-Fischer titration, no coupling was observed even 
though active zinc reagent was still present, as determined by reaction with iodine.  This 
became a frequent problem as the water content of commercial (Aldrich) N,N-
dimethylaceamide used in this study was often over 150 ppm.  To overcome this problem 
double distillation of the N,N-dimethylacetamide from barium oxide at reduced pressures 
was required and proved effective.   
Having determined the optimal reaction conditions and breifly explored the 
reaction scope, we turned our attention back to our original goal of applying this reaction 
to natural product synthesis.  As discussed in Chapter II, we planned to apply this 
methodology to the coupling of the western hemisphere and the THF fragment resulting 
in the C8-C9 bond of the haterumalides.  Toward this goal, we considered various routes 
to diene 2.52, which would be serviceable for an eventual total synthesis of haterumalide 
NA.  After a survey of the literature, we found that the two most common methods for 
construction of the 1,1-dichloro-alkene motif were Corey-Fuchs reaction of an appropiate 
aldehyde with carbon tetrachoride in the presence of triphenyl phosphine138, and 
reductive fragmentation of trichloromethyl group bearing an adjacent leaving group.139  
This led us to devise two retrosyntheses of diene 2.52 with the first employing aldehyde 
4.20 using a Corey-Fuchs protocol.  While this stategy was straight-forward since all 
proposed steps were precedented, there were two potential problems with this route.  The 
first being the intermediacy of a voliatile siloxy-aldehyde 4.21140 and the the other being 
the Corey-Fuchs reaction on an enolizable aldhyde.  Ultimately consideration of these 
problems led to the exploration of an alternate one.133 
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Table 4.4.  Scope of the Coupling of a Model 1,1-Dichloroolefins 4.12 and 4.8 and 
Various Alkyl Zinc Reagents.   
R1H
Cl Cl
R1H
ClR2
R1H
R2 R2R
2ZnBr
Pd(Pt-Bu3)2
DMA/THF
µW, 100 oC 4.144.134.12: R1= heptyl
4.8: R1= Ph(CH2)2
+
 
 
 
 
 
 
 
 
 
 
 
 
 
a Refers to isolated yields.  b No reaction. 
 
 
 
 
 
 
 
Entry R1 R2 Product/ Ratio yield
a
 
1 4.12 
ZnBrNC
 
4.15 
4.13a:4.14a 
100:0 52% 
2 4.8 ZnBr
O
O
 
4.10 
4.13b:4.14b 
100:0 60% 
3 4.12 O
O ZnBr
 
4.16 
4.13c:4.14c 
100:0 39% 
4 4.8 ZnBrO  4.17 
4.13d:4.14d 
100:0 40% 
5 4.8 
TBDPSO ZnBr
 
4.18 NR
b
 0% 
6 4.12 
ZnBr
 
4.19 
NRb 0% 
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Scheme 4.3.  First Retrosynthesis of Diene 2.52  
Cl Cl
OTBS
O
OTBS
OHHO
2.52 4.20 4.22
OTBSO
4.21
 
 
 The second retrosynthesis considered for diene 2.52 would begin with a reductive 
fragmentation to yield the 1,1-dichloro-alkene and protection of the allylic alcohol to give 
diol 4.23.  This would be constructed by either reductive cleavage or hydrolysis of acetal 
4.24 followed by reduction of the corresponding aldehyde and protection.  Pyran 4.24 
would be constructed from known ethoxy-diene 4.25 and chloral 4.26 in a hetero-Diels-
Alder reaction.141 
 
Scheme 4.4.  Second Generation Retrosynthesis of Diene 2.52. 
Cl Cl
OTBS OH
OH
CCl3
OEtO CCl3
O
CCl3
OEt
2.52 4.23 4.24 4.25 4.26
 
 
Attempted Synthesis of Diene 2.52 
 The synthesis of diene 2.52 began with the hetero-Diels-Alder reaction between 
ethoxy-diene 4.25, available in two steps from tiglic aldehyde, and chloral 4.26 to give 
pyran 4.24 in moderate yields on gram scale.141   The use of toluene was crucial as other 
solvents led to very low yields.   
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 Attepts were made to directly cleave pyran 4.24 to give aldehyde 4.27 with a 
variety of metal reagents, such as Zn(0), Cr(II), and Pb/Cd, however all of these reagents 
led to no reaction.  Due to this result we sought to utilize pyran 4.24 in an alternative 
route. 
 
Scheme 4.5  Attempted reductive cleavage of pyran 4.24. 
OEtO CCl3 [M]
ClCl
O
4.24 4.27
 
 
We next considered hydroysis of pyran 4.24 with aqueous HCl in acetone to 
provide the corresponding lactol.  However, an aldehyde was obtained as the product 
which we initially assigned as aldehyde 4.28.  We rationalized the absence of the 
expected lactol on the basis of the attenuated nucleophilicity of the alcohol with the 
attached electron-withdrawing trichloromethyl group.  Aldehyde 4.28 was then reduced 
under Luche conditions to the allylic alcohol 4.29 which enabled unambiguous 
assignment of the geometry of allylic alcohol 4.29 since it was a crystalline solid.   
 
Scheme 4.6.  Second Generation Synthesis of Diene 2.52. 
O
CCl3
OEt
OEtO CCl3
OH
OH
CCl3
OH
O
CCl3
PhMe, 0oC
(55%)
HCl
acetone
(41%)
CeCl3, NaBH4
EtOH
(70%)
4.25 4.26 4.24 4.28 4.29
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 Based on X-ray analysis the olefin geometry was found to be the undesired (E)-
allylic alcohol 4.29 (Figure 4.2). As it was not known whether the hydrolysis step or 
reduction steps were responsible for the isomerization, we choose to explore another 
route to diene 2.52. 
 
 
Figure 4.2. X-ray structure of diol 4.29. 
 
Alternate Retrosynthesis of Diene 2.52 
 In light of the olefin isomerization problem, we decided to take another look at 
the retrosynthesis of diene 2.52.  Taking a note from the literature, we choose to pursue a 
method used by Hale in his partial synthesis of bryostatin.  Following the hetero-Diels-
Alder reaction between ethoxy diene 4.25 and chloral 4.26, the intermediate acetal would 
be oxidized with Jones reagent to give lactone 4.31.142, 143   
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Scheme 4.4.  Third Generation Retrosynthesis of Diene 2.52. 
Cl Cl
OTBS OH
OH
CCl3
O CCl3
O
CCl3
OEt
O
4.25 4.264.30 4.312.52
 
 
Synthesis of Diene 2.52 
 The revised synthesis of diene 2.52 began from pyran 4.24 and Jones oxidation to 
the lactone and direct Luche reduction to the diol 4.30, which proceeded in overall modes 
yield of 24% for the two steps.  The primary alcohol was protected over the secondary 
and following exposure to samarium diiodide to effect the reductive fragmentation, the 
delevered the desired skipped diene 2.52 in good overall yield 58% for the 3 steps.  The 
geometry of the olefin was confirmed by nOe experiments. 
 
Scheme 4.5.  Synthesis of Diene 2.52. 
OEtO CCl3 OH
OH
CCl3
ClCl
OTBS
1)TBSCl, im.
2)Ac2O, pyr.
3)SmI2, THF(58%, three steps)
1)Jones Ox.
2)CeCl3, NaBH4
MeOH, 0-23oC
(24%, 2 steps)
4.24 4.30 2.52
H
0.2%
H
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Synthesis of a Model Coupling Partner 
 With a viable synthesis of diene 2.52 in hand we next turned our attention to the 
synthesis of a coupling partner.  To best model the desired coupling nessecary for 
haterumalide, we set out to synthesize an appropiate alkyl zinc with a pendant THF 
which following our model studies, the appropriately placed heteroatom, i. e. oxygen of 
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the THF ring would be essential for successful coupling.  The synthesis of an appropriate 
THF began with known lactone 4.32,144, 145 which is available from glutamic acid by 
reduction and then Horner-Wadsworth-Emmons olefination with phosphonate 4.33.  This 
sequence gave α,β-unsaturated ester 4.34146 which was cyclized to the desired THF by a 
Michael reaction.  The intermediate ester proved to be unstable to silica gel 
chromatography so the crude ester was reduced with DIBAl-H to alcohol 4.35, which 
was then converted to the bromide using a two step procedure. Mesylation and then 
displacement with bromide to gave the alkyl zinc precursor 4.36 readied for coupling 
with the previously made skipped diene 2.52. 
 
Scheme 4.6.  Synthesis of Model THF. 
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 With both fragments in hand, we decided to test the coupling with three available 
methods for dichloroolefins including our developed procedure (Scheme 4.7).  Initial 
studies with the Negishi protocol for coupling skipped diene 2.52 with the corresponding 
zinc reagent derived from bromide 4.36 consistently gave no reaction for this system.129  
The Roulland procedure using an alkyl borane as the coupling partner led to several 
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products presumably due to partial or complete deprotection of the silyl groups and 
isomerization of the olefins.   
 
Scheme 4.7 Alternate Methods for Coupling Diene 2.52. 
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Conclusions 
 In conclusion, we were able to develop a coupling reaction between a 1,1-
dichloro-alkene and an alkyl zinc reagent.  We hope to apply this to a model study and 
eventually to the the construction of the C8-C9 bond of the haterumalides.  We were also 
able to determine that the coupling reaciton necessitates a heteroatom incorporated in the 
zinc reagent.  Finally, we have also been able to devise a synthesis of diene 2.52 which 
would be nesecary in such a reaction.  
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CHAPTER V 
CONCLUSIONS 
 Marine natural products have continued to inspire a great diversity of 
methodologies that are geared toward their synthesis.  Two such natural products are 
haterumalide NA and maculalactone A.  In fact it was the knowledge gained in trying to 
develop a strategy for the synthesis of haterumalide NA that ultimately led to the first 
synthesis of spiroepoxy-β-lactones and the pursuit of the synthesis of maculalactone A. 
 In our quest to devise a synthesis of a γ-silyloxy-cis-β-lactone for the construction 
of the tetrahydrofuran of haterumalide NA we discovered a novel class of spiro-
heterocycles, namely spiroepoxy-β-lactones.  These heterocycles exhibited interesting 
strucural features that were gleaned from the x-ray structure of one example.  Based on  
this x-ray structure and calculations we were able to determine that the unexpected 
stablility of this ring system may be derived from a double anomeric effect.  While these 
systems did not demonstrate the desired reactivity necessary for the synthesis of the 
tetrahydrofuran fragment found in haterumalide NA, they did demonstrate various 
interesting modes of reactivity.  For example, this spiro ring system underwent an 
interesting rearrangement to butenolides in the presence of an appropriate base.  It was 
this mode of reactivity that led to the potential utility of this ring system in a synthesis of 
maculalactone A.  Unfortunately, this did not culminate in a successful total synthesis of 
this natural product. 
 Another key reaction for our proposed route to haterumalide NA was a palladium-
catalyzed cross coupling between and alkyl zinc reagent and a 1,1-dichloro-alkene.  An 
appropriate skipped diene substrate that bears the required dichloroolefin was prepared 
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using a hetero-Diels-Alder reaction followed by subsequent ring cleavage to deliver a 
Western fragment that is serviceable for the total synthesis of the haterumalides.  We 
successfully demonstrated the utility of the coupling strategy for a variety of heteroatom 
substituted zinc reagents in the presence of the highly dipolar solvent N,N-
dimethylacetamide and with the aid of microwave heating.  We also sought to apply this 
coupling strategy to a functionalized tetrahydrofuran and the skipped diene substrate 
which constitutes a model study for the synthesis of haterumalide.   
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APPENDIX A  EXPERIMENTAL PROCEDURES 
 
AND SELECTED SPECTRA 
 
 
TIPSO
O
O
 
Methyl 6-(triisopropylsilyloxy)hexanoate. was prepared from methyl-6-hydroxy 
hexanoate (3.66 g, 25.0 mmol) by dissolving in DMF (30 mL) followed by the addition 
of imidazole (2.04 g, 30 mmol) and TIPSCl (5.80 g, 30.0 mmol).  The colorless solution 
was stirred at 23 oC for 2 d.  The reaction was quenched with brine (10 mL) and extracted 
with Et2O (3 X 50 mL).  The combined organic phase was back extracted with brine (2 X 
5 mL) and then dried over Na2SO4.  This crude oil was purified by flash chromatography 
(5:95 Et2O/hexanes) to afford the methyl 6-(triisopropylsilyloxy)hexanoate (5.33 g, 
70%).  Rf 0.19 (5:95, Et2O /hexanes); IR (thin film) νmax 1737 cm-1; 1H NMR (500 MHz, 
benzene-d6) δ 3.52 (t, J = 6.5 Hz, 2H), 3.31 (s, 3H), 2.07 (t, J = 7.5 Hz, 2H), 1.53 (pentet, 
J = 7.5 Hz, 2H), 1.41 (dt, J = 6.5, 15.0 Hz, 2H), 1.30-1.23 (m, 2H), 1.09-0.99 (m, 21H); 
13C NMR (125 MHz, benzene-d6) δ 173.2, 63.4, 50.9, 34.1, 33.0(2), 25.7, 18.3(6), 
12.3(3); LRMS (ESI) Calcd. For C16H34O3Si [M+Li] 309, found 309. 
TIPSO
O
OH
 
6-(triisopropylsilyloxy)hexanoic acid. 6-(triisopropylsilyloxy)hexanoic acid was 
prepared from methyl-6-(triisopropylsilyloxy)hexanoate.  (5.33 g, 17.6 mmol) by 
dissolving in THF (200 mL) and adding LiOH (22.8 mL, 1 M) at 23 oC.  Stirring was 
continued at the same temperature for 6.5 h.  The reaction was acidified to pH 2 with 
dilute HCl.  The solution was extracted with Et2O (3 X 50 mL).  The combined organic 
fractions were washed with brine (2 X 10 mL).  The organic phase was dried over 
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MgSO4 and concentrated.  Purification by flash chromatography (1:9 to 1:4 
Et2O/hexanes) to afford the 6-(triisopropylsilyloxy)hexanoic acid (1.98 g, 39%) as a pale 
yellow oil.  Rf  0.1 (1:4 Et2O /hexanes); IR (thin film) νmax 1716 cm-1; 1H NMR (500 
MHz, benzene-d6) δ 3.50 (t, J = 6.5 Hz, 2H), 2.03 (t, J = 7.5 Hz, 2H), 1.45 (pentet, J = 
7.5 Hz, 2H), 1.38 (app. pentet, J = 6.5 Hz, 2H), 1.22-1.19 (m, 2H), 1.17-0.95 (m, 21H); 
13C NMR (125 MHz, benzene-d6) δ 180.7, 63.2, 34.0, 32.8, 25.5, 24.6, 18.1(6), 12.2(3); 
LRMS (ESI) Calcd. for C15H32O3Si [M-H] 287, found 287. 
TIPSO
O
Cl
 
6-(Triisopropylsilyloxy)hexanoyl chloride.  6-(Triisopropylsilyloxy)hexanoyl chloride 
was prepared from 6-(triisopropylsilyloxy)hexanoic acid (1.37 g, 4.70 mmol) in CH2Cl2 
(47 mL) by the addition of oxalyl chloride (783 mg, 6.15 mmol).  This solution was 
stirred until gas evolution had stopped, 3.5 h.  The solution was concentrated by rotary 
evaporation and then placed under vacuum to yield 6-(triisopropylsilyloxy)hexanoyl 
chloride (1.44 g, 100%) as a pale yellow oil.  IR (thin film) νmax 1803 cm-1; 1H NMR 
(500 MHz, benzene-d6) δ 3.44 (t, J = 6.5 Hz, 2H), 2.16 (t, J = 7.5 Hz, 2H), 1.27-1.18 (m, 
4H), 1.10-0.97 (m, 26H); 13C NMR (125 MHz, benzene-d6) δ 173.1, 63.0, 46.8, 32.5, 
24.8, 24.8, 18.1(6), 12.2(3). 
TIPSO
O
OTIPS
O
 
(Z)-3-(4-(triisopropylsilyloxy)butyl)-4-(5-(triisopropylsilyloxy)pentylidene)oxetan-2-
one.  To a solution of quinuclidine.HCl (83.1 mg, 0.52 mmol) and diisopropylethylamine 
(739 mg, 5.72 mmol) in CH2Cl2 (32 mL) at -78 oC was added a solution of 6-
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(triisopropylsilyloxy)hexanoyl chloride (1.44g, 5.20 mmol) in CH2Cl2 (20 mL).  This 
solution was slowly warmed to 23 oC over 5 h.  The reaction mixture was concentrated to 
a third of its volume and the amine hydrochlorides were precipitated by the addition of 
pentane (50 mL).  This solution was filtered to remove the salts and concentrated to an 
oil.  Immediate purification by flash chromatography (5:95, Et2O/hexanes) afforded (Z)-
3-(4-(triisopropylsilyloxy)butyl)-4-(5-(triisopropylsilyloxy)pentylidene)oxetan-2-one 
(344 mg, 25%) as a colorless oil.  Rf 0.29 (5:95 Et2O /hexanes); IR (thin film) νmax 1875, 
1726 cm-1; 1H NMR (500 MHz, benzene-d6) δ 4.39 (dt, J = 1.5, 7.5 Hz, 1H), 3.63 (t, J = 
6.0 Hz, 1H), 3.49 (t, J = 6.0 Hz, 2H), 3.28 (app. t, J = 7.5 Hz, 1H), 2.19-2.08 (m, 2H), 
1.57-1.44 (m, 4H), 1.40-1.29 (m, 6H), 1.14-1.01 (m, 42 H); 13C NMR (125 MHz, 
benzene-d6) δ 168.8, 146.6, 101.0, 63.3, 63.1, 54.0, 32.7(2), 27.5, 26.2, 24.8, 23.2, 
18.3(6), 18.2(6), 12.3(3), 12.3(3); LRMS (ESI) Calcd. for C30H60O4Si2 541, found 541. 
N3
O
N3
O
 
(Z)-3-(4-azidobutyl)-4-(5-azidopentylidene)oxetan-2-one.  To a solution of 
quinuclidine.HCl (101 mg, 0.620 mmol) and diisopropylethylamined (881 mg, 6.80 
mmol) in CH2Cl2 (40 mL) was added freshly prepared 6-azido-hexanoyl chloride (1.01 g, 
6.20 mmol) at -78 oC.  This solution was allowed to slowly warm to 23 oC over 10 h.  
The solution was concentrated to a third of its volume and the amine hydrochloride were 
precipitated by the addition of pentane (50 mL).  The solution was filtered to remove the 
salts and concentrated to an oil.  Immediate purification by flash chromatography (3:7 
EtOAc/hexanes) afforded (Z)-3-(4-azidobutyl)-4-(5-azidopentylidene)oxetan-2-one (471 
mg, 55%) as a yellow oil.  Rf  0.4 (1:4 EtOAc/hexanes); IR (thin film) νmax 2100, 1849 
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cm-1; 1H NMR (500 MHz, benzene-d6) δ 4.16 (dt, J = 1.3, 7.0 Hz, 1H), 3.15 (app. dt, J = 
1.0, 7.0 Hz, 1H), 2.65 (t, J = 6.5 Hz, 2H), 2.51 (t, J = 6.5 Hz, 2H), 1.88 (m, 2H), 1.18-0.9 
(m, 10H); 13C NMR (125 MHz, benzene-d6) δ 168.4, 146.4, 100.4, 53.6, 50.9, 50.6, 28.2, 
28.2, 26.8, 26.4, 24.2, 23.5; LRMS (ESI) Calcd. for C12H18N6O2 285, found 285 [M+Li]. 
General Procedure for the Preparation of Dimethyldioxirane (DMDO) in Acetone. 
 This procedure was adapted from the described by Murray and Singh.  To a 2 L 
three neck round-bottom flask was added 350 mL of water, 146 g of sodium bicarbonate 
and 300 mL of acetone and were rapidly stirred.  A flask containing 300 g of Oxone® was 
attached to the 2 L flask via flexible tubing.  A jacketed condenser was attached to one 
neck and the third neck was stoppered.  To the condenser was attached a glass U-tube 
followed by another glass condenser leading to a 100 mL round bottom flask that 
contained activated 4 Å molecular sieves and was vented to a water aspirator.  This flask 
was cooled to -78 oC with a dry ice/acetone bath and Oxone® was added in three portions 
over 20 min.  Upon complete addition of Oxone®, the reaction apparatus was maintained 
under vacuum to collect the DMDO as a yellow solution in acetone for 15 min.  This 
DMDO solution was determined to be 0.076 M by titration by the method of Murray and 
Singh.  The DMDO solution was used immediately in the epoxidations as described.   
Representative Procedure for Epoxidation of 4-Alkylidene-2-oxetanones as 
described for Spiroepoxy-β-Lactone (+/-) 2.61. 
O
O
O
 
To as solution of (Z)-3-butyl-4-pentylideneoxetan-2-one (370 mg, 1.90 mmol) in CH2Cl2 
(100 mL) at 0 oC was added MgSO4 (100 mg, 0.83 mmol, ~0.5 equiv) and an acetone 
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solution of DMDO (60 mL, 0.076 M, ~2.5 equiv) in one portion to give a pale yellow 
slurry which was warmed to 23 oC and stirred for 5 h.  The reaction mixture was then 
filtered through a pad of MgSO4 and the volatiles were removed by rotary evaporation.  
The colorless residue was purified by flash chromatography on SiO2 (1:9 
EtOAc/hexanes); Rf 0.4 (1:9 EtOAc/hexanes); IR (thin film) νmax 1859 cm-1; 1H NMR 
(500 MHz, benzene-d6) δ 3.18 (dd, J = 7.0, 7.8 Hz, 1H), 2.72 (dd, J = 5.5, 6.8 Hz, 1H), 
1.62-1.56 (m, 1 H), 1.48-1.40 (m, 1H), 1.28-1.08 (m, 7H), 1.04-0.94 (m, 3H), 0.74 (t, J = 
7.5 Hz, 3H), 0.68 (t, J = 6.5 Hz, 3H); 13C NMR (75 MHz, benzene-d6) δ 167.2, 91.0, 
58.8, 53.8, 28.6, 28.0, 27.8, 25.1, 22.5, 22.4, 13.9, 13.8; LRMS (ESI) Calcd. for C12H20O3 
[M+H] 213, found 213. 
O O
O
 
Spiroepoxy-β-lactone 2.63a.  The spiroepoxy-β-lactone 2.63a was prepared according to 
the general procedure from (Z)-4-(2-cyclohexylethylidene)-3-(cyclohexylmethyl)oxetan-
2-one  (174 mg, 0.63 mmol).  Purification by flash chromatography (1:9, Et2O/hexanes) 
afforded the spiroepoxy-β-lactone 2.63a (140 mg, 76%, dr 10:1) as a clear oil, which 
crystallized upon storage at -20 oC.  Recrystallization from pentane via slow evaporation 
at -20 oC afforded small white crystals, m.p. 64-65 oC (pentane).   Rf 0.45 (1:9 Et2O 
/hexanes); IR (thin film) νmax 1854 cm-1; 1H NMR (500 NMR, benzene-d6) δ 3.37 (dd, J = 
6.6, 8.7 Hz, 1H), 2.95 (dd, J = 5.4, 6.9 Hz, 1H), 1.7-0.4 (m, 26 H); 13C NMR (125 MHz, 
benzene-d6) δ 167.5, 91.5, 58.1, 52.0, 35.65, 35.63, 35.45, 35.44, 33.11, 33.08, 32.9, 
32.7, 26.43, 26.40, 26.33, 26.26, 26.29, 26.17; LRMS (APCI) Calcd. for C18H28O3 
[M+H] 293, found 293. 
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Spiroepoxy-β-lactone 2.63b.  Spiroepoxy-β-lactone 2.63b was prepared according to the 
general procedure from (Z)-3-benzyl-4-(2-phenylethylidene)oxetan-2-one121 (112 mg, 
0.424 mmol).  Purification by flash chromatography (1:5, Et2O/hexanes) afforded 
spiroepoxy-β-lactone 2.63b (68 mg, 57%, 24:1) as a clear oil. Rf 0.25 (1:5, Et2O 
/hexanes); [α]D 23 -26.6 (c = 1.0, CH2Cl2); IR (thin film) νmax 1854 cm-1; 1H NMR (500 
MHz, benzene-d6) δ 7.09-7.00 (m, 3H), 6.99-6.89 (m, 5H), 6.71-6.67 (m, 2H), 3.46 (dd, J 
= 6.5, 8.0 Hz, 1H), 2.87 (app. t, J = 6.5 Hz, 1H), 2.72 (dd, J = 6.5, 14.5 Hz, 1H), 2.55 (dd, 
J = 6.5, 14.5 Hz, 1H), 2.41 (dddd, J = 6.5, 8.0, 8.0, 15.5 Hz, 2H); 13C NMR (125 MHz, 
benzene-d6) δ 166.5, 136.1, 136.0, 129.1, 129.0(2), 128.8, 128.6(2), 127.2(2), 127.2(2), 
90.8, 59.2, 54.3, 34.6, 31.0; LRMS (APCI) Calcd. for C18H16O3 [M+H] 281, found 281. 
TIPSO
O
OTIPS
O
O
 
Spiroepoxy-β-lactone 2.63c.  Spiroepoxy-β-lactone 2.63c was prepared according to the 
general procedure from (Z)-3-(4-(triisopropylsilyloxy)butyl)-4-(5-
(triisopropylsilyloxy)pentylidene)oxetan-2-one (158 mg, 0.118 mmol) with the exception 
of the reaction time of 2 h.  Purification by flash chromatography (1:9, Et2O/hexanes) 
afforded spiroepoxy-β-lactone 2.63c (65 mg, 40%, dr 16.5:1) as a clear oil.  Rf 0.33 (1:9 
Et2O /hexanes); IR (thin film) νmax 1854 cm-1; 1H NMR (500 MHz, benzene-d6) δ 3.54 (t, 
J = 5.5 Hz, 2H), 3.46 (t, J = 5.5 Hz, 2H), 3.20 (t, J = 7.5 Hz, 1H), 2.85 (dd, J = 5.0, 7.0 
Hz, 1H), 1.73-1.00 (m, 54H); 13C NMR (125 MHz, benzene-d6) δ 167.1, 91.0, 63.1, 63.0, 
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59.0, 53.9, 32.7, 32.7, 28.0, 25.4, 23.1, 22.6, 18.3(6), 18.2(6), 12.28(3), 12.25(3); LRMS 
(ESI) Calcd. for C30H60O5Si2 [M+Li] 563, found 563. 
N3
O
N3
O
O
 
Spiroepoxy-β-lactone 2.63d.  Spiroepoxy-β-lactone 2.63d was prepared according to the 
general procedure from (Z)-3-(4-azidobutyl)-4-(5-azidopentylidene)oxetan-2-one (150 
mg, 0.539 mmol).  Purification by flash chromatography (3:10 EtOAc/hexanes) afforded 
spiroepoxy-β-lactone 2.63d (97 mg, 61%, dr 16:1) as a pale yellow oil. Rf 0.33 (1:9 Et2O 
/hexanes); IR (thin film) νmax 1849 cm-1; 1H NMR (300 MHz, benzene-d6) δ 3.09 (t, J = 
6.3 Hz, 1H), 2.63 (dd, J = 5.4, 11.7 Hz, 1H), 2.56 (t, J = 4.2 Hz, 2H), 2.52 (t, J = 4.2 Hz, 
2H), 1.50-0.85 (m, 12H); 13C NMR (125 MHz, benzene-d6) δ 166.8, 90.7, 58.4, 53.6, 
50.8, 50.6, 28.4, 28.2, 27.5, 24.8, 23.5, 23.0; LRMS (APCI) Calcd. for C12H18N6O3 
[M+H] 295, found 295. 
 
Cl
O
 
α-Chloroketone 3.6.  To a solution of spiroepoxy-β-lactone 2.63a (90.0 mg, 0.308 
mmol) in CH2Cl2 (1.6 mL) was added tetra-n-butylammonium chloride (170 mg, 0.616 
mmol) as a solution in CH2Cl2 (1.5 mL) and stirred at 23 oC for 14 h.  The solution was 
concentrated and the residue was purified by flash chromatography (5:95 Et2O/hexanes) 
to give chloroketone 3.6 (28.2 mg, 32%) as a colorless oil.  Rf 0.63 (1:9 Et2O /hexanes); 
IR (thin film) νmax 1721, 1445 cm-1; 1H NMR (500 MHz, benzene-d6) δ 4.14 (t, J = 7.5 
Hz, 1H), 2.43 (dt, J = 7.5, 17.5 Hz, 1H), 2.41 (dt, J = 7.5, 17.5 Hz, 1H), 1.68, (t, J = 7.0 
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Hz, 2H), 1.64-1.41 (m, 14H), 1.18-0.95 (m, 8H), 0.81-0.57 (m, 4H); 13C NMR (125 MHz, 
benzene-d6) δ 204.4, 61.8, 41.1(2), 37.2, 35.9, 34.5, 33.5(2), 33.2(2), 31.3, 26.7, 26.50, 
26.48, 26.3, 26.1; LRMS (ESI) Calcd. for C17H29ClO [M+H] 285, found 285. 
N3
O
 
α-azidoketone 3.7.  To a solution of spiroepoxy-β-lactone 2.63a (61.1 mg, 0.209 mmol) 
in THF/H2O (2.5 mL, 4:1) was added sodium azide (33.5 mg, 0.515 mmol) and the 
homogenous solution was stirred at 23 oC for 38 h.  The reaction mixture was dried over 
Na2SO4 and after washing with CH2Cl2 (3 X 5 mL), the combined organics were 
concentrated and the residue was purified by flash chromatography (1:4 Et2O/hexanes) to 
give azidoketone 3.7 (12.5 mg, 21%) as a pale yellow oil.  Rf 0.74 (1:4 Et2O /hexanes); 
IR (thin film) νmax 2100, 1726 cm-1; 1H NMR (500 MHz, CDCl3) δ 3.86 (app. t, J = 12 
Hz, 1H), 2.56 (ddd, J = 6.0, 6.5, 18.0 Hz, 1H), 2.53 (ddd, J = 6.0, 6.5, 18.0 Hz, 1H), 1.87-
1.13 (m, H), 1.07-0.84 (m, H); 13C NMR (125 MHz, CDCl3) δ 208.4, 65.7, 38.0, 37.2, 
37.0, 34.4, 33.7, 33.07, 33.05, 32.2, 30.7, 26.5, 26.3, 26.2(2), 26.1, 25.9; LRMS (APCI) 
Calcd. for C17H29N3O [M+H] 292, found 292. 
OH
O
 
α-hydroxy-ketone 3.11.  To a solution of spiroepxoy-β-lactone 2.63a (46.5 mg, 0.159 
mmol) in THF (1.45 mL) was added doubly distilled H2O (0.25 mL, pH=6.5).  The 
solution was allowed to sir for 19 h at 23 oC.  The reaction was then filtered through 
Na2SO4 and concentrated.  The residue was purified by flash chromatography (1:4 
Et2O/hexanes) to give the α-hydroxy ketone 3.11 (9.9 mg, 53%) as a colorless oil.  Rf 
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0.48 (1:4 Et2O /hexanes); IR (thin film) νmax 3475, 1709, 1446 cm-1; 1H NMR (500 MHz, 
benzene-d6) δ 4.04 (ddd, J = 3.1, 5.0, 15.5 Hz, 1H), 3.55 (d, J = 5.0 Hz, 1H), 2.14 (ddd, J 
= 6.5, 26.0 Hz, 1H), 1.98 (ddd, J = 6.5, 26.0 Hz, 1H), 1.95-1.89 (m, 2H), 1.82-0.64 (m, 
31H); 13C NMR (125 MHz, benzene-d6) δ 213.8, 74.5, 41.6, 37.2, 35.3, 34.40, 33.97, 
33.1, 33.0, 32.16, 31.2, 26.49, 26.46, 26.3, 26.2(2), 26.0; LRMS (ESI) Calcd. for 
C17H30O2Li [M+Li] 273, found 273. 
OH
OH
OH
 
Triol 3.16.  A solution of spiroepoxy-β-lactone 2.63a (112.1 mg, 0.384 mmol) in Et2O 
(0.9 mL) was added dropwise to a suspension of LiAlH4 (18.5 mg, 0.768 mmol) in 2.6 
mL of Et2O at -20 oC.  The reaction mixture was stirred for 8 min and then warmed to 0 
oC for 0.75 h and then to 23 oC for 2 h.  The reaction was quenched by dilution with 4 mL 
Et2O and slow addition of 0.02 mL H2O, followed by the addition of 0.02 mL 15% 
NaOH, and 0.06 mL H2O.  The reaction mixture was stirred vigorously until the all the 
gray color disappeared and K2CO3 was added and the solution was stirred for 15 min  and 
then filtered through MgSO4 and concentrated.  The residue was purified by flash 
chromatography (1:1 Et2O/hexanes) to yield the triol 3.16 (106 mg, 92%) as a milky oil 
as a mixture of diastereomers.  Rf 0.40 (1:1 Et2O/hexanes); IR (thin film) νmax 3362, 1447 
cm-1; 1H NMR (300 MHz, CDCl3) δ 3.84-3.71 (m, 6H), 3.70-3.60 (m, 2H), 3.42-3.34 (m, 
1H), 3.20-3.02 (br s, 1H), 2.84-2.64 (br s, 1H), 2.02-0.63 (m, 81H); 13C NMR (125 MHz, 
CDCl3) δ 78.1, 77.5, 70.1, 69.9, 64.6, 63.5, 41.8, 41.0(2), 39.4, 38.0, 36.8, 35.1, 34.9, 
34.7, 34.3, 34.00, 33.97, 33.8, 33.3, 32.7, 32.6, 32.5, 32.1, 29.7, 26.61, 26.55(2), 
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26.43(2), 26.35, 26.30, 26.2(2), 26.1(2); LRMS (APCI) Calcd. for C18H35O3 [M+H] 299, 
found 299. 
Experiment to Determine Site of Attack by H2O.  The reaction was run under identical 
conditions utilizing 90% H2O18 to determine the site of incorporation of water into the 
spiroepoxy-β-lactone.  Incorporation of a single 18O was confirmed based on 13C NMR 
which reflected a characteristic ~0.023-0.026 ppm upfield shift (δ 74.443; actual shift 
0.014) due to the attached 18O atom and a residual 16O peak was observed at the chemical 
shift for the unlabelled compound (δ 74.457).  Additionally, ESI-MS showed the 
incorporation of a single 18O atom. 
O
 
Enone 3.17.  A solution of spiroepoxy-β-lactone 2.63a (340mg, 1.17 mmol) in CH2Cl2 (9 
mL) was cooled to -96 oC.  To the solution was added diisopropylethylamine (0.59 mL, 
2.0 M) followed directly by addition of trimethylsilyl triflate (0.45 mL, 2.6 M) both as 
solutions in CH2Cl2.  The solution was stirred for 0.5 h, then warmed to -78 oC for 2 h 
and then -40 oC for 2 h.  The reaction was quenched by the addition of saturated NaHCO3 
(5 mL) at -40 oC.  The solution was warmed to 23 oC, extracted with CH2Cl2 (4 X 5 mL), 
dried through MgSO4, and concentrated.  The residue was purified by flash 
chromatography (0:100 5:95→Et2O/hexanes) to afford enone 3.17 (18.6 mg, 6%) as a 
colorless oil.  Rf 0.63 (1:4 Et2O/hexanes); IR (thin film) νmax 1754, 1721, 1697, 1673, 
1628, 1448 cm-1; 1H NMR (300 MHz, benzene-d6) δ 6.72 (dd, J = 6.6, 15.9 Hz, 1H), 6.03 
(d, J = 15.9 Hz, 1H), 2.35 (t, J = 7.5 Hz, 2H), 2.06-0.64 (m, 47H); 13C NMR (125 MHz, 
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benzene-d6) δ 199.1, 150.6, 128.2, 40.5, 37.9, 37.5, 33.3, 31.9, 31.8, 30.1(2), 26.8, 
26.5(2), 26.0, 25.8(2); LRMS (ESI) Calcd. for C17H28OLi [M+Li] 255, found 255. 
OH
O O
N(i-Pr)2
 
Diisopropyl amide 3.19.  To a solution of spiroepoxy-β-lactone 2.63a (39.9 mg, 0.136 
mmol) in CH2Cl2 (3 mL) was added diisopropylamine (27.6 mg, 0.273 mmol) at 23 oC 
and stirred for 19 h.  The solution was concentrated and the residue was puified by flash 
chromatograpy (1:1 Et2O/hexanes) to give amide 3.19 as an inseparable mixture of 
diastereomers (27.7 mg, 52%, dr 1:1.14) as a clear oil.  Rf 0.25 (1:1 Et2O/hexanes); IR 
(thin film) νmax 1716, 1639 cm-1; 1H NMR (500 MHz, benzene-d6) δ 6.15 (t, J = 6.0 Hz, 
1H), 6.03 (t, J = 5.5 Hz, 1H), 4.49-4.44 (m, 1H), 4.43-4.36 (m, 2H), 4.22 (d, J = 6.5 Hz, 
1H), 4.09 (q, J = 7.5 Hz, 2H), 3.05 (app. septet, J = 6.5 Hz, 4H), 1.91-1.46 (m, 34H), 
1.37-0.74 (m, 41H); 13C NMR (125 MHz, benezene-d6) δ 212.6, 211.7, 168.8, 168.7, 
75.9, 75.4, 54.6, 54.1, 41.9, 41.2, 39.64, 39.59, 38.9, 37.7, 36.1, 36.0, 34.6, 34.4, 34.3, 
34.2, 33.7, 33.4, 33.3, 32.33, 32.31, 31.76, 26.84, 26.78, 26.70, 26.69, 26.65, 26.48, 
26.44, 26.42, 26.40, 26.36, 20.21, 20.20, 13.8; LRMS (ESI) Calcd. for C24H43NO3 
[M+Li-CH2CH2] 372, found 372. 
OH
O O
NEt2
 
Diethyl amide 3.18.  To a solution of spiroepoxy-β-lactone 2.63a (47.2 mg, 0.160 mmol) 
in CH2Cl2 (2 mL) was added diethylamine (0.03 mL, 0.32 mmol) and stirred at 23 oC for 
22 h.  The solution was concentrated and the residue purified by flash chromatography 
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(1:1 Et2O/hexanes) to give amide 3.18 (42.8 mg, 73%) as a white solid, m.p. 106-108 oC, 
which was recrystallized from CH2Cl2.  Rf 0.19 (1:1 Et2O/hexanes); IR (thin film) νmax 
1721, 1609 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.30 (dd, J = 0.31, 10.5 Hz, 1H), 3.88 
(dd, J = 5.5, 8.0 Hz, 1H), 3.43-3.32 (m, 4H), 2.04 (ddd, J = 5.5, 8.0, 13.5 Hz, 1H), 1.89 
(br s, 1H), 1.86 (br s, 1H), 1.75-1.53 (m, 13 H), 1.38-1.09 (m, 15H), 1.01-0.82 (m, 4H); 
13C NMR (125 MHz, CDCl3) δ 169.1, 73.7, 50.9, 42.3, 41.7, 40.6, 36.3, 36.0, 34.4, 33.9, 
33.6, 32.9, 32.0, 26.5, 26.4, 26.3, 26.1, 26.0, 14.5, 12.7; LRMS (ESI) Calcd. for 
C22H39NO3 [M+Li] 372, found 372. 
O
O
OH
 
Butenolide 3.24.  Butenolide 3.24 was prepared from spiroepoxy-β-lactone .  To a 
solution of 2.64a (34.9 mg, 0.119 mmol) in CH2Cl2 (1.5 mL) was added DBU (36.3 mg, 
0.239 mmol) and the solution was stirred at 23 oC for 12 h.  The reaction was quenched 
with saturated NH4Cl and then extracted with EtOAc (5 X 10 mL) dried over Na2SO4 and 
concentrated.  The residue was purified by flash chromatography (2:1 Et2O/hexanes) to 
give butenolide 3.24 (24.8 mg, 71%) as a white solid m.p. 147-148 oC which was 
recrystallized from CH2Cl2.  Rf 0.22 (6:3 Et2O/hexanes); IR (thin film) νmax 1716, 1639 
cm-1; 1H NMR (500 MHz, CD3OD) δ 4.78 (dd, J = 2.8, 9 Hz, 1H), 2.03 (ddd, J = 6.5, 7.0, 
13.5 Hz, 1H), 1.99 (ddd, J = 7.0, 7.0, 13.5, Hz, 1H), 1.90-1.64 (m, 12H), 160-1.45 (m, 
2H), 1.42-1.15 (m, 9H), 1.08-0.87 (m, 6H); 13C NMR (125 MHz, CD3OD) δ 177.2, 
177.0, 99.2, 76.2, 39.8, 37.1, 34.4, 34.1, 32.99, 32.93, 32.8, 28.4, 26.4, 26.29, 26.26, 
26.20(2), 26.1; LRMS (ESI) Calcd. for C18H28O3 [M+H] 293, found 293. 
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Benzyl Butenolide 3.57.  To a solution of spiroepoxy-β-lactone 2.64b (61.4 mg, 2.19 
mmol) in CH2Cl2 (5 mL) was added N,O-dimethylhydroxylamine (20 mL, 0.219 mmol) 
and stirred at 23 oC for 6 h at which time the solution had copious amounts of white solid.  
The suspension was concentrate to give butenolide 3.57 (61.4 mg, 100%) as a white 
solid.  Purification of butenolide 3.57 was not possible due to its instablity to silica gel. 
IR νmax 1715, 1650 cm-1; 1H NMR (500 MHz, CD3OD) δ 7.25-7.20 (m, 5H), 7.13-7.05 
(m, 3H), 6.76 (d, J = 7.5Hz, 2H), 5.05 (t, J = 4.3 Hz, 1H), 3.43-3.28 (obs, 2H), 3.01 (dd, J 
= 5.0, 14.5 Hz, 1H); 13C NMR (125 MHz, CD3OD) δ 176.3, 175.8, 138.8, 134.8, 129.8, 
128.1(2), 128.0(2), 127.7, 126.9, 125.6, 100.5, 78.3, 36.8, 26.3; LRMS (ESI) Calcd. for 
C18H16O3 280, found 287 [M+Li]. 
Ph O
O
PhTfO
 
Triflate 3.55.  To a solution of butenolide 3.52 (37.9 mg, 0.14 mmol) in CH2Cl2 (1.4 mL) 
was added Hunig’s base (0.3 mL, 0.15 mmol) and Tf2O (0.2 mL, 0.14 mmol) at -78 oC 
and stirred for 2 h.  The reaction was quenched at -78 oC with pH 7 buffer and extracted 
with CH2Cl2 (3 X 5 mL) and dried with MgSO4 and concentrated.  The residue was 
purified by column chromatography (3:10 Et2O/hexanes) to give triflate 3.50 (47.9 mg, 
52%) as an oily solid.  Rf  0.50 (3:7 Et2O/hexanes); [α]D 23 +71 (c = 1.0, CH2Cl2); IR νmax 
1779 cm-1; 1H NMR (500 MHz, benzene-d6) δ  7.26-7.12 (m, 8H), 6.79-6.75 (m, 2H), 
5.40 (t, J = 5.0 Hz, 1H), 3.51 (s, 2H), 3.41 (dd, J = 4.3, 14.5 Hz, 1H), 3.03 (dd, J = 4.3, 
14.5 Hz, 1H); 13C NMR (125 MHz, benzene-d6) δ 167.8, 161.3, 135.2, 132.8, 129.7, 
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128.8, 128.7, 128.5, 128.2, 126.9, 77.6, 36.7, 28.3; LRMS (ESI) Calcd. for C19H15O5F3S 
412, found 419 [M+Li]. 
 
Ph O
O
PhO
 
Enol Ether 3.53.  To a solution of butenolide 3.52 in CH2Cl2 (2 mL) was added 
Me3OBF4 (38.7 mg, 0.248 mmol) and stirred at 23 oC for 24 h.  Starting material was still 
present and an additional amount of Me3OBF4 (21.2 mg, 0.143 mmol) was added.  The 
reaction was quenched with pH 7 buffer (2 mL) and extracted with CH2Cl2 (3 X 5 mL) to 
give enol ether 3.53 (23.6 mg, 97%) as a clear oil.  Purification of enol ether 3.53 was not 
possible due to its instability to silica gel.  IR νmax 1729, 1658 cm-1; 1H NMR (500 MHz, 
benzene-d6) δ 7.17 (d, J = 8.0 Hz, 2H), 7.07 (d, J = 8.0 Hz, 2H), 7.02-6.96 (m, 6H), 4.31 
(dd, J = 4.1, 6.5 Hz, 1H), 3.47 (d, J=15.5 Hz, 1H), 3.37 (d, J=15.5 Hz, 1H), 3.00 (s, 3H), 
3.00-2.97 (obs., 1H), 2.80 (dd, J = 6.5, 14.5 Hz, 1H); 13C NMR (benzene-d6) δ 195.6, 
180.0, 140.8, 135.7, 129.7, 128.5, 128.46, 128.3, 128.2(2), 126.9, 126.0, 93.5, 81.4, 54.9, 
36.8, 25.9; LRMS (APCI) Calcd. for C19H18O3 [M+H] 295, found 295. 
MsO O
 
3-Methoxypropyl methansulfonate.  To a solution of 3-methoxypropanol in CH2Cl2 
(200 mL) was added Et3N (6.789 g, 67.1 mmol) and cooled to 0 oC.  To this mixture was 
added methanesulfonyl chloride (7.042 g, 61.5 mmol) and stirred at this temperature for 2 
h.  The reaction of then quenched by the addition of pH 7 buffer (10 mL) and extracted 
with Et2O (3 X 20 mL).  The combined organic were then dried with Na2SO4 and 
concentrated to a light yellow oil.  This oil was purified by flash chromatography (8:2, 
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Et2O:hexanes) to give 3-methoxypropyl methansulfonate as a clear oil (8.85 g, 94%).  Rf  
0.35 (8:2 Et2O/hexanes); IR (thin film) νmax 1650 cm-1; 1H NMR (500 MHz, CDCl3) δ 
4.35 (t, J = 6.5 Hz, 2H), 3.51 (t, J = 7.0 Hz, 2H), 3.36 (s, 3H), 3.03 (s, 3H), 2.02 (pentet, J 
= 6.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 68.1, 67.6, 59.0, 37.4, 29.7; LRMS (CI) 
Calcd. for C5H12O4S [M+H] 169, found 169. 
Br O
 
1-Bromo-3-methoxypropane.  To a solution of 3-methoxypropyl methansulfonate (8.85 
g, 52.6 mmol) in acetone was added lithium bromide (13.81 g, 157.8 mmol) and heated to 
reflux for 6 h.  The reaction mixture was cooled and then concentrated.  The residue was 
dissolved in water and extracted with CH2Cl2 (3 X 10 mL).  The combined organics were 
dried with Na2SO4 and concentrated to give 1-bromo-3-methoxypropane as a pale yellow 
oil (4.81 g, 60%).  IR (thin film) νmax 1116 cm-1; 1H NMR (500 MHz, CDCl3) δ 3.52 (t, 
J= 6.5 Hz, 4H), 3.37 (s, 3H), 2.12 (pentet, J = 6.0 Hz, 2H); 13C NMR (125 MHz, CDCl3) 
δ 70.3, 59.0, 33.0, 30.8; LRMS (CI) Calcd. for C4H9BrO [M+H] 153.9,  found 153.9. 
General Procedure for the formation of zincates.  To an oven dried flask containing 
zinc powder (1.702 g, 26.0 mmol) was added DMA (12.8 mL) and iodine (0.325 g, 1.28 
mmol).  This slurry was stirred at 60 oC until the brown color of the iodine had 
disappeared.  The alkyl bromide (2.500 g, 12.8 mmol) was then added to this slurry and 
heated to 85 oC for 6-24 h.  The disappearance of the starting material was monitored by 
TLC and 1H NMR. 
H
Cl CN
 
Typical Procedure for Trans-selective Cross Coupling.  To a 10 mL microwave tube 
was added bis(tri-tert-butylphosphine)palladium (0) (11.2 mg, 0.0219 mmol) in a glove 
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box.  This was followed by 1,1-dichloroalkene 4.12 (96.1 mg, 0.492 mmol) as a solution 
in THF (1.5 mL).  Finally zincate derived from 4-bromobutyronitrile (1 M, 1.5 mL) was 
added to make a dark purple-brown solution.  A microwave cap was affixed to the tube 
and argon was bubbled through the solution to degass for 15 min.  The tube was then 
heated with µW irradiation for 5 h at 100 oC.  After cooling the solution was then 
quenched with ammonium chloride (2 mL) and extracted with ether (4 X 2 mL).  The 
combined organics were then was with brine (3 X 1 mL).  Finally the organics were dried 
with MgSO4 and concentrated.  The golden residue was then purified by flash 
chromatography (1:20, ethyl ether:hexanes) to give 4.13a as a clear oil (58.1 mg, 52%).  
Rf 0.24 (5:95 Et2O/hexanes); IR (thin film) νmax 2248 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 5.59 (t, J = 7.0 Hz, 1H), 2.49 (t, J = 6.5 Hz, 2H), 2.34 (t, J = 6.5 Hz, 2H), 2.17 (q, J = 
6.5 Hz, 2H), 1.93 (pentet, J = 6.5 Hz, 2H), 1.42-1.35 (m, 2H), 1.32-1.24 (m, 9H), 0.89 (t, 
J = 7.0 Hz, 3H); 13C (125 MHz, CDCl3) δ 131.7, 128.6, 119.5, 38.0, 32.0, 29.4, 29.3, 
28.8(2), 23.1, 22.9, 15.9, 14.3; LRMS (CI) Calcd. for C13H22ClN [M+H] 228, found 228. 
H
Cl
O
O
 
Chloroalkene 4.13b.  Chloroalkene 4.13b was prepared by the general procedure with 
1,1-dichloroalkene 4.8 (45.6 mg, 0.227 mmol).  Purification by flash chromatography 
(20:80 ethyl ether:hexanes) gave chloroalkene 4.13b (42.0 mg, 60%) as a clear oil.  Rf  
0.37 (5:95 Et2O/hexanes); IR (thin film) νmax 1730 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.31-7.18 (m, 5H), 5.49 (t, J = 7.0 Hz, 1H), 2.70 (t, J = 8.0 Hz, 2H), 2.50 (q, J = 7.0 Hz, 
2H), 2.34 (t, J = 7.0 Hz, 2H), 2.18 (t, J = 7.0 Hz, 2H), 1.82 (pentet, J = 7.5Hz, 2H), 1.45 
(s, 9H); 13C NMR (125 MHz, CDCl3) δ 172.6, 141.4, 134.3, 128.4, 128.3, 125.9, 125.3, 
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80.2, 38.5, 34.7, 34.0, 30.2, 28.1(3), 22.7; LRMS (CI) Calcd. for C18H25ClO2 [M+H] 309, 
found 309. 
H
Cl O
O
 
Chloroalkene 4.13c. Chloroalkene 4.13c was prepared by the general procedure with 
1,1-dichloroalkene 4.12 (87.7 mg, 0.450 mmol).  Purification by flash chromatography 
(15:85 ethyl ether:hexanes) gave chloroalkene 4.13c (48.6 mg, 39%) as a clear oil.  IR 
(thin film) νmax 1147 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.48 (t, J = 7.0 Hz, 1H), 4.52 
(t, J = 5.0 Hz, 1H), 4.11 (dd, J = 5.0, 11.0 Hz, 2H), 3.75 (dt, J = 2.6, 12.5 Hz, 2H), 2.41 
(app. t, J = 7.5 Hz, 2H), 2.15 (q, J = 7.0 Hz, 2H), 2.12-2.02 (m, 1H), 1.87-1.82 (m, 2H), 
1.40-1.23 (m, 12H), 0.89 (t, J = 7.0 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 133.8, 
126.3, 101.4, 67.1(2), 34.2, 33.3, 32.1, 29.4, 28.9, 28.7, 26.0, 22.9, 14.3; LRMS (CI) 
Calcd. for  C15H27ClO2 [M+H] 275, found 275. 
H
Cl O
 
Chloroalkene 4.13d.  Chloroalkene 4.13d was prepared by the general procedure with 
1,1-dichloroalkene 4.8 (54.4 mg, 0.27 mmol).  Purification by flash chromatography 
(5:95 ethyl ether:pentane) to give chloroalkene 4.13d (25.8 mg, 40 %) as a clear oil. IR 
νmax 1445 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.34-7.18 (m, 5H), 5.53 (t, J = 6.6 Hz, 
1H), 3.40-3.30 (m, 5H), 2.73 (t, J = 6.9 Hz, 2H), 2.52 (q, J = 6.6 Hz, 2H), 2.40 (t, J = 7.5 
Hz, 2H), 1.82 (pentet, J = 6.9 Hz, 2H); 13C NMR (125MHz, CDCl3) δ 141.7, 134.9, 
128.7, 128.6, 126.2, 125.2, 71.5, 58.8, 36.3, 35.0, 30.3, 27.6; LRMS (CI) Calcd. for 
C14H19ClO 238, found 239 [M+H] 
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OEtO CCl3
 
Dihydropyran 4.24.  To a solution of ethoxydiene 4.25 (2.249 g, 20 mmol) in toluene 
(10 mL) was added chloral 4.26 (14.74 g, 100 mmol) ,which had been distilled and stored 
over Na2CO3, at 0 oC.  The solution was slowly warmed to 23 oC overnight and stirred for 
2 days.  The reaction mixture was then concentrated by rotory evaporation.  The white 
paste was then purified by flash chromatography (1:9, ether/hexanes) to give a mixture of 
diastereomeric dihyropyrans 4.24 as a clear oil (2.991g, 58%, dr 1:4) Note: The dr 
observed in this reaction was variable and ranged from 1:1 to 1:4, the diastereomers 
could be seperated when the diastereomeric ratio was 1:4.  Rf 0.68 (1:9 Et2O/hexanes); IR 
(thin film) νmax 2974 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.67 (br s, 1H), 5.00 (s, 1H), 
4.45 (dd, J = 4.0, 10.5 Hz, 1H), 4.06 (dq, J = 2.5, 7.5 Hz, 1H), 3.65 (dq, J = 2.5, 7.5 Hz, 
1H), 2.51-2.39 (m, 2H), 1.77 (br s, 3H), 1.28 (t, J = 7.0 Hz, 3H); 13C (125 MHz, CDCl3) δ 
132.6, 121.1, 100.8, 98.9 (2), 64.3, 27.0, 18.8, 15.3; LRMS (APCI) Calcd. for 
C9H13Cl3O2 [M+H] 259, found 259. 
 
Diol 4.29.  To a solution of aldehyde 4.28 (245.3 mg, 1.06 mmol) in EtOH (5 mL) was 
added a solution of CeCl3.7H2O (1.21 g, 3.18 mmol) in EtOH (5 mL).  This was followed 
by the addition of NaBH4 (60.1 mg, 1.59 mmol) at which time the solution fizzed and 
turned cloudy brown.  After stirring for 5 h the reaction was quenched with sat. NH4Cl (6 
mL) and extracted with EtOAc (3 X 5 mL), dried with Na2SO4 and concentrated.  The 
residue was purified by flash chromatography (1:1 EtOAc/hexanes) to give diol 4.29 
(172.7 mg, 70%) as a white solid.  IR νmax 3400 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.59 
(t, J = 8.5 Hz, 1H), 4.09-4.05 (m, 2H), 3.59-3.45 (m, 2H), 2.84 (dd, J = 6.5, 14.0 Hz, 1H), 
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2.77 (d, J = 5.0 Hz, 1H)2.47-2.39 (m, 1H), 1.73 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
138.9, 120.0, 103.8, 83.1, 68.6, 30.4, 14.2; LRMS (CI) Calcd. for C7H11Cl3O2 232, found 
233 [M+H]. 
 
 
O CCl3O
 
Lactone 4.31.  To a solution of dihyropyan 4.24 (204 mg, 0.786 mmol) in acetone (20 
mL) was added Jones reagent (2.06 mL, 3 M in H2O) at 0 oC.  The reaction was warmed 
to 23 oC and stirred for 3 h.  The reaction was quenched with 2-propanol (2 mL) and 
stirred until the solution had turned from orange to green, and then extracted with EtOAc 
(3 X 5mL).  The combined organics were washed with brine (3 X 2 mL) and dried with 
MgSO4 and concentrated.  The crude oil was purified by flash chromatography (60:40 
Et2O:hexanes) to give lactone 4.31 as a white solid (95.9 mg, 53%).  Rf 0.42 (3:2 
Et2O/hexanes); IR (ATR) νmax 3043, 1732 cm-1; 1H NMR (500 MHz, CDCl3) δ 6.67-6.64 
(m, 1H), 4.87 (dd, J = 4.3, 12.0 Hz, 1H), 2.90 (br dt, J = 5.0, 18.0 Hz, 1H), 2.83-2.75 (m, 
1H), 2.0 (app pentet, J = 1.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 163.3, 137.3, 
128.7, 97.9, 85.1, 26.2, 17.1; LRMS (CI) Calcd. for C7H7Cl3O2 [M+H], 229 found 228.9. 
OH
OH
CCl3
 
Diol 4.30.  To lactone 4.31 (305.4 mg,1.33 mmol) was added a solution of CeCl3.7H2O 
(0.5M, 13.3 mL) in anhydrous MeOH.  This was followed by the addition of solid NaBH4 
(252 mg, 6.65 mmol) at 0 oC.  The reaction mixture was allowed to warm to 23 oC 
overnight.  The solution was quenched by the addition of sat. NH4Cl (2 mL) and 
extracted repeatedly with Et2O.  The combined organics were dried with Na2SO4 and 
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concentrated.  The crude oil was purified by flash chromatography (40:60→50:50 
Et2O:hexanes) to give diol 4.30 as an oil (134 mg, 43%).  Rf 0.25 (1:1 Et2O/hexanes); IR 
(thin film) νmax 3342 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.49 (d of pentets, J = 1.4, 8.0 
Hz, 1H), 4.36 (d, J = 12.0 Hz, 1H), 4.04 (dd, J = 2.2, 10.0 Hz, 1H), 3.99 (d, J = 12.0 Hz, 
1H), 2.78 (dd, J = 7.0, 12.0 Hz, 1H), 2.61 (dt, J = 10.0, 14.0 Hz, 1H); 13C NMR (125 
MHz, CDCl3) δ 139.4, 123.2, 103.9, 81.9, 61.9, 30.7, 22.9; LRMS (CI) Calcd. for 
C7H11Cl3O2 232.8 [M+H], found 232.8. 
OH
OTBS
CCl3
 
(Z)-6-(Tert-butyldimethylsilyloxy)-1,1,1-trichloro-5-methylhex-4-en-2-ol.  To a 
solution of diol 4.30 (133 mg, 0.56 mmol), freshly azeotroped with toluene, in DMF (1 
mL) was added imidazole (63.0 mg, 0.93 mmol).  Finally TBSCl (108 mg, 0.68 mmol) 
was added to the reaction mixture and stirred at 23 oC for 42 h.  The reaction was 
quenched with brine (1 mL) and extracted with ether (3 X 1 mL), dried with MgSO4 and 
concentrated.  The crude oil was purified by flash chromatography (10:90 Et2O/hexanes) 
to yield (Z)-6-(tert-butyldimethylsilyloxy)-1,1,1-trichloro-5-methylhex-4-en-2-ol (192.4 
mg, 97%) as a clear oil.  Rf 0.30 (2:8 Et2O/hexanes); IR (thin film) νmax 3389 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 5.46 (br. t, J = 8.0 Hz, 1H), 4.31 (d, J = 11.5 Hz, 1H), 4.08 (d, 
J = 5.5 Hz, 1H), 4.01 (d, J = 11.5 Hz, 1H), 4.01 (obs., 1H), 2.80 (br. dd, J = 6.5, 14.0 Hz, 
1H), 2.57 (dt, J = 10.0, 14.0 Hz, 1H), 1.84 (s, 3H), 0.94 (s, 9H), 0.14 (s, 6H); 13C NMR 
(125 MHz, CDCl3) δ 139.3, 122.7, 104.2, 81.9, 62.5, 31.0, 26.2, 22.9, 18.8(3), -5.07, -5.1; 
LRMS (CI) Calcd. for C13H25Cl3O2Si [M+H] 347, found 347. 
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OAc
OTBS
CCl3
 
(Z)-5-(Tert-butyldimethylsilyloxy)-1,1,1-trichloro-4-methylpent-3-en-2-yl acetate.  
To a solution of (Z)-6-(tert-butyldimethylsilyloxy)-1,1,1-trichloro-5-methylhex-4-en-2-ol 
(152 mg, 0.44 mmol) in pyridine (1.5 mL) was added acetic anhydride (89 mg, 0.87 
mmol, 0.09 mL) and stirred for 21 h.  An additional equivalent of acetic anhydride (45 
mg, 0.44 mmol, 0.04 mL) was added and stirred for an additional 2 h.  The reaction was 
concentrated en vacuo to give (Z)-6-(tert-butyldimethylsilyloxy)-1,1,1-trichloro-5-
methylhex-4-en-2-yl acetate (168 mg, 99%) as a pale yellow oil which is of sufficient 
purity to take on to the next step.  IR (thin film) νmax 1762 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 5.54 (dd, J = 2.6, 10 Hz), 5.38 (br. t, J = 7.5 Hz, 1H), 4.01 (s, 2H), 2.88 (dd, J = 
6.5, 15.0 Hz, 1H), 2.72 (ddd, J = 8.0, 11.0, 15.0 Hz, 1H), 2.15 (s, 3H), 1.66 (br. s, 3H), 
0.92 (s, 9H), 0.072 (s, 3H), 0.069 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 169.7, 140.0, 
119.0, 99.9, 80.7, 62.0, 29.2, 26.2(3), 21.5, 20.9, 18.6, -5.16, -5.15; LRMS (APCI) Calcd. 
for C15H27Cl3O3Si [M+H] 389, found 389. 
Cl Cl
OTBS
 
1,1-dichloroolefin 2.52. To (Z)-6-(tert-butyldimethylsilyloxy)-1,1,1-trichloro-5-
methylhex-4-en-2-yl acetate (17.9 mg, 0.046 mmol) was added degassed THF (0.5 mL).  
To this solution was added SmI2 (0.1 M, 1.84 mL) at 0oC and stirred.  The reaction 
mixture was then concentrated and the residue purified by flash chromatography (10:90 
Et2O/hexanes) to give 1,1-dichloroolefin 2.52 (8.1 mg, 60%) as a pale yellow oil.  Rf 0.67 
(1:9 Et2O/hexanes); IR (thin film) νmax  1430 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.82 (t, 
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J = 7.5 Hz, 1H), 5.19 (br. t, J = 7.5 Hz, 1H), 4.18 (s, 2H), 2.93 (t, J = 7.5 Hz, 2H), 1.77 
(br. s, 3H), 0.93 (s, 9H), 0.10 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 137.8, 128.7, 121.1, 
120.3, 62.0, 28.5, 26.2(3), 21.3, 18.6, -5.1(2); LRMS (CI) Calcd. for C13H24Cl2OSi 
[M+H] 295, found 295. 
O
EtO
OH
OTBS
 
α, β-unsaturated ester 4.34.  To a solution of lactone 4.32 (3.01 g, 13.1 mmol) in THF 
(60 mL) at -78 oC was added DIBAl-H (1.95 g, 13.7 mmol, 2.4 mL) as a neat liquid.  
This solution was stirred at this temperature for 2 h.  In a separate flask, a suspension of 
NaH (628 mg, 26.2 mmol) in THF (90 mL) was added triethyl phosphonoacetate 4.33 
(3.52 g, 15.7 mmol) at 23 oC and stirred at that temperature for 2 h.  After stirring the 
soluition of pale yellow sodium phosphonate was added to the lactol at -78 oC.  The 
resulting solution was allowed to warm to 23 oC and stirred overnight.  The reaction 
mixture was carefully quenched with H2O (2 mL) followed by then a saturated soluition 
of Rochelle’s salt (50 mL), and EtOAc (50 mL).  The resulting biphasic solution was 
stirred until both layers were clear.  The aqueous phase was then extracted with EtOAc (3 
X 10 mL), dried Na2SO4 and concentrated.  The crude oil was then purified by flash 
chromatography (20:80 Et2O:hexanes) to give α, β-unsaturated ester 4.34 (2.57 g, 65%) 
as a clear oil.  IR (thin film) νmax 3474, 1719 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.00 
(dt, J = 7.0, 15.5 Hz 1H), 5.87 (dt, J = 1.6, 15.5 Hz, 1H), 4.21 (q, J = 7.5 Hz, 2H), 3.70-
3.63 (m, 2H), 3.43 (dd, J = 7.0, 9.0 Hz, 1H), 2.43 (d, J = 4.2 Hz, 1H), 2.47-2.39 (m, 1H), 
2.33 (app. sextet, J = 7.5 Hz, 1H), 1.65-1.52 (m, 1H), 1.31 (t, J = 7.5 Hz, 3H), 0.92 (s, 
9H), 0.10 (s, 6H); 13C NMR (125 MHz, CDCl3) δ 166.9, 148.9, 121.9, 71.2, 67.3, 60.5, 
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31.4, 28.6, 26.1, 18.5, 14.5, -5.1, -5.2; LRMS (ESI) Calcd. for C15H30O4Si [M+Li] 309, 
found 309. 
O
HO OTBS
 
Tetrahydrofuran 4.35.  To a solution of α, β-unsaturated ester 4.34 (2.57 g, 8.50 mmol) 
in THF (120 mL) at 0 oC was added KHMDS (0.85 mmol, 1.7 mL, 0.5M) in toluene.  
The reaction was warmed to 23 oC over 1 h.  Once TLC showed consumption of starting 
material the reaction solution was concentrated and used in the next step without further 
purification.  The light yellow crude oil was redissolved in CH2Cl2 (90 mL) and cooled to  
oC.  To this solution was added neat DIBAl-H (4.23g, 30 mmol, 5.3 mL).  After the initial 
fizzing stopped, the solution became colorless.  The reaction mixture was then warmed to 
23 oC and stirred for 6 h.  The solution was quenched by the addition of a saturated 
solution of Rochelle’s salt (50 mL) and EtOAc (50 mL) and stirred overnight.  The 
solution was then extracted with EtOAc (3 X 10 mL), dried Na2SO4 and concentrated to 
give a colorless oil.  The crude oil was then purified by flash chromatography (30:70 
EtOAc:hexanes) to give tetrahydrofuran 4.35 (998 mg, 45%) as a colorless oil and a 
mixture of diastereomers of an indeterminable ratio by 1H NMR due to overlaping peaks.  
Rf 0.17 (3:7 EtOAc/hexanes); IR (thin film) νmax 3398 cm-1; 1H NMR (500 MHz, CDCl3) 
δ 3.88 (ddd, J = 2.5, 4.8, 10.5 Hz, 1H), 3.80-3.75 (m, 2H), 3.65 (app. septet, J = 4.8 Hz, 
1H), 3.50-3.44 (m, 1H), 3.12 (app. t, J = 10.5 Hz, 1H), 2.59 (br. s, 1H), 2.03-1.97 (m, 
1H), 1.74-1.66 (m, 3H), 1.50-1.40 (m, 2H), 0.89 (s, 9H), 0.07 (s, 3H), 0.06 (s, 3H); 13C 
NMR (125 MHz, CDCl3) δ 78.0, 73.1, 67.1, 61.7, 37.7, 33.5, 31.1, 26.0(3), 18.4, -4.45, -
4.48; LRMS (APCI) Calcd. for C13H28O3Si [M+H] 261, found 261. 
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O
MsO OTBS
 
2-(5-((Tert-butyldimethylsilyloxy)methyl)tetrahydrofuran-2-yl)ethyl 
methanesulfonate.  To a solution of THF 4.27 in CH2Cl2 (10 mL) was added Et3N (260 
µL, 1.86 mmol) at 0 oC.  Methanesulfonyl chloride (130 µL, 1.70 mmol) was then added 
to this solution and stirred at 0 oC.  After 24 h starting material was still present 
methansulfonyl chloride (260 µL, 1.70 mmol) and Et3N (260 µL, 1.86 mmol) were 
added.  This solution was allowed to slowly warm to 23 oC for 1 h.  The reaction was 
then quenched with pH 7 buffer (2 mL) and extracted with Et2O (3 X 5 mL) dried with 
Na2SO4 and concentrated. The residue was purified by flash chromatography (4:1 
Et2O/hexanes) to yield 2-(5-((tert-butyldimethylsilyloxy)methyl)tetrahydrofuran-2-
yl)ethyl methanesulfonate (367 mg, 70%) as a clear oil and a mixture of diastereomers of 
an indeterminable ratio by 1H NMR due to overlaping peaks. Rf 0.5 (4:1 Et2O/hexanes); 
IR (thin film) νmax 1356 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.40 (m, 2H), 3.86 (ddd, J = 
2.2, 5.0, 11.0 Hz, 1H), 3.80-3.75 (m, 1H), 3.65 (app. septet, J = 5.0 Hz, 1H), 3.54-3.44 
(m, 1H), 3.41-3.35 (m, 1H), 3.09 (t, J = 10.5 Hz, 1H), 3.02 (s, 3H), 2.05-1.67 (m, 4H), 
1.52-1.33 (m, 2H), 0.92 (s, 3H), 0.89 (s, 6H), 0.08 (s, 4H), 0.07 (s, 2H); 13C NMR (500 
MHz, CDCl3) δ 73.1, 67.6, 67.4, 67.1, 37.3, 35.44, 35.40, 33.5, 31.0, 30.9, 26.2, 26.0, 
18.5, 18.4, -4.4, -4.5, -4.6; LRMS (CI) Calcd. for C14H30O5SSi [M+H] 339, found 339. 
O
OTBS
Br
 
THF Bromide 4.36.  To a solution of 2-(5-((tert-
butyldimethylsilyloxy)methyl)tetrahydrofuran-2-yl)ethyl methanesulfonate (88.4 mg, 
0.261 mmol) in acetone (3 mL) as added anhydrous lithium bromide (68.0 mg, 0.783 
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mmol) and refluxed for 4 h.  After cooling the salts were dissolved in water and the 
solution was extracted with CH2Cl2 (3 X 5 mL), dried with MgSO4 and concentrated to 
give THF bromide 4.36 (58.8 mg, 70%) as a pale yellow oil and a mixture of 
diastereomers of an indeterminable ratio by 1H NMR due to overlaping peaks.   IR νmax 
1249 cm-1; 1H NMR (500 MHz, CDCl3) δ 3.86 (ddd, J = 0.24, 4.9, 11 Hz, 1H), 3.79-3.74 
(m, 1H), 3.64 (septet, J = 5.0 Hz, 1H), 3.59-3.46 (m, 3H), (tdd, J = 2.5, 3.5, 9.5, 1H), 3.11 
(app. t, J = 10.5, 1H), 2.19-2.10 (m, 1H), 2.04-1.87 (m, 3H), 1.82-1.65 (m, 2H), 1.51-1.32 
(m, 3H), 0.91 (s, H), 0.88 (s, H), 0.70 (s, H), 0.60 (s, H); 13C NMR (125 MHz, CDCl3) δ 
75.0, 74.9, 73.2, 72.6, 67.2, 65.5, 39.1, 33.5, 31.0, 30.7, 30.6, 30.3, 26.2, 26.16, 26.0, 
18.5, 18.4, -4.4, -4.46, -4.47, -4.6; LRMS (CI) Calcd. for C13H27BrO2Si [M+H] 323, 
found 323. 
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APPENDIX B  SINGLE CRYSTAL X-RAY 
 DATA FOR β-LACTONE 2.64a 
 
Table B.1.  Crystal data and structure refinement for 2.64a. 
 
Identification code  dr30a 
Empirical formula  C18H28O3 
Formula weight  292.40 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 15.4756(15) Å α= 90°. 
 b = 10.1169(11) Å β= 94.168(6)°. 
 c = 10.6297(11) Å γ = 90°. 
Volume 1659.8(3) Å3 
Z 4 
Density (calculated) 1.170 Mg/m3 
Absorption coefficient 0.614 mm-1 
F(000) 640 
Crystal size 0.10 x 0.05 x 0.05 mm3 
Theta range for data collection 2.86 to 58.94°. 
Index ranges -17<=h<=17, -11<=k<=11, -11<=l<=10 
Reflections collected 10097 
Independent reflections 2344 [R(int) = 0.0997] 
Completeness to theta = 58.94° 98.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9699 and 0.9411 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 2344 / 0 / 236 
Goodness-of-fit on F
2
 1.024 
Final R indices [I>2sigma(I)] R1 = 0.0575, wR2 = 0.1284 
R indices (all data) R1 = 0.0861, wR2 = 0.1374 
Largest diff. peak and hole 0.169 and -0.159 e.Å-3 
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 Table B.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) for dr30a.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
 
 x y z U(eq) 
 
O(1) 4039(1) 655(2) 11216(2) 39(1) 
O(2) 5426(1) 261(2) 12028(2) 41(1) 
O(3) 3147(1) 2597(2) 10871(2) 43(1) 
C(1) 6353(1) 2867(2) 10383(2) 29(1) 
C(2) 6932(2) 2800(3) 9286(3) 48(1) 
C(3) 7876(2) 3023(3) 9689(3) 49(1) 
C(4) 8012(2) 4307(3) 10407(3) 41(1) 
C(5) 7461(2) 4358(4) 11518(3) 50(1) 
C(6) 6507(1) 4145(3) 11102(3) 38(1) 
C(7) 5403(2) 2673(3) 9932(2) 34(1) 
C(8) 4818(1) 2365(3) 10979(2) 31(1) 
C(9) 4893(2) 974(3) 11532(2) 32(1) 
C(10) 3894(2) 1932(3) 10623(3) 35(1) 
C(11) 3260(2) 2098(3) 9578(3) 37(1) 
C(12) 2673(2) 1015(3) 9087(3) 42(1) 
C(13) 1778(2) 1455(3) 8601(3) 52(1) 
C(14) 1237(6) 2171(10) 9309(10) 48(2) 
C(15) 393(4) 2605(8) 8603(10) 62(3) 
C(16) -173(8) 1563(12) 8117(16) 63(3) 
C(17) 448(14) 575(17) 7240(20) 74(5) 
C(18) 1265(12) 170(17) 7924(18) 63(4) 
C(13') 1778(2) 1455(3) 8601(3) 52(1) 
C(14') 1243(6) 1586(12) 9887(11) 62(3) 
C(15') 311(4) 1989(11) 9578(11) 81(4) 
C(16') -74(9) 947(13) 8477(18) 84(5) 
C(17') 366(14) 1154(18) 7380(20) 74(5) 
C(18') 1328(11) 663(14) 7754(18) 49(4) 
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Table B.3.   Bond lengths [Å] and angles [°] for  2.64a. 
O(1)-C(9)  1.378(3) 
O(1)-C(10)  1.448(3) 
O(2)-C(9)  1.190(3) 
O(3)-C(10)  1.380(3) 
O(3)-C(11)  1.486(3) 
C(1)-C(6)  1.513(4) 
C(1)-C(2)  1.523(3) 
C(1)-C(7)  1.525(3) 
C(1)-H(1A)  1.0000 
C(2)-C(3)  1.509(4) 
C(2)-H(2A)  0.9900 
C(2)-H(2B)  0.9900 
C(3)-C(4)  1.514(4) 
C(3)-H(3C)  0.9900 
C(3)-H(3D)  0.9900 
C(4)-C(5)  1.507(4) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(6)  1.525(3) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-H(6A)  0.9900 
C(6)-H(6B)  0.9900 
C(7)-C(8)  1.517(3) 
C(7)-H(7A)  0.9900 
C(7)-H(7B)  0.9900 
C(8)-C(10)  1.517(3) 
C(8)-C(9)  1.526(4) 
C(8)-H(8)  1.0000 
C(9)-C(10)  2.012(4) 
C(10)-C(11)  1.437(4) 
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Table B.3.   (Continued) 
C(11)-C(12)  1.493(4) 
C(11)-H(11A)  1.0000 
C(12)-C(13)  1.511(4) 
C(12)-H(12A)  0.9600 
C(12)-H(12B)  0.9599 
C(13)-C(14)  1.372(10) 
C(13)-C(18)  1.659(16) 
C(13)-H(13A)  1.0000 
C(14)-C(15)  1.523(11) 
C(14)-H(14A)  0.9900 
C(14)-H(14B)  0.9900 
C(15)-C(16)  1.442(13) 
C(15)-H(15A)  0.9900 
C(15)-H(15B)  0.9900 
C(16)-C(17)  1.71(2) 
C(16)-H(16A)  0.9900 
C(16)-H(16B)  0.9900 
C(17)-C(18)  1.47(3) 
C(17)-H(17A)  0.9900 
C(17)-H(17B)  0.9900 
C(18)-H(18A)  0.9900 
C(18)-H(18B)  0.9900 
C(14')-C(15')  1.513(13) 
C(14')-H(14C)  0.9900 
C(14')-H(14D)  0.9900 
C(15')-C(16')  1.654(17) 
C(15')-H(15C)  0.9900 
C(15')-H(15D)  0.9900 
C(16')-C(17')  1.41(3) 
C(16')-H(16C)  0.9900 
C(16')-H(16D)  0.9900 
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Table B.3.   (Continued) 
C(17')-C(18')  1.59(3) 
C(17')-H(17C)  0.9900 
C(17')-H(17D)  0.9900 
C(18')-H(18C)  0.9900 
C(18')-H(18D)  0.9900 
C(9)-O(1)-C(10) 90.73(18) 
C(10)-O(3)-C(11) 60.07(16) 
C(6)-C(1)-C(2) 110.2(2) 
C(6)-C(1)-C(7) 112.4(2) 
C(2)-C(1)-C(7) 111.2(2) 
C(6)-C(1)-H(1A) 107.6 
C(2)-C(1)-H(1A) 107.6 
C(7)-C(1)-H(1A) 107.6 
C(3)-C(2)-C(1) 112.8(2) 
C(3)-C(2)-H(2A) 109.0 
C(1)-C(2)-H(2A) 109.0 
C(3)-C(2)-H(2B) 109.0 
C(1)-C(2)-H(2B) 109.0 
H(2A)-C(2)-H(2B) 107.8 
C(2)-C(3)-C(4) 111.6(2) 
C(2)-C(3)-H(3C) 109.3 
C(4)-C(3)-H(3C) 109.3 
C(2)-C(3)-H(3D) 109.3 
C(4)-C(3)-H(3D) 109.3 
H(3C)-C(3)-H(3D) 108.0 
C(5)-C(4)-C(3) 111.0(2) 
C(5)-C(4)-H(4A) 109.4 
C(3)-C(4)-H(4A) 109.4 
C(5)-C(4)-H(4B) 109.4 
C(3)-C(4)-H(4B) 109.4 
H(4A)-C(4)-H(4B) 108.0  
C(4)-C(5)-C(6) 111.0(2) 
C(4)-C(5)-H(5A) 109.4 
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Table B.3.   (Continued) 
C(6)-C(5)-H(5A) 109.4 
C(4)-C(5)-H(5B) 109.4 
C(6)-C(5)-H(5B) 109.4 
H(5A)-C(5)-H(5B) 108.0 
C(1)-C(6)-C(5) 112.4(2) 
C(1)-C(6)-H(6A) 109.1 
C(5)-C(6)-H(6A) 109.1 
C(1)-C(6)-H(6B) 109.1 
C(5)-C(6)-H(6B) 109.1 
H(6A)-C(6)-H(6B) 107.9 
C(8)-C(7)-C(1) 114.1(2) 
C(8)-C(7)-H(7A) 108.7 
C(1)-C(7)-H(7A) 108.7 
C(8)-C(7)-H(7B) 108.7 
C(1)-C(7)-H(7B) 108.7 
H(7A)-C(7)-H(7B) 107.6 
C(7)-C(8)-C(10) 118.5(2) 
C(7)-C(8)-C(9) 116.0(2) 
C(10)-C(8)-C(9) 82.75(18) 
C(7)-C(8)-H(8) 112.2 
C(10)-C(8)-H(8) 112.2 
C(9)-C(8)-H(8) 112.2 
O(2)-C(9)-O(1) 126.0(2) 
O(2)-C(9)-C(8) 139.5(2) 
O(1)-C(9)-C(8) 94.4(2) 
O(2)-C(9)-C(10) 171.4(2) 
O(1)-C(9)-C(10) 46.03(13) 
C(8)-C(9)-C(10) 48.43(14) 
O(3)-C(10)-C(11) 63.64(17) 
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Table B.3.   (Continued) 
O(3)-C(10)-O(1) 117.2(2) 
C(11)-C(10)-O(1) 121.1(2) 
O(3)-C(10)-C(8) 126.8(2) 
C(11)-C(10)-C(8) 137.5(2) 
O(1)-C(10)-C(8) 92.03(18) 
O(3)-C(10)-C(9) 140.2(2) 
C(11)-C(10)-C(9) 152.3(2) 
O(1)-C(10)-C(9) 43.24(12) 
C(8)-C(10)-C(9) 48.82(14) 
C(10)-C(11)-O(3) 56.29(16) 
C(10)-C(11)-C(12) 123.2(3) 
O(3)-C(11)-C(12) 117.5(2) 
C(10)-C(11)-H(11A) 115.5 
O(3)-C(11)-H(11A) 115.5 
C(12)-C(11)-H(11A) 115.5 
C(11)-C(12)-C(13) 115.0(3) 
C(11)-C(12)-H(12A) 107.1 
C(13)-C(12)-H(12A) 104.7 
C(11)-C(12)-H(12B) 108.3 
C(13)-C(12)-H(12B) 113.9 
H(12A)-C(12)-H(12B) 107.3 
C(14)-C(13)-C(12) 123.3(4) 
C(14)-C(13)-C(18) 111.1(8) 
C(12)-C(13)-C(18) 108.4(8) 
C(14)-C(13)-H(13A) 104.0 
C(12)-C(13)-H(13A) 104.0 
C(18)-C(13)-H(13A) 104.0 
C(13)-C(14)-C(15) 114.6(7) 
C(13)-C(14)-H(14A) 108.6 
C(15)-C(14)-H(14A) 108.6 
C(13)-C(14)-H(14B) 108.6 
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Table B.3.   (Continued) 
C(15)-C(14)-H(14B) 108.6 
H(14A)-C(14)-H(14B) 107.6 
C(16)-C(15)-C(14) 116.3(7) 
C(16)-C(15)-H(15A) 108.2 
C(14)-C(15)-H(15A) 108.2 
C(16)-C(15)-H(15B) 108.2 
C(14)-C(15)-H(15B) 108.2 
H(15A)-C(15)-H(15B) 107.4 
C(15)-C(16)-C(17) 105.8(10) 
C(15)-C(16)-H(16A) 110.6 
C(17)-C(16)-H(16A) 110.6 
C(15)-C(16)-H(16B) 110.6 
C(17)-C(16)-H(16B) 110.6 
H(16A)-C(16)-H(16B) 108.7 
C(18)-C(17)-C(16) 112.8(14) 
C(18)-C(17)-H(17A) 109.0 
C(16)-C(17)-H(17A) 109.0 
C(18)-C(17)-H(17B) 109.0 
C(16)-C(17)-H(17B) 109.0 
H(17A)-C(17)-H(17B) 107.8 
C(17)-C(18)-C(13) 111.3(13) 
C(17)-C(18)-H(18A) 109.4 
C(13)-C(18)-H(18A) 109.4 
C(17)-C(18)-H(18B) 109.4 
C(13)-C(18)-H(18B) 109.4 
H(18A)-C(18)-H(18B) 108.0 
C(15')-C(14')-H(14C) 109.3 
C(15')-C(14')-H(14D) 109.3 
H(14C)-C(14')-H(14D) 107.9 
C(14')-C(15')-C(16') 105.7(8) 
C(14')-C(15')-H(15C) 110.6 
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Table B.3.   (Continued) 
C(16')-C(15')-H(15C) 110.6 
C(14')-C(15')-H(15D) 110.6 
C(16')-C(15')-H(15D) 110.6 
H(15C)-C(15')-H(15D) 108.7 
C(17')-C(16')-C(15') 108.8(11) 
C(17')-C(16')-H(16C) 109.9 
C(15')-C(16')-H(16C) 109.9 
C(17')-C(16')-H(16D) 109.9 
C(15')-C(16')-H(16D) 109.9 
H(16C)-C(16')-H(16D) 108.3 
C(16')-C(17')-C(18') 104.0(17) 
C(16')-C(17')-H(17C) 110.9 
C(18')-C(17')-H(17C) 110.9 
C(16')-C(17')-H(17D) 110.9 
C(18')-C(17')-H(17D) 110.9 
H(17C)-C(17')-H(17D) 109.0 
C(17')-C(18')-H(18C) 108.7 
C(17')-C(18')-H(18D) 108.7 
H(18C)-C(18')-H(18D) 107.6 
 
Symmetry transformations used to generate equivalent atoms:  
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 Table B.4.   Anisotropic displacement parameters  (Å2x 103) for 2.64a.  The anisotropic 
displacement factor exponent takes the form:  -2pi
2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22  U33 U23 U13 U12 
 
O(1) 40(1)  40(1) 36(1)  10(1) -1(1)  -11(1) 
O(2) 44(1)  42(1) 37(1)  10(1) 3(1)  -2(1) 
O(3) 37(1)  47(1) 47(1)  -15(1) 6(1)  -2(1) 
C(1) 33(1)  27(2) 28(2)  6(1) 9(1)  7(1) 
C(2) 52(2)  51(2) 44(2)  -9(2) 24(2)  -10(2) 
C(3) 47(2)  49(2) 55(2)  8(2) 30(2)  5(2) 
C(4) 27(1)  49(2) 46(2)  13(2) 3(1)  0(1) 
C(5) 30(1)  76(2) 42(2)  -8(2) -1(1)  -6(2) 
C(6) 30(1)  44(2) 39(2)  -11(1) 4(1)  3(1) 
C(7) 40(1)  35(2) 27(2)  0(1) 6(1)  -6(1) 
C(8) 33(1)  30(2) 31(2)  -2(1) 2(1)  -2(1) 
C(9) 38(2)  36(2) 23(2)  -2(1) 7(1)  -5(1) 
C(10) 34(1)  35(2) 36(2)  -1(1) 8(1)  -5(1) 
C(11) 32(1)  40(2) 39(2)  7(1) 4(1)  -1(1) 
C(12) 39(2)  51(2) 38(2)  -11(2) 6(1)  -4(1) 
C(13) 33(2)  60(2) 63(2)  9(2) -1(2)  -14(2) 
C(14) 36(4)  50(6) 57(6)  -25(4) -3(4)  -14(4) 
C(15) 32(3)  93(6) 61(6)  -28(5) -4(3)  8(4) 
C(16) 27(5)  52(8) 107(9)  -44(7) -8(5)  11(5) 
C(17) 42(5)  118(14) 61(6)  -44(11) 1(4)  -4(10) 
C(18) 53(6)  79(11) 54(7)  -31(6) -8(5)  -34(6) 
C(13') 33(2)  60(2) 63(2)  9(2) -1(2)  -14(2) 
C(14') 43(4)  82(8) 64(8)  -32(5) 18(5)  -18(5) 
C(15') 52(4)  120(8) 73(8)  -60(7) 24(4)  -26(5) 
C(16') 19(4)  59(9) 170(15)  -55(9) -12(6)  12(6) 
C(17') 39(8)  94(12) 87(10)  -43(10) -16(7)  -10(10) 
C(18') 34(5)  63(10) 54(6)  -36(7) 17(4)  -11(6) 
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 Table B.5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 3) for 2.64a. 
 
 x  y  z  U(eq) 
 
H(1A) 6522 2124 10971 35 
H(2A) 6866 1922 8879 57 
H(2B) 6740 3476 8653 57 
H(3C) 8214 3042 8933 59 
H(3D) 8093 2279 10229 59 
H(4A) 8630 4391 10708 49 
H(4B) 7862 5059 9837 49 
H(5A) 7534 5227 11940 60 
H(5B) 7655 3666 12135 60 
H(6A) 6166 4137 11855 45 
H(6B) 6299 4893 10561 45 
H(7A) 5190 3486 9493 40 
H(7B) 5360 1942 9312 40 
H(8) 4849 3061 11649 37 
H(11A) 3400 2784 8947 44 
H(12A) 2578 445 9786 51 
H(12B) 2971 506 8491 51 
H(13A) 1885 2054 7880 63 
H(14A) 1551 2967 9636 57 
H(14B) 1097 1631 10044 57 
H(15A) 70 3158 9177 75 
H(15B) 537 3171 7887 75 
H(16A) -667 1934 7587 75 
H(16B) -401 1055 8816 75 
H(17A) 112 -224 6976 89 
H(17B) 581 1056 6463 89 
H(18A) 1644 -257 7331 75 
H(18B) 1141 -485 8579 75 
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Table B.5.   (Continued) 
 
H(13B) 1824 2354 8220 63 
H(14C) 1258 726 10333 75 
H(14D) 1532 2250 10458 75 
H(15C) 278 2910 9261 97 
H(15D) -23 1925 10336 97 
H(16C) 13 26 8774 100 
H(16D) -703 1095 8293 100 
H(17C) 360 2101 7139 89 
H(17D) 99 633 6661 89 
H(18C) 1302 -238 8113 59 
H(18D) 1647 606 6982 59 
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APPENDIX C SINGLE CRYSTAL X-RAY 
STRUCTURE OF TETRONATE 3.20 
 
Table C.1.  Crystal data and structure refinement for 3.20. 
Identification code  dr35a 
Empirical formula  C18H28O3 
Formula weight  292.40 
Temperature  110(2) K 
Wavelength  1.54178 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 14.447(3) Å α= 90°. 
 b = 9.549(2) Å β= 95.406(13)°. 
 c = 12.138(3) Å γ = 90°. 
Volume 1667.1(7) Å3 
Z 4 
Density (calculated) 1.165 Mg/m3 
Absorption coefficient 0.611 mm-1 
F(000) 640 
Crystal size 0.10 x 0.01 x 0.01 mm
3
 
Theta range for data collection 5.91 to 59.99°. 
Index ranges -16<=h<=16, -10<=k<=9, -13<=l<=13 
Reflections collected 10030 
Independent reflections 2161 [R(int) = 0.0815] 
Completeness to theta = 59.99° 87.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9939 and 0.9414 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 2161 / 0 / 192 
Goodness-of-fit on F
2
 1.034 
Final R indices [I>2sigma(I)] R1 = 0.0822, wR2 = 0.1805 
R indices (all data) R1 = 0.1106, wR2 = 0.1973 
Extinction coefficient 0.0023(6) 
Largest diff. peak and hole 0.409 and -0.255 e.Å-3 
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Table C.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) 
for 3.20.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
 
O(1) 6234(2) 1222(3) 9141(2) 21(1) 
O(2) 5675(2) 1033(3) 10812(2) 21(1) 
O(3) 4885(2) 3987(3) 7717(2) 25(1) 
C(1) 5634(3) 1628(5) 9894(3) 20(1) 
C(2) 5019(3) 2757(5) 9453(3) 16(1) 
C(3) 5268(3) 3024(5) 8420(3) 17(1) 
C(4) 6099(3) 2131(5) 8170(3) 17(1) 
C(5) 4291(3) 3426(5) 10087(4) 21(1) 
C(6) 3465(3) 2436(5) 10289(3) 18(1) 
C(7) 2902(3) 1995(5) 9208(4) 24(1) 
C(8) 2071(3) 1039(5) 9407(4) 26(1) 
C(9) 1453(3) 1696(6) 10224(4) 27(1) 
C(10) 2009(3) 2145(6) 11302(4) 26(1) 
C(11) 2823(3) 3128(5) 11071(4) 22(1) 
C(12) 6993(3) 2977(5) 8073(4) 20(1) 
C(13) 7843(3) 2079(5) 7813(4) 21(1) 
C(14) 8748(3) 2953(6) 8019(4) 27(1) 
C(15) 9611(3) 2109(6) 7740(4) 33(1) 
C(16) 9500(3) 1564(6) 6544(4) 32(1) 
C(17) 8609(3) 683(5) 6353(4) 26(1) 
C(18) 7744(3) 1524(5) 6618(4) 25(1) 
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Table C.3.   Bond lengths [Å] and angles [°] for  3.20. 
 O(1)-C(1)  1.373(5) 
O(1)-C(4)  1.462(5) 
O(2)-C(1)  1.247(5) 
O(3)-C(3)  1.339(5) 
C(1)-C(2)  1.466(6) 
C(2)-C(3)  1.361(6) 
C(2)-C(5)  1.503(6) 
C(3)-C(4)  1.525(6) 
C(4)-C(12)  1.538(6) 
C(5)-C(6)  1.559(6) 
C(6)-C(7)  1.536(6) 
C(6)-C(11)  1.538(6) 
C(7)-C(8)  1.545(7) 
C(8)-C(9)  1.530(6) 
C(9)-C(10)  1.531(7) 
C(10)-C(11)  1.550(6) 
C(12)-C(13)  1.554(6) 
C(13)-C(18)  1.538(6) 
C(13)-C(14)  1.551(6) 
C(14)-C(15)  1.548(7) 
C(15)-C(16)  1.536(7) 
C(16)-C(17)  1.537(6) 
C(17)-C(18)  1.545(6) 
C(1)-O(1)-C(4) 108.9(3) 
O(2)-C(1)-O(1) 119.1(4) 
O(2)-C(1)-C(2) 129.6(4) 
O(1)-C(1)-C(2) 111.4(4) 
C(3)-C(2)-C(1) 105.6(4) 
C(3)-C(2)-C(5) 130.6(4) 
C(1)-C(2)-C(5) 123.8(4) 
O(3)-C(3)-C(2) 126.0(4) 
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Table C.3.   (Continued) 
O(3)-C(3)-C(4) 122.8(4) 
C(2)-C(3)-C(4) 111.1(4) 
O(1)-C(4)-C(3) 102.6(3) 
O(1)-C(4)-C(12) 108.9(3) 
C(3)-C(4)-C(12) 113.8(4) 
C(2)-C(5)-C(6) 113.9(4) 
C(7)-C(6)-C(11) 110.1(3) 
C(7)-C(6)-C(5) 112.6(4) 
C(11)-C(6)-C(5) 110.6(4) 
C(6)-C(7)-C(8) 112.7(4) 
C(9)-C(8)-C(7) 111.6(4) 
C(8)-C(9)-C(10) 112.2(4) 
C(9)-C(10)-C(11) 111.1(4) 
C(6)-C(11)-C(10) 111.4(4) 
C(4)-C(12)-C(13) 114.3(4) 
C(18)-C(13)-C(14) 109.8(4) 
C(18)-C(13)-C(12) 112.1(4) 
C(14)-C(13)-C(12) 109.9(4) 
C(15)-C(14)-C(13) 111.6(4) 
C(16)-C(15)-C(14) 111.6(4) 
C(15)-C(16)-C(17) 109.8(4) 
C(16)-C(17)-C(18) 111.5(4) 
C(13)-C(18)-C(17) 111.7(4) 
Symmetry transformations used to generate equivalent atoms:  
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 Table C.4.   Anisotropic displacement parameters  (Å2x 103) for dr35a.  The anisotropic 
displacement factor exponent takes the form:  -2pi
2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22  U33 U23 U13 U12 
O(1) 24(2)  21(2) 20(2)  2(1) 11(1)  5(1) 
O(2) 25(2)  20(2) 20(2)  6(1) 7(1)  1(1) 
O(3) 28(2)  29(2) 18(2)  3(1) 4(1)  8(2) 
C(1) 21(2)  23(3) 15(2)  -5(2) 5(2)  0(2) 
C(2) 17(2)  16(2) 17(2)  2(2) 4(2)  1(2) 
C(3) 18(2)  18(2) 15(2)  3(2) 1(2)  0(2) 
C(4) 15(2)  20(3) 15(2)  5(2) 4(2)  -3(2) 
C(5) 24(2)  24(3) 16(2)  1(2) 4(2)  4(2) 
C(6) 18(2)  19(3) 18(2)  1(2) 6(2)  0(2) 
C(7) 22(2)  27(3) 22(3)  -4(2) 1(2)  7(2) 
C(8) 24(2)  30(3) 23(2)  -2(2) -1(2)  1(2) 
C(9) 19(2)  31(3) 33(3)  1(2) 3(2)  -2(2) 
C(10) 16(2)  35(3) 29(3)  0(2) 13(2)  -3(2) 
C(11) 21(2)  26(3) 19(2)  -2(2) 7(2)  0(2) 
C(12) 16(2)  24(3) 20(2)  5(2) 8(2)  -1(2) 
C(13) 20(2)  18(3) 24(2)  4(2) 2(2)  3(2) 
C(14) 19(2)  35(3) 26(3)  -5(2) 2(2)  -5(2) 
C(15) 15(2)  51(4) 34(3)  -4(2) 6(2)  -3(2) 
C(16) 22(2)  34(3) 41(3)  -4(2) 12(2)  0(2) 
C(17) 22(2)  25(3) 33(3)  -6(2) 11(2)  -4(2) 
C(18) 17(2)  32(3) 24(2)  -4(2) 4(2)  0(2) 
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 Table C.5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 
3) for 3.20. 
 
 
 x  y  z  U(eq) 
H(3) 5105 3904 7103 37 
H(4) 5942 1561 7486 20 
H(5A) 4043 4261 9676 25 
H(5B) 4587 3748 10812 25 
H(6) 3730 1570 10658 22 
H(7A) 3316 1495 8735 28 
H(7B) 2667 2844 8805 28 
H(8A) 1697 865 8695 31 
H(8B) 2307 126 9701 31 
H(9A) 972 1011 10395 33 
H(9B) 1133 2523 9876 33 
H(10A) 2258 1305 11705 31 
H(10B) 1592 2636 11778 31 
H(11A) 2569 4009 10735 26 
H(11B) 3187 3365 11778 26 
H(12A) 7153 3483 8777 24 
H(12B) 6871 3686 7482 24 
H(13) 7890 1258 8327 25 
H(14A) 8692 3809 7557 32 
H(14B) 8831 3245 8804 32 
H(15A) 10169 2713 7845 39 
H(15B) 9705 1306 8255 39 
H(16A) 10045 986 6404 38 
H(16B) 9467 2364 6023 38 
H(17A) 8670 -161 6828 31 
H(17B) 8528 371 5572 31 
H(18A) 7652 2323 6099 29 
H(18B) 7187 917 6509 29 
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APPENDIX D  SINGLE CRYSTAL X-RAY  
STRUCTURE OF TRIFLATE 3.55 
 
Absolute Configuration :   
 
The absolute configuration (stereochemistry) at position C4 is S. 
The absolute configuration was determined from the anomalous x-ray scattering from the 
heavy atom (Sulfur). 
 
The FLACK parameter was -0.003 ± .009 where a value of zero represents the correct 
structure and a value of one represents the inverted structure. The parameter was 
determined from the refinement of 7000 Bjvioet pairs (TWIN/BASF, SHELX97). [See 
Flack, Bernardinelli J. Applied Crystallograpy (2000). 33, 1143-1148.] 
 
A second crystal was examined and the FLACK parameter of 0.01 ± .001 was determined 
for the structure. 
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Table D.1.  Crystal data and structure refinement for 3.55. 
Identification code  dr37 
Empirical formula  C19H15F3O5S 
Formula weight  412.37 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.0114(8) Å α= 90°. 
 b = 7.4934(7) Å β= 90°. 
 c = 34.767(3) Å γ = 90°. 
Volume 1826.6(3) Å3 
Z 4 
Density (calculated) 1.500 Mg/m3 
Absorption coefficient 2.125 mm-1 
F(000) 848 
Crystal size 0.20 x 0.04 x 0.01 mm
3
 
Theta range for data collection 2.54 to 58.93°. 
Index ranges -7<=h<=7, -8<=k<=8, -38<=l<=38 
Reflections collected 20057 
Independent reflections 20057 [R(int) = 0.0000] 
Completeness to theta = 58.93° 99.9 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9791 and 0.6760 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 20057 / 0 / 313 
Goodness-of-fit on F
2
 1.068 
Final R indices [I>2sigma(I)] R1 = 0.0313, wR2 = 0.0802 
R indices (all data) R1 = 0.0356, wR2 = 0.0847 
Absolute structure parameter -0.003(9) 
Largest diff. peak and hole 0.176 and -0.271 e.Å-3 
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Table D.2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement 
parameters (Å2x 103) 
for 3.55.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
 
 x y z U(eq) 
 
S(1) 3586(1) 5481(1) 9664(1) 21(1) 
F(1) 2776(1) 3602(1) 10260(1) 27(1) 
F(2) 2006(1) 2358(1) 9723(1) 26(1) 
F(3) 303(1) 4507(1) 9947(1) 31(1) 
O(1) -1456(1) 8657(1) 9103(1) 18(1) 
O(2) -113(1) 11306(1) 8966(1) 24(1) 
O(3) 2486(1) 5628(1) 9268(1) 19(1) 
O(4) 3491(2) 7109(1) 9868(1) 30(1) 
O(5) 5310(1) 4572(1) 9586(1) 34(1) 
C(1) 80(2) 9754(2) 9038(1) 16(1) 
C(2) 1865(2) 8721(2) 9087(1) 16(1) 
C(3) 1310(2) 7118(2) 9193(1) 16(1) 
C(4) -812(2) 6877(2) 9202(1) 16(1) 
C(5) 3791(2) 9501(2) 9022(1) 21(1) 
C(6) 4147(2) 10116(2) 8610(1) 17(1) 
C(7) 3203(2) 9344(2) 8301(1) 19(1) 
C(8) 3616(2) 9862(2) 7927(1) 22(1) 
C(9) 4986(2) 11142(2) 7858(1) 26(1) 
C(10) 5940(2) 11924(2) 8164(1) 28(1) 
C(11) 5508(2) 11413(2) 8538(1) 24(1) 
C(13) 2061(2) 3871(2) 9912(1) 20(1) 
C(14) -1592(2) 5498(2) 8921(1) 18(1) 
C(15) -918(2) 5726(2) 8516(1) 16(1) 
C(16) -1835(2) 6909(2) 8270(1) 20(1) 
C(17) -1232(2) 7119(2) 7893(1) 25(1) 
C(18) 292(2) 6134(2) 7756(1) 24(1) 
C(19) 1227(2) 4968(2) 7998(1) 24(1) 
C(20) 623(2) 4756(2) 8375(1) 19(1) 
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Table D.3.   Bond lengths [Å] and angles [°] for  3.55. 
S(1)-O(4)  1.4120(8) 
S(1)-O(5)  1.4138(9) 
S(1)-O(3)  1.5823(8) 
S(1)-C(13)  1.8282(13) 
F(1)-C(13)  1.3225(13) 
F(2)-C(13)  1.3115(12) 
F(3)-C(13)  1.3272(15) 
O(1)-C(1)  1.3734(15) 
O(1)-C(4)  1.4497(14) 
O(2)-C(1)  1.1974(13) 
O(3)-C(3)  1.4123(13) 
C(1)-C(2)  1.4813(17) 
C(2)-C(3)  1.3154(16) 
C(2)-C(5)  1.4891(18) 
C(3)-C(4)  1.4990(18) 
C(4)-C(14)  1.5240(17) 
C(5)-C(6)  1.5230(16) 
C(6)-C(11)  1.3849(18) 
C(6)-C(7)  1.3887(16) 
C(7)-C(8)  1.3872(16) 
C(8)-C(9)  1.3786(18) 
C(9)-C(10)  1.3866(19) 
C(10)-C(11)  1.3885(18) 
C(14)-C(15)  1.4966(15) 
C(15)-C(16)  1.3897(17) 
C(15)-C(20)  1.3915(17) 
C(16)-C(17)  1.3846(18) 
C(17)-C(18)  1.3832(19) 
C(18)-C(19)  1.3791(18) 
C(19)-C(20)  1.3836(16) 
O(4)-S(1)-O(5) 123.53(6) 
O(4)-S(1)-O(3) 110.70(5) 
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Table D.3 (Continued) 
O(5)-S(1)-O(3) 106.49(5) 
O(4)-S(1)-C(13) 107.80(6) 
O(5)-S(1)-C(13) 105.81(6) 
O(3)-S(1)-C(13) 99.89(5) 
C(1)-O(1)-C(4) 110.22(10) 
C(3)-O(3)-S(1) 119.96(7) 
O(2)-C(1)-O(1) 121.80(12) 
O(2)-C(1)-C(2) 128.84(12) 
O(1)-C(1)-C(2) 109.32(9) 
C(3)-C(2)-C(1) 105.03(11) 
C(3)-C(2)-C(5) 132.03(12) 
C(1)-C(2)-C(5) 122.94(10) 
C(2)-C(3)-O(3) 126.93(12) 
C(2)-C(3)-C(4) 114.18(11) 
O(3)-C(3)-C(4) 118.71(10) 
O(1)-C(4)-C(3) 101.13(10) 
O(1)-C(4)-C(14) 111.01(10) 
C(3)-C(4)-C(14) 115.14(11) 
C(2)-C(5)-C(6) 114.27(11) 
C(11)-C(6)-C(7) 118.70(11) 
C(11)-C(6)-C(5) 119.67(11) 
C(7)-C(6)-C(5) 121.55(12) 
C(8)-C(7)-C(6) 120.64(13) 
C(9)-C(8)-C(7) 120.18(12) 
C(8)-C(9)-C(10) 119.80(12) 
C(9)-C(10)-C(11) 119.76(14) 
C(6)-C(11)-C(10) 120.91(12) 
F(2)-C(13)-F(1) 109.73(9) 
F(2)-C(13)-F(3) 109.12(10) 
F(1)-C(13)-F(3) 108.96(10) 
F(2)-C(13)-S(1) 110.53(8) 
F(1)-C(13)-S(1) 108.06(9) 
F(3)-C(13)-S(1) 110.41(8) 
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Table D.3 (Continued) 
C(15)-C(14)-C(4) 114.43(11) 
C(16)-C(15)-C(20) 118.37(11) 
C(16)-C(15)-C(14) 120.43(12) 
C(20)-C(15)-C(14) 121.19(11) 
C(17)-C(16)-C(15) 120.88(13) 
C(18)-C(17)-C(16) 120.02(13) 
C(19)-C(18)-C(17) 119.70(12) 
C(18)-C(19)-C(20) 120.26(13) 
C(19)-C(20)-C(15) 120.75(12) 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
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Table D.4.   Anisotropic displacement parameters  (Å2x 103) for 3.55.  The anisotropic 
displacement factor exponent takes the form:  -2pi
2[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
 
 U11 U22  U33 U23 U13 U12 
S(1) 17(1)  26(1) 19(1)  8(1) -2(1)  -2(1) 
F(1) 37(1)  32(1) 14(1)  7(1) -3(1)  -7(1) 
F(2) 33(1)  20(1) 25(1)  -2(1) -1(1)  -1(1) 
F(3) 24(1)  30(1) 40(1)  9(1) 13(1)  6(1) 
O(1) 14(1)  17(1) 22(1)  0(1) 1(1)  1(1) 
O(2) 25(1)  18(1) 28(1)  2(1) -2(1)  3(1) 
O(3) 20(1)  23(1) 13(1)  1(1) -3(1)  8(1) 
O(4) 43(1)  24(1) 22(1)  3(1) -12(1)  -11(1) 
O(5) 14(1)  50(1) 38(1)  22(1) 5(1)  12(1) 
C(1) 17(1)  18(1) 12(1)  -1(1) -1(1)  -1(1) 
C(2) 16(1)  20(1) 11(1)  -2(1) -2(1)  1(1) 
C(3) 15(1)  19(1) 13(1)  -2(1) -2(1)  6(1) 
C(4) 16(1)  16(1) 16(1)  3(1) 3(1)  3(1) 
C(5) 16(1)  25(1) 21(1)  -2(1) -2(1)  0(1) 
C(6) 12(1)  18(1) 23(1)  -1(1) 0(1)  3(1) 
C(7) 14(1)  19(1) 24(1)  -1(1) 0(1)  -3(1) 
C(8) 18(1)  25(1) 23(1)  -2(1) -3(1)  0(1) 
C(9) 23(1)  29(1) 25(1)  6(1) 2(1)  0(1) 
C(10) 20(1)  27(1) 38(1)  5(1) 2(1)  -6(1) 
C(11) 21(1)  24(1) 27(1)  -3(1) -5(1)  -3(1) 
C(13) 23(1)  21(1) 16(1)  -2(1) 0(1)  3(1) 
C(14) 18(1)  15(1) 22(1)  1(1) 3(1)  -3(1) 
C(15) 15(1)  15(1) 17(1)  -2(1) -1(1)  -5(1) 
C(16) 16(1)  21(1) 22(1)  -3(1) -2(1)  2(1) 
C(17) 28(1)  25(1) 21(1)  2(1) -5(1)  -2(1) 
C(18) 28(1)  31(1) 13(1)  -3(1) 2(1)  -6(1) 
C(19) 20(1)  27(1) 25(1)  -9(1) 5(1)  2(1) 
C(20) 22(1)  17(1) 19(1)  -2(1) -5(1)  5(1) 
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Table D.5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (Å2x 
10 
3) for 3.55. 
 
 x  y  z  U(eq) 
H(4) -1306(17) 6650(12) 9455(3) 10(3) 
H(5A) 3917(18) 10476(16) 9204(3) 34(4) 
H(5B) 4790(20) 8661(17) 9100(3) 33(4) 
H(7) 2261(18) 8488(15) 8339(3) 22(4) 
H(8) 2946(16) 9333(13) 7724(3) 13(3) 
H(9) 5210(20) 11484(17) 7603(3) 39(4) 
H(10) 6820(20) 12801(18) 8131(4) 42(4) 
H(11) 6105(19) 11943(15) 8745(3) 25(4) 
H(14A) -1294(18) 4359(15) 9010(3) 25(3) 
H(14B) -2990(18) 5539(15) 8932(3) 22(4) 
H(16) -2860(20) 7581(15) 8357(3) 28(4) 
H(17) -1894(19) 7977(15) 7721(4) 31(4) 
H(18) 730(18) 6258(15) 7495(3) 22(3) 
H(19) 2190(20) 4315(16) 7905(3) 35(4) 
H(20) 1169(17) 3962(14) 8523(3) 12(3) 
  
 218 
Table D.6.  Crystal data and structure refinement for 3.55 (xtal 1) and 3.55_2 (xtal2) 
Identification code  dr37 dr37_2nd xtal 
Empirical formula  C19H15F3O5S 
Formula weight  412.37 
Temperature  100(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 7.0114(8) Å a = 7.0153(5) Å  
 b = 7.4934(7) Å b = 7.4932(6) Å 
 c = 34.767(3) Å c = 34.774(3) Å  
Volume 1828.0(2) Å3 1826.6(3) Å3  
Z 4 
Density (calculated) 1.500 Mg/m3 1.498 Mg/m3 
Absorption coefficient 2.125 mm
-1
 2.123 mm
-1
 
F(000) 848 
Crystal size 0.20 x 0.04 x 0.01 mm
3
 0.04 x 0.04 x 0.01 mm
3
 
Theta range for data collection 2.54 to 58.93°. 2.54 to 58.93°. 
Index ranges -7<=h<=7, -8<=k<=8, -38<=l<=38
 -7<=h<=7, -8<=k<=8, -38<=l<=38 
Reflections collected 20057 19215 
Independent reflections 20057 [R(int) = 0.0000] 19215 [R(int) = 0.0000] 
Completeness to theta = 58.93° 99.9 %  99.6 % 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9791 and 0.6760 0.9791 and 0.9199 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 20057 / 0 / 313 19215 / 0 / 314 
Goodness-of-fit on F
2
 1.068 1.037 
Final R indices [I>2sigma(I)] R1 = 0.0313, wR2 = 0.0802 R1 = 0.0414, wR2 = 0.1027 
R indices (all data) R1 = 0.0356, wR2 = 0.0847 R1 = 0.0537, wR2 = 0.1141 
Absolute structure parameter -0.003(9) 0.01(1) 
Largest diff. peak and hole  0.176 and -0.271 e.Å-3  0.251 and -0.374 e.Å-3 
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APPENDIX E SINGLE CRYSTAL X-RAY  
STRUCTURE OF DIOL 4.23. 
 
Table E.1.  Crystal data and structure refinement for 4.23. 
Identification code  dr60a 
Empirical formula  C7H11Cl3O2 
Formula weight  233.51 
Temperature  110(2) K 
Wavelength  0.71073 Å 
Crystal system  Tetragonal 
Space group  I-4 
Unit cell dimensions a = 18.6042(4) Å α= 90°. 
 b = 18.6042(4) Å β= 90°. 
 c = 11.8256(3) Å γ = 90°. 
Volume 4093.03(16) Å3 
Z 16 
Density (calculated) 1.516 Mg/m3 
Absorption coefficient 0.855 mm-1 
F(000) 1920 
Crystal size 0.25 x 0.25 x 0.18 mm
3
 
Theta range for data collection 2.99 to 28.31°. 
Index ranges -24<=h<=24, -24<=k<=24, -15<=l<=15 
Reflections collected 29227 
Independent reflections 4181 [R(int) = 0.0353] 
Completeness to theta = 28.31° 84.0 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.8614 and 0.8147 
Refinement method Full-matrix least-squares on F
2
 
Data / restraints / parameters 4181 / 0 / 217 
Goodness-of-fit on F
2
 1.028 
Final R indices [I>2sigma(I)] R1 = 0.0467, wR2 = 0.1114 
R indices (all data) R1 = 0.0508, wR2 = 0.1149 
Absolute structure parameter -0.05(7) 
Largest diff. peak and hole 0.934 and -0.300 e.Å-3 
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Table E.2.  Atomic coordinates ( x 104) and equivalent isotropic displacement 
parameters (Å2x 103) for 4.23.  U(eq) is defined as one third of the trace of the 
orthogonalized U
ij
 tensor. 
 
 x y z U(eq) 
 
Cl(1A) 8874(1) 999(1) 344(1) 35(1) 
Cl(2A) 8098(1) 1682(1) 2181(1) 32(1) 
Cl(3A) 7983(1) 148(1) 1820(1) 31(1) 
O(1A) 11557(1) 578(1) 4528(2) 28(1) 
O(2A) 8982(1) 686(1) 3679(2) 28(1) 
C(1A) 11690(2) 1226(2) 3913(3) 29(1) 
C(2A) 11069(2) 1478(2) 3200(3) 25(1) 
C(3A) 10433(2) 1148(2) 3209(3) 26(1) 
C(4A) 9786(2) 1365(2) 2530(3) 25(1) 
C(5A) 9219(2) 760(2) 2553(3) 24(1) 
C(6A) 8570(2) 906(2) 1766(3) 25(1) 
C(7A) 11237(2) 2140(2) 2506(3) 32(1) 
Cl(1B) 9355(1) 7129(1) 5462(1) 37(1) 
Cl(2B) 7909(1) 6581(1) 5341(1) 46(1) 
Cl(3B) 8882(1) 6065(1) 7073(1) 47(1) 
O(1B) 9716(1) 3386(1) 2997(2) 26(1) 
O(2B) 9079(1) 5985(1) 3718(2) 28(1) 
C(1B) 9116(2) 3177(2) 3676(3) 27(1) 
C(2B) 8771(2) 3772(2) 4349(3) 24(1) 
C(3B) 8978(2) 4457(2) 4275(3) 25(1) 
C(4B) 8628(2) 5064(2) 4927(3) 27(1) 
C(5B) 9085(2) 5748(2) 4850(3) 24(1) 
C(6B) 8813(2) 6354(2) 5631(3) 28(1) 
C(7B) 8169(2) 3523(2) 5096(3) 29(1) 
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Table E.3.   Bond lengths [Å] and angles [°] for 4.23. 
Cl(1A)-C(6A)  1.783(3) 
Cl(2A)-C(6A)  1.759(3) 
Cl(3A)-C(6A)  1.784(3) 
O(1A)-C(1A)  1.430(4) 
O(1A)-H(1AA)  0.8499 
O(2A)-C(5A)  1.409(4) 
O(2A)-H(2AA)  0.8500 
C(1A)-C(2A)  1.505(4) 
C(1A)-H(1AB)  0.9900 
C(1A)-H(1AC)  0.9900 
C(2A)-C(3A)  1.333(4) 
C(2A)-C(7A)  1.512(4) 
C(3A)-C(4A)  1.502(4) 
C(3A)-H(3AA)  0.9500 
C(4A)-C(5A)  1.542(4) 
C(4A)-H(4AA)  0.9900 
C(4A)-H(4AB)  0.9900 
C(5A)-C(6A)  1.548(4) 
C(5A)-H(5AA)  1.0000 
C(7A)-H(7AA)  0.9800 
C(7A)-H(7AB)  0.9800 
C(7A)-H(7AC)  0.9800 
Cl(1B)-C(6B)  1.771(3) 
Cl(2B)-C(6B)  1.767(4) 
Cl(3B)-C(6B)  1.792(4) 
O(1B)-C(1B)  1.430(4) 
O(1B)-H(1B)  0.8500 
O(2B)-C(5B)  1.409(4) 
O(2B)-H(2BA)  0.8499 
C(1B)-C(2B)  1.506(4) 
C(1B)-H(1BB)  0.9900 
C(1B)-H(1BC)  0.9900 
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Table E.3 (Continued) 
C(2B)-C(3B)  1.334(4) 
C(2B)-C(7B)  1.499(4) 
C(3B)-C(4B)  1.514(4) 
C(3B)-H(3BA)  0.9500 
C(4B)-C(5B)  1.533(4) 
C(4B)-H(4BA)  0.9900 
C(4B)-H(4BB)  0.9900 
C(5B)-C(6B)  1.544(4) 
C(5B)-H(5BA)  1.0000 
C(7B)-H(7BA)  0.9800 
C(7B)-H(7BB)  0.9800 
C(7B)-H(7BC)  0.9800 
C(1A)-O(1A)-H(1AA) 110.5 
C(5A)-O(2A)-H(2AA) 102.7 
O(1A)-C(1A)-C(2A) 114.5(3) 
O(1A)-C(1A)-H(1AB) 108.6 
C(2A)-C(1A)-H(1AB) 108.6 
O(1A)-C(1A)-H(1AC) 108.6 
C(2A)-C(1A)-H(1AC) 108.6 
H(1AB)-C(1A)-H(1AC) 107.6 
C(3A)-C(2A)-C(1A) 122.2(3) 
C(3A)-C(2A)-C(7A) 124.2(3) 
C(1A)-C(2A)-C(7A) 113.6(3) 
C(2A)-C(3A)-C(4A) 125.7(3) 
C(2A)-C(3A)-H(3AA) 117.1 
C(4A)-C(3A)-H(3AA) 117.1 
C(3A)-C(4A)-C(5A) 110.1(3) 
C(3A)-C(4A)-H(4AA) 109.6 
C(5A)-C(4A)-H(4AA) 109.6 
C(3A)-C(4A)-H(4AB) 109.6 
C(5A)-C(4A)-H(4AB) 109.6 
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Table E.3 (Continued) 
H(4AA)-C(4A)-H(4AB) 108.2 
O(2A)-C(5A)-C(4A) 107.6(2) 
O(2A)-C(5A)-C(6A) 110.0(2) 
C(4A)-C(5A)-C(6A) 113.2(2) 
O(2A)-C(5A)-H(5AA) 108.6 
C(4A)-C(5A)-H(5AA) 108.6 
C(6A)-C(5A)-H(5AA) 108.6 
C(5A)-C(6A)-Cl(2A) 111.4(2) 
C(5A)-C(6A)-Cl(1A) 109.7(2) 
Cl(2A)-C(6A)-Cl(1A) 109.95(17) 
C(5A)-C(6A)-Cl(3A) 108.5(2) 
Cl(2A)-C(6A)-Cl(3A) 109.47(17) 
Cl(1A)-C(6A)-Cl(3A) 107.69(16) 
C(2A)-C(7A)-H(7AA) 109.5 
C(2A)-C(7A)-H(7AB) 109.5 
H(7AA)-C(7A)-H(7AB) 109.5 
C(2A)-C(7A)-H(7AC) 109.5 
H(7AA)-C(7A)-H(7AC) 109.5 
H(7AB)-C(7A)-H(7AC) 109.5 
C(1B)-O(1B)-H(1B) 100.5 
C(5B)-O(2B)-H(2BA) 109.3 
O(1B)-C(1B)-C(2B) 115.5(3) 
O(1B)-C(1B)-H(1BB) 108.4 
C(2B)-C(1B)-H(1BB) 108.4 
O(1B)-C(1B)-H(1BC) 108.4 
C(2B)-C(1B)-H(1BC) 108.4 
H(1BB)-C(1B)-H(1BC) 107.5 
C(3B)-C(2B)-C(7B) 123.3(3) 
C(3B)-C(2B)-C(1B) 123.0(3) 
C(7B)-C(2B)-C(1B) 113.7(3) 
C(2B)-C(3B)-C(4B) 123.8(3) 
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Table E.3 (Continued) 
C(2B)-C(3B)-H(3BA) 118.1 
C(4B)-C(3B)-H(3BA) 118.1 
C(3B)-C(4B)-C(5B) 110.6(3) 
C(3B)-C(4B)-H(4BA) 109.5 
C(5B)-C(4B)-H(4BA) 109.5 
C(3B)-C(4B)-H(4BB) 109.5 
C(5B)-C(4B)-H(4BB) 109.5 
H(4BA)-C(4B)-H(4BB) 108.1 
O(2B)-C(5B)-C(4B) 108.1(2) 
O(2B)-C(5B)-C(6B) 109.8(3) 
C(4B)-C(5B)-C(6B) 112.9(3) 
O(2B)-C(5B)-H(5BA) 108.7 
C(4B)-C(5B)-H(5BA) 108.7 
C(6B)-C(5B)-H(5BA) 108.7 
C(5B)-C(6B)-Cl(2B) 111.8(2) 
C(5B)-C(6B)-Cl(1B) 109.8(2) 
Cl(2B)-C(6B)-Cl(1B) 109.02(18) 
C(5B)-C(6B)-Cl(3B) 109.1(2) 
Cl(2B)-C(6B)-Cl(3B) 108.99(18) 
Cl(1B)-C(6B)-Cl(3B) 108.10(17) 
C(2B)-C(7B)-H(7BA) 109.5 
C(2B)-C(7B)-H(7BB) 109.5 
H(7BA)-C(7B)-H(7BB) 109.5 
C(2B)-C(7B)-H(7BC) 109.5 
H(7BA)-C(7B)-H(7BC) 109.5 
H(7BB)-C(7B)-H(7BC) 109.5 
Symmetry transformations used to generate equivalent atoms:  
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Table E.4.   Anisotropic displacement parameters (Å2x 103) for 4.23.  The anisotropic 
displacement factor exponent takes the form: -2pi
2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
 
 U11 U22 U33 U23 U13 U12 
Cl(1A) 36(1)  43(1) 25(1)  2(1) -2(1)  -1(1) 
Cl(2A) 28(1)  27(1) 40(1)  -6(1) -7(1)  4(1) 
Cl(3A) 30(1)  28(1) 35(1)  -1(1) -7(1)  -3(1) 
O(1A) 25(1)  32(1) 27(1)  1(1) 2(1)  2(1) 
O(2A) 27(1)  31(1) 27(1)  2(1) 0(1)  -4(1) 
C(1A) 21(1)  31(2) 35(2)  -3(1) -1(1)  -4(1) 
C(2A) 24(1)  26(1) 24(1)  0(1) 3(1)  1(1) 
C(3A) 23(1)  28(1) 27(1)  2(1) -1(1)  2(1) 
C(4A) 22(1)  25(1) 29(1)  1(1) -2(1)  -2(1) 
C(5A) 24(1)  22(1) 25(1)  -1(1) -5(1)  2(1) 
C(6A) 25(1)  26(1) 24(1)  -2(1) -3(1)  -5(1) 
C(7A) 29(2)  35(2) 32(2)  2(1) 5(1)  -5(1) 
Cl(1B) 43(1)  28(1) 40(1)  -9(1) 6(1)  -6(1) 
Cl(2B) 31(1)  37(1) 68(1)  -9(1) 6(1)  7(1) 
Cl(3B) 74(1)  43(1) 24(1)  -5(1) 6(1)  -5(1) 
O(1B) 24(1)  29(1) 25(1)  0(1) -1(1)  4(1) 
O(2B) 34(1)  29(1) 23(1)  -4(1) 0(1)  -7(1) 
C(1B) 28(2)  24(1) 30(2)  -1(1) -2(1)  -1(1) 
C(2B) 26(1)  22(1) 24(1)  3(1) -2(1)  -1(1) 
C(3B) 23(1)  24(1) 28(1)  -1(1) 1(1)  0(1) 
C(4B) 30(2)  22(1) 29(2)  -5(1) 3(1)  2(1) 
C(5B) 27(1)  22(1) 23(1)  -6(1) 2(1)  1(1) 
C(6B) 33(2)  24(1) 28(2)  -7(1) 1(1)  -4(1) 
C(7B) 31(2)  25(1) 31(2)  3(1) 6(1)  -2(1) 
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Table E.5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 
10
3) for 4.23. 
 
 x  y  z  U(eq) 
H(1AA) 11232 645 5023 34 
H(2AA) 8849 250 3706 42 
H(1AB) 12111 1151 3416 35 
H(1AC) 11815 1611 4458 35 
H(3AA) 10385 740 3687 31 
H(4AA) 9931 1461 1739 30 
H(4AB) 9577 1811 2847 30 
H(5AA) 9453 301 2314 29 
H(7AA) 10813 2275 2062 48 
H(7AB) 11639 2038 1996 48 
H(7AC) 11367 2537 3012 48 
H(1B) 9500 3565 2429 39 
H(2BA) 9481 6177 3562 42 
H(1BB) 9275 2798 4207 33 
H(1BC) 8746 2963 3176 33 
H(3BA) 9366 4570 3785 30 
H(4BA) 8574 4923 5729 32 
H(4BB) 8144 5159 4615 32 
H(5BA) 9591 5627 5065 29 
H(7BA) 7970 3935 5507 44 
H(7BB) 8352 3168 5637 44 
H(7BC) 7792 3303 4632 44 
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